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Abstract
c-Jun expression is down-regulated in v-Jun- and c-Jun-transformed 
chicken embryo fibroblasts. The down-regulation is a specific 
consequence of high Jun expression suggesting that c-jun, like several 
other immediate early genes, is subject to negative autoregulation.
The work in this thesis has attempted to define the consequences of and 
the molecular basis for Jun-mediated autorepression in vivo. c-Jun is the 
sole or predominant Jun family protein expressed in primary CEFs. 
Repression of endogenous p39 c-Jun in ASV17-transformed cultures 
results in the replacement of c-Jun-containing AP-1/TRE binding 
complexes with v-Jun-containing alternatives. The absence of auxiliary 
Jun family proteins facilitates the displacement and may contribute to the 
unique transforming activites of v-Jun (and c-Jun) in avian cells. v-Jun- 
mediated auto-repression is primarily directed at the level of transcription 
and correlates with specific changes in occupancy at the proximal junTRE 
and adjacent junRSRE binding sites in the c-jun promoter. In normal 
asynchronous cultures specific binding factors compete for the adjacent 
junTRE and junRSRE regulatory elements. In ASV17-transformed cells 
the junTRE is exclusively occupied by v-Jun-containing complexes and 
endogenous c-jun expression is down-regulated. The absence of 
junRSRE occupancy in ASV17-transformed cells is associated with high 
levels of the v-Jun oncoprotein which physically disrupt or inhibit the 
binding activity of junRSRE-specific complexes. Mutually exclusive binding 
at the junTRE and junRSRE or a Jun-dependent sequestration of specific 
accessory factors have been proposed to direct the single pattern of 
occupancy in ASV17-transformed cells and to, thereby, contribute to the 
down-regulation of endogenous c-jun expression.
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CHAPTER I - INTRODUCTION.
CHAPTER I.A. - INTRODUCTION
1
C-JUN - MODULAR DOMAINS AND KINETICS OF
EXPRESSION
LA-1 HISTORICAL BACKGROUND
c-jun was isolated as a retroviral transforming gene from Avian Sarcoma 
Virus 17 (ASV17), and derived its name from the Japanese translation of 
seventeen : Ju-nana (Maki et al, 87). v-Jun is expressed as a 65kD gag- 
Jun fusion protein. Homology between human c-Jun and v-Jun is 
approximately 80% but increases to 98% at the C-terminus (Bohmann et 
al, 87). This region also exhibits a 44% homology with the DNA binding 
domain of the yeast transactivator, GCN4 (Vogt et al, 87). Domain swap 
experiments between v-Jun and GCN4 revealed that v-Jun was able to 
functionally substitute for GCN4 in DNA binding assays, suggesting a role 
for v-Jun in transactivation (Struhl et al, 87).
The consensus binding site for GCN4 closely ressembles that of the 
mammalian transcription factor AP-1 (Activator Protein 1). AP-1 was 
originally identified as a DNA binding activity in HeLa cell extracts that 
recognized a specific enhancer element in the SV40 viral promoter (Angel 
et al, 87). The sequence, TGACTCA, is found in the upstream regions of 
many genes, and imparts sensitivity to phorbol esters such as 12-o- 
tetradecanoyl phorbol 13-acetate (TPA). Consequently, it has been 
named the TPA Response Element or the TRE (Lee et al, 87). The 
similarity between the DNA binding sites of GCN4 and AP-1 prompted an 
investigation into their relationship, which demonstrated that c-Jun was
capable of binding to a synthetic TRE and was contained within the AP-1 
transcription factor complex (Angel et al, 88(i)). Other proteins within the 
complex had not been identified, but the product of the cellular proto­
oncogene, c-fos, was a strong candidiate. c-fos, like c-jun, was isolated
as retroviral oncogene from two independent murine osteosarcoma viruses 
: Finkel Biskis Jinkins and Finkel Biskis Reilly (Reviewed in Curran, 91). c- 
Fos and v-Fos are nuclear phosphoproteins. c-Fos is more highly 
phosphorylated than v-Fos and is transiently induced in response to 
mitogenic, differentiation, and neural cell depolarizing stimuli. Both c-Fos 
and v-Fos form part of a nuclear protein complex of which the major Fos 
associated protein in fibroblasts is p39 (Curran et al, 85). From in vitro 
DNA binding and transactivation analyses it was proposed that the 
Fos/p39 complex played a role in gene regulation (Sambucetti et al, 86; 
Setoyama et al, 86). Specifically, the Fos/p39 complex was shown to 
interact with a DNA binding element within the promoter region of an 
adipocyte gene, aP2, that was subsequently identified as the recognition 
sequence for AP-1 (Distel etal, 87).
The availability of Jun-specific antisera facilitated immunological
comparisons between p39 and c-Jun, and revealed that they were 
identical. In addition, p39 c-Jun was shown to form a stable complex with 
c-Fos and v-Fos in the nucleus, and to bind DNA directly and specifically 
(Franza et al, 88; Rauscher et al, 88(i)). This provided conclusive 
evidence that the products of the proto-oncogenes c-fos and c-jun formed 
the major components of the mammalian transcription factor AP-1 
(Rauscher etal, 88(ii)). It has subsequently been shown that c-Jun and c- 
Fos belong to multigene families. Under different conditions individual 
members from both families contribute to the overall AP-1 activity in the 
cell (Nakabeppu etal, 88).
3l.A.2. JUN FUNCTIONAL DOMAINS
c-Jun is structurally arranged in modular domains that direct its hierarchical 
functions of dimerization, DNA binding, and transactivation.
I.A.2a Dimerization
c-Jun dimerization is mediated through a leucine zipper domain (Ransome 
et al, 89). The leucine zipper was initially described in the transcription 
factor C/EBP, as a heptad repeat of leucine residues capable of forming 
an alpha helix (Landshultz et al, 88). Leucine zippers have subsequently 
been identified in many other transcription factors, including the Fos and 
Jun multigene families, and are an absolute requirement for dimerization 
(Kouzarides etal, 89). The Coiled Coil model for dimerization describes an 
alignment of two parallel alpha helices (Kouzarides etal, 89). Hydrophobic 
interactions between extending leucine residues are proposed to stabilize 
the dimer. Additional interactions between two minor hydrophobic ridges 
and between charged nucleotide bases contribute to the overall stability 
and increase the specificity of dimerization (Kouzarides et al, 89; Smeal et 
al, 89).
In vitro analysis has shown that c-Jun is capable of homo and 
heterodimerization. c-Jun/c-Fos heterodimers are relatively more stable 
than c-Jun homodimers and exhibit a higher affinity for the TRE 
(Kouzarides et al, 88; Rauscher et al, 88(iii)). This has been partially 
attributed to ionic interactions between c-Fos and c-Jun which are not 
permitted within the c-Jun homodimer (O'Shea etal, 92, Smeal 89).
In vitro dimerization analysis has now been extended to include other 
members of the Fos and Jun gene families : FosB, Fra1, Fra2, FosB-
4short form, JunB, and JunD. This analysis has demonstrated that homo 
and heterodimerization between Jun and Fos family proteins is always 
permitted, but that dimerization between Fos family members is physically 
inhibited (Nakabeppu et al, 88). Interfamily dimerization generates a wide 
variety of different AP-1 transcription factors that specifically modulate 
gene expression through distinct but related AP-1 regulatory elements, 
thereby expanding the AP-1 mediated transcriptional response (Abate et 
al, 90(ii); Lamb et al, 91).
I.A.2b DNA Binding
AP1 DNA binding is absolutely dependent on the leucine zipper and an 
adjacent domain described as the basic region. The basic region consists 
of a cluster of basic amino acids which, upon dimerization, align to form 
the DNA contact surface (Rauscher et al, 88(ii)). In the presence of 
sequence-specific DNA, the basic regions adopt an alpha helical 
configuration (Patel etal, 90). The palindromic TRE sequence was initially 
described as the consensus AP-1 DNA binding site (Abate et al, 90(iii)), 
but subsequent analysis has shown that AP-1 dimers are capable of 
binding to a wide variety of TRE and TRE-like sites. Binding affinities vary 
for different AP-1 dimers, and include both the core and the flanking DNA 
sequences (Ryseck etal, 91)
From crystallographic analysis, sequence-specific AP-1 DNA binding is 
best described by the "Scissor Grip" model (Ellenberger et al, 92). In this 
model a continuous alpha helix is proposed to track the major groove of 
the dyad symmetrical binding site, contacting it at specific bases and 
phosphate oxygens as it wraps the DNA (Ellenberger et al, 92; Sauer et 
al, 90). The dimerization interphase is oriented almost perpendicular to the
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DNA axis in the shape of the letter T. Contacts between the palindromic 
half sites and the basic regions of each contributing monomer have been 
confirmed by UV cross linking experiments (Risse etal, 89).
I.A.2c Transactivation
Dimerization and DNA binding are essential for c-Jun transactivation. 
Transactivation activity has been mapped to several independent 
transactivation domains depending on the assay system used. Their 
functional integration is proposed to contribute to the overall complexity of 
the transcriptional response (Abate et al, 91). The major transactivation 
domains are discussed below.
- N-Terminal Domain
A cell-type-specific transactivation domain has been described at the 
extreme amino terminus of c-Jun (Alani et al, 91; Angel et al, 89). Similar 
assays in different cell types have failed to confirm this region as a 
transactivation domain (Baichwal et al, 90; Bohman et al, 89; Bos et al, 
90) and, consequently, its overall contribution to transactivation is not 
known.
- A2 Transactivation Domain
A2 was identified using an in vitro transcription assay as a constitutively 
active transactivation domain adjacent to the basic region (Bohman et al, 
89). Subsequent analysis failed to confirm A2 as a bonafide 
transactivation domain (Abate etal, 91; Alani etal, 91; Baichwal etal, 91;
6Hirai et al, 90), but did show that this region plays an important role in the 
regulation of AP-1 : DNA binding activity (Boyle etal, 91).
- delta (8) Domain
The 8 domain has been identified as a negative transactivation domain in 
vitro (Bohman et al, 89) and in vivo (Abate et al, 91; Bos et al, 90). From 
initial observations, it was proposed that the 8 domain facilitated or 
stabilized an interaction between c-Jun and a cell-type-specific inhibitor 
(Baichwal et al, 90). Subsequent experiments have shown that the 8 
domain overlaps with the binding site for a c-Jun amino terminal kinase, 
JNK, essential for the regulation of c-Jun transactivation activity (Hibi etal, 
93, section IV.A.2).
- A1 Transactivation Domain
A1 is a composite transactivation domain composed of two subdomains : 
a1 and E (Baichwal etal, 92). E is proposed to interact directly with a cell- 
type-specific inhibitor, thereby regulating the activity of the a1 
transactivation domain (section I.C.2a). The a1 transactivation domain is 
highly conserved within the Jun family (Abate et al, 91; Alani et al, 91; 
Baichwal et al, 91; Hirai et al, 90) but does not encompass serines 63 and 
73, whose phosphorylation has been positively associated with c-Jun 
transactivation in vitro and in vivo (Binetruy et al, 91; Hibi et al, 93). a1 
does contain multiple threonie residues that occur in a sequence known to 
be phosphorylated by proline-dependent protein kinases in vitro (Baichwal 
et al, 92). Two of these threonines, positioned directly adjacent to a 
proline residue, are phosphorylated by kinases isolated from Ha-ras 
transformed FR3T3 and UV irradiated HeLa cells. The same kinases have
7been associated with the phosphorylation of serines 63 and 73, which are 
also followed by a highly conserved proline residue in all characterized c- 
Jun amino acid sequences (Hibi etal, 93).
An independent transactivation domain, Homology Domain 2, has been 
identified that overlaps with the E region of the A1 transactivation domain 
(Sutherland et al, 92). HOB2 synnergizes with a second domain, 
Homology Domain 1, that encompasses serine 73. The functional 
activities of HOB domains 1 & 2 are discussed in section I.B.3a.
I.A.3. c-JUN EXPRESSION
I.A.3a Expression
c-jun was initially described as an immediate early gene as the mRNA was 
rapidly and transiently induced in response to serum growth factors and 
tumour promoters (Lamph et al, 88; Quantin et al, 88; Ryder et al, 88; 
Ryseck et al, 88) and superinduced in the presence of protein synthesis 
inhibitors (Greenberg etal, 86; Ryder etal, 88; Ryseck etal, 88). 
Subsequent analysis has revealed that c-jun expression is not exclusively 
characterized by immediate early gene kinetics. c-Jun mRNA has been 
observed at G1/S transitions (Carter et al, 91), and during differentiation 
as cells exit from the cell cycle. In embryonal carcinoma and embryonal 
stem cells, for example, differentiation is associated with a concomitant 
and prolonged increase in c-jun mRNA expression. Likewise, 
overexpression of c-Jun in these cells induces differentiation and the loss 
of the tumourigenic phenotype (de Groot et al, 90(i); de Groot et al, 90(ii); 
Yang-Yen et al, 90(ii)). Differentiation along the monocyte macrophage
8lineage is similarly associated with an increase in c-Jun expression. The 
pattern of expression reflects the nature of the inducing stimulus and is 
mediated through both transcriptional and post-transcriptional levels of 
control (Kharbanda e ta l, 92; Nakamura e ta l, 91; Sherman etal, 90).
I.C.3b Induction
Serum growth factors and tumour promoters were traditionally associated 
with the induction of c-jun and other immediate early genes (Lamph et al, 
88; Quantin et al, 88; Ryder et al, 88; Ryseck et al, 88). Subsequent 
observations have extended the range of c-yu/7-inducing stimuli to include 
transforming oncogenes, DNA damaging agents, and steroid hormones 
(de Groot et al, 90(ii); Stein et al, 92; Wasylyk et al, 90). One 
consequence of multiple inducing stimuli is to expand the c-Jun 
transcriptional response. Many transforming oncogenes, for example, 
cooperate on a single signal transduction pathway that results in the 
activation of Jun/AP-1 (Reviewed in Gutman et al, 91; Karin etal, 92). c- 
Jun is similarly activated by DNA damaging agents such as oxidative 
stress and UV irradiation, but under these conditions alternative activation 
pathways are favoured (Hallahan et al, 91; Stein et al, 92; Xanthoudakis 
et al, 92(ii)), suggesting that c-Jun is the effector of multiple signal 
transduction pathways in vivo.
A wide range of independent inducing stimuli may also be important for the 
fine regulation of AP-1-dependent transactivation in vivo. Independent AP- 
1 dimers exhibit distinct transcriptional activities (Chiu et al, 89) and are 
induced in response to specific patterns of external stimuli. Depolarization 
of PC12 cells, a pheochromocytoma cell line, for example, rapidly 
induces c-fos and JunB expression, c-jun, in contrast, is refractory to
9depolarization but is induced with c-fos and junB in response to serum 
growth factors (Bartel et al, 89). These observations suggest that subtle 
changes in AP-1-dependent gene expression may be mediated through 
the activation of distinct AP-1 effector molecules, that are specifically 
induced in response to different inducing stimuli.
I.A.4. c-JUN PROMOTER
c-jun expression is regulated by a number of cooperating and independent 
enhancer elements within the c-jun promoter. It is presumed that the 
integration of these activities is responsible for the specific patterns of c-jun 
expression observed in response to different inducing stimuli.
I.A.4a Post-Translational Modifications and Factor Exchange
In vivo DNA footprinting analysis has revealed that UV- and TPA-induced 
expression of c-jun is not accompanied by crude changes in promoter site 
occupancy (Herr et al, 94; Rozek et al, 93). Similar results were reported 
at the c-fos promoter in response to serum stimulation, suggesting that 
post-translational modifications to pre existing factors and/or subtle factor 
exchanges may be responsible for specific alterations in immediate early 
gene expression (Herrera etal, 89). Serum-induced expression of c-fos is 
regulated through the Serum Response Element (SRE) in the c-fos 
promoter (Rivera et al, 90). The SRE is recognized by the Serum 
Response Factor (SRF) which binds as a ternary complex with the Elk-1 
transcription factor (Dalton et al, 93; Marais et al, 93). Elk-1 is multiply
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phosphorylated in the conserved "C Box" in response to mitogenic stimuli 
(Marais et al, 93). Phosphorylation of Elk-1 is both rapid and transient and 
contributes to the subsequent transactivation activity of the SRF. c-jun, 
like c-fos, is also induced in response to serum stimulation although serum 
associated changes in c-jun promoter site occupancy have not been 
investigated, c-jun does not posess an SRE in the gene promoter but does 
contain a related element that shares many characteristics with the SRE. 
The Related-to-Serum Response Element (RSRE) is found in the promoter 
regions of several growth factor responsive and muscle specific genes, 
and binds a family of transcription factors known as the Related-to-Serum 
Response Factors (RSRF). The RSRFs share sequence homology with 
the SRF over a conserved MADS BOX. Homology is highest over the DNA 
binding and dimerization domains, but cross dimerization and DNA 
binding is not exhibited by the SRF and RSRFs (Pollock et al, 91). 
Sequence homology between the SRF and the RSRFs completely 
diverges at the carboxy terminus of the MADS BOX. This region is rich in 
proline and glutamine residues and functions as the Elk-1 binding domain 
in the SRF (Dalton et al, 93). The divergent region is also an absolute 
requirement for SRF and RSRF DNA binding activity suggesting, that 
additional protein:protein interactions may also be important for RSRF 
DNA binding and the subsequent regulation of RSRF transactivation 
activity (Pollock et al, 91). The functional significance of the junRSRE in 
vivo is complicated by the refractibility of this element to DNase 1 digestion 
(Flemington et al, 90; Rozek et al, 93). However, it has been associated 
with serum and EGF-induced expression of c-jun, and is specifically 
recognized by HeLa cell RSRFs in vitro (Han etal, 92).
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I.A.4b Cooperation and Redundancy
- Cooperation
Cooperative regulatory elements have been demonstrated to mediate the 
wide ranging patterns of c-jun expression in response to different inducing 
stimuli. Maximal activation of the c-jun promoter by adenovirus E1A 
proteins, for example, requires cooperativity between two TRE-like sites 
and an additional CTF element within the c-jun promoter (van Dam et al, 
93). Retinoic acid-induced expression of c-jun in differentiating embryonal 
carcinoma cells is similarly mediated through multiple cooperating 
elements that have been described as retinoic acid responsive elements or 
REREs. Induction is restricted to differentiating conditions and depends on 
the exact number and spacing of REREs. Two junREREs overlap with the 
proximal and distal TR E-like sites in the c-jun promoter (Kitabayashi et al
92). This may account for the potentiation of retinoic acid-induced c-jun 
expression by E1A, and suggests that E1A cooperates with independent 
factors to regulate mitogenic- and differentiation-induced patterns of c-jun 
expression (van Dam etal, 93).
- Redundancy
Functional analyses of full length and minimal gene promoters has 
demonstrated that single mutations within the context of a complete 
promoter often have little effect on subsequent gene expression. This has 
led to the proposal that cooperative sites compensate for lost activity and 
that individual sites are redundant for the functional activity of full length 
gene promoters.
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Redundant binding sites are characteristic of several immediate early gene 
promoters, including c-jun. Multiple independent regulatory elements 
have been identified in the c-jun promoter that specifically activate c-jun 
expression in response to a wide range of different inducing stimuli. 
Mutation of these individual binding motifs has no effect on c-ya/7-induced 
expression in the context of a full length c-jun promoter fragment but can 
completely abolish a response when minimal c-jun promoter fragments are 
assembled in a reporter construct (Angel et al, 88(ii); Han et al, 92; Unlap 
et al, 92). From these observations, it has been proposed that c-jun 
expression is regulated through a complex integration of multiple but 
cooperative enhancer elements. Each is presumed to respond to distinct 
signal transduction pathways and thereby contribute to the multiple 
patterns of c-jun expression observed in response to different inducing 
stimuli.
I.A.5. C-JUN AUTOREGULATION
Autoregulation is a characteristic shared by many independent 
transcription factors (Serfling et al, 89). c-Fos and c-Myc, for example, 
negatively regulate their own gene promoters in a concentration- 
dependent manner (Grignani et al, 90; Lucibello et al, 89; Sassoni-Corsi 
et al, 88). Multiple homeobox-containing genes in drosophila and certain 
eukaryotic transcription factors, including MyoD, Myogenin, and c-ets1, 
in contrast, exhibit positive autogenous transactivation (Serfling et al, 89; 
Seth et al, 90; Weintraub et al, 91 (i)). c-Jun has been associated with 
both positive and negative autoregulation in vivo, and this has been 
proposed to contribute to its complex patterns of gene expression.
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I.A.5a Positive Autogenous Transactivation
Two TRE-like sites within the c-jun promoter have been shown to mediate 
c-jun expression in response to a wide range of inducing stimuli, including 
steroid hormones, UV irradiation, and phorbol esters (Kitabayashi et al, 
92; Stein et al, 92; Unlap et al, 92). Both junTREs differ from the 
canonical TRE by the inclusion of single base pair (Angel et al 88(ii); 
Unlap et al, 92). The proximal junTRE has retained the ability to bind c- 
Jun homodimers in vitro and has been reported to activate CAT expression 
in response to c-Jun overexpression in two independent cell lines (Angel et 
al, 88(ii)). A number of other in vitro observations support a positive 
autoregulatory role for c-Jun in vivo. Collagenase gene expression in 
primary human fibroblasts, for example, is prolonged in response to TNF- 
a. The response has been attributed to a persistent overexpression of c- 
Jun/AP-1, which is proposed to result from a putative positive 
autoregulatory loop (Brenner et al, 89). A similar enhancement and 
extension of c-jun expression has been observed during the in vitro 
differentiation of P19 embryonal carcinoma cells (de Groot et al, 90(i); de 
Groot et al, 90(ii)). The mechanism responsible for this has not been 
investigated, but it has been suggested that the negative feedback loop 
associated with transient c-jun expression is, in some way, delayed or 
overridden during differentiation.
Subsequent investigations have failed to confirm a positive role for c-Jun 
homodimers in vivo (Kovary et al, 92; Kovary et al, 91). In addition, 
characterization of the proximal and distal junTRE binding complexes has 
identified contributions by CREB/ATF factors rather than c-Jun 
homodimers (van Dam et al, 93). This supports the observation that the 
junTREs more closely resemble CREs than TREs and that Jun/ATF 
heterodimers exhibit a higher affinity for CRE- than TRE-containing
14
oligonucleotides (Benbrook et al, 90). Distinct junTRE-specific protein 
complexes may provide an explanation for the differences reported 
between the junTRE and collagenase TRE binding sites in vitro. The 
collagenase TRE, for example, binds c-Jun/c-Fos heterodimers and c-Jun 
homodimers, but has no affinity for CREB/ATF-containing complexes and 
does not compete for junTRE-specific complexes in electrophoretic 
mobility shift assays (Hai et al, 91; Stein et al, 92). Similarly, adenovirus 
E1A proteins and retinoic acid have been reported to repress gene 
expression through a canonical TRE but to activate c-jun expression 
through the proximal and distal junTRE-like sites (de Groot et al, 91; 
Kitabayashi etal, 91; Offringa etal, 90; van Dam et al, 90). E1A-induced 
transactivation of the c-jun promoter is proposed to depend on 
CREB/ATF2 proteins which both bind to the junTREs and are widely 
recognized transactivation targets of the 289R E1A protein (van Dam et al, 
93).
From these observations it is hypothesized that auto-induction of c-jun may 
not represent true autoregulation, and that alternative c-Jun-containing or 
c-Jun-lacking heterodimeric complexes positively regulate c-jun expression 
in vivo.
I.A.5b Auto-repression
Overexpression of c-Jun or v-Jun in primary CEFs induces a repression of 
endogenous c-jun expression that is dependent on high levels of 
exogenous Jun proteins (Castellazzi et al, 90; Castellazzi et al, 91; 
Hughes et al, 92). Elements within the c-jun promoter responsible for 
auto-repression have not been identified but observations suggest that, in 
common with positive autogenous transactivation, Jun homodimers may
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not be the true in vivo effector. GCN4/v-Jun fusion proteins, for example, 
exclusively homodimerize and, in contrast to wild type p65 gag-v-Jun, 
have been shown to up regulate c-jun expression in primary CEFs 
(Hughes et al, 92). In addition, no correlation has been reported between 
exogenous v-Jun expression and the levels of TRE or TRE-like DNA 
binding activity in ASV17-transformed CEFs (Hadman etal, 93; Hawker et 
al, 93). Consequently, Jun-dependent auto-repression may be mediated 
through a squelching mechanism that requires high levels of c-Jun or v- 
Jun protein but is independent of Jun/AP-1 DNA binding activity (Oehler et 
al, 92). Conventional squelching mechanisms are directed by productive 
protein:protein interactions mediated through intact transactivation 
domains (section I.B.6b). Mutational analysis of c-Jun has identified the 
singular importance of the Jun leucine zipper domain for endogenous c- 
Jun repression in primary CEFs (Castellazzi et al, 91). Consequently, an 
alternative type of squelching mechanism may be essential for Jun auto­
repression in vivo, that may or may not require functional Jun\AP-1 DNA 
binding activity but absolutely depends on intact Jun dimerization domains. 
The kinetics of c-jun expression clearly include a period of gene repression 
in response to a wide range of different inducing stimuli (Lamph et al, 88; 
Quantin et al, 88; Ryder et al, 88; Ryseck et al, 88). This, together with 
the down-regulation of c-Jun expression in c-Jun and v-Jun transformed 
primary CEFs, suggests that auto-repression plays an important role in 
the regulation of c-jun expression during both normal and transformed 
conditions of growth (Castellazzi et al, 90; Castellazzi et al 91; Hartle et 
al, 92; Havarstein etal, 92).
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CHAPTER 1.B - INTRODUCTION
TRANSCRIPTIONAL ACTIVATION AND REPRESSION BY 
CELLULAR TRANSCRIPTION FACTORS
Factors involved in the accurate initiation of eukaryotic transcription can be 
classified into two groups : general or basal transcription factors, and 
sequence-specific activator proteins. (Reviewed in Saltzman et al, 89; 
Ptashne et al, 90). The general transcription factors assemble on the 
promoter in an ordered fashion to form a preinitiation complex. Gene 
expression is then modulated through subsequent interactions with DNA- 
bound activator proteins. Activator proteins or sequence-specific cellular 
transcription factors can transactivate gene expression through direct 
interactions with components of the basal transcriptional machinary that 
may (Lin et al, 91) or may not (Kerr et al, 93; Liu et al, 93) facilitate the 
assembly of the pre-initiation complex on the DNA. Alternatively, co­
activators have been isolated that function as bridging proteins (Chrivia et 
al, 93; Gill et al, 94) or DNA structural re-organizers (Natesan et al, 93), 
and thereby mediate indirect protein:protein interactions that enhance the 
transactivation of specific genes.
Transcriptional repression has similarly been associated with several 
cellular and oncogenic transcription factors in vivo and is mediated through 
direct and indirect interactions with components of the basal transcriptional 
machinary. c-Myc, for example, has been reported to repress 
transcriptional initiation through a direct interaction with the initiator binding 
protein, TFII-I (Lucas et al, 93; Roy et al, 93), and a direct and non­
productive interaction between v-Rel and the TATA-box binding protein
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contributes to the dominant negative phenotype exhibited by the v-Rel 
oncoprotein (Kerr etal, 93).
Indirect transcriptional repression is generally mediated through 
proteimprotein interactions outwith the DNA. The interaction between c- 
Myc and Yin-Yang-1 (YY1), a zinc-finger eukaryotic transcription factor, for 
example, (Shrivastava et al, 93), inhibits the dual transactivator and 
repressor functions of YY1 (Riggs et al, 93; Seto et al, 91) and has been 
proposed to mediate c-myc transcriptional auto-repression in vivo 
(Grignani etal, 90)
Transactivation and transrepression have been associated with several 
cellular transcription factors in vivo. Dual functionality is directly and 
indirectly modulated by a variety of complex mechanisms; some of which 
are described below.
I.B.1. FUNCTIONAL MODIFICATION BY PHOSPHORYLATION
Phosphorylation of pre-existing and newly synthesized transcription factors 
provides a rapid and highly specific mode of transcriptional control. 
Phosphorylation has been reported to regulate the transactivation, DNA 
binding and nuclear localization of cellular transcription factors depending 
on the precise domain targeted for modification.
I.B.Ia Transactivation
c-Jun transactivation is regulated by the phosphorylation of two amino- 
terminal sites : serines 63 and 73 (Pulverer et al, 91; Smeal et al, 91; 
Smeal et al, 92). A c-Jun amino-terminal kinase (JNK) has now been
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identified (Hibi et al, 93) that is upregulated under conditions associated 
with the phosphorylation of serines 63 and 73 in c-Jun (Devary et al, 92; 
Pulverer et al, 91; Pulverer et al, 92; Smeal et al, 92). A series of 
threonine residues in the c-Jun A1 transactivation domain are also 
phosphorylated under these conditions and may present additional targets 
for JNK phosphorylation (Devary et al, 92). A major 46kD isoform of JNK 
has been identified that binds to a specific site within the c-Jun 
transactivation domain and phosphorylates c-Jun on serines 63 and 73 in 
vitro. Phosphorylation is proposed to induce a conformational change in 
the c-Jun protein that is responsible for c-Jun transactivation and the 
concomitant dissociation of JNK (Hibi etal, 93).
JNK is distantly related to the Mitogen Activated Protein Kinases (Derijard 
et al, 94). Mitogen Activated protein kinases have been shown to 
phosphorylate numerous transcription factors in vitro including c-Jun 
(Pulverer et al, 91; Pulverer et al, 92) and the serum response factor 
(SRF) associated protein Elk-1 (Marais et al, 93). DNA binding by 
monomeric Elk-1 is potentiated by the formation of a ternary complex with 
the SRF at the c-fos serum response element (SRE) (Hipskind et al, 91; 
Shaw et al, 89). Two conserved domains are required to mediate the Elk- 
1/SRF-interaction. A third conserved domain is phosphorylated at multiple 
sites in vitro by MAP kinases. Like c-Jun, phosphorylation is associated 
with increased Elk-1 transactivation, thereby linking growth factor 
regulated phosphorylation to transactivation through the SRE (Marais et al,
93)
For certain transcription factors phosphorylation-induced transcriptional 
activation is potentiated by more than one kinase. CREB is 
phosphorylated at serine 133 in response to at least two independent 
signal transduction pathways. Activation of protein kinase A, through the 
adenyl cyclase pathway, leads to a dramatic increase in the
19
transactivating potential of CREB (Gonzalez et al, 91). A similar increase 
is observed upon membrane depolarization of PC12 cells but, in this case, 
the calmodulin-dependent protein kinases I and II have been proposed as 
the in vivo effectors (Dash etal, 91; Sheng etal, 91).
The mechanisms responsible for phosphorylation-induced transactivation 
are poorly understood but phosphorylation is frequently associated with 
conformational changes that may be significant for subsequent 
transcriptional regulation. Immunoprecipitated, phosphorylated c-Jun, for 
example, migrates as a ladder of 4-5 specific bands that correlate with 
amino terminal phosphorylations (Pulverer etal, 92) and an increase in the 
activity of JNK (Hibi et al, 93). A similar increase in the electrophoretic 
mobility of the SRE ternary complex has been observed following the post- 
translational phosphorylation of Elk-1 (Marais etal, 93).
Conformational changes may be significant for subsequent protein:protein 
interactions necessary for transactivation and transrepression. CREB 
phosphorylation at serine 133, for example, induces a conformational 
change that exposes a glutamine rich transactivation domain essential for 
transactivation (Gonzalez et al, 91). Direct interactions between 
transcription factors and components of the basal transcriptional 
machinary have similarly been associated with phosphorylation-induced 
conformational changes. Phosphorylated c-Jun, for example, binds 
purified TATA-binding factors TFIIB and TBP in vitro (Kraft; in press), 
while SRF transactivation is enhanced through an interaction with the 
TATA-binding factor TFIID that facilitates formation of an active 
preinitiation complex (Zhu etal, 91).
Post-translational modifications to transactivation domains have also been 
associated with a stimulation of DNA binding activity that indirectly 
activates transactivation. Phosphorylation of Elk-1, for example, has
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been reported to increase ternary complex formation over the SRE (Gille et 
al, 92). The affinity of CREB for low affinity CRE binding sites is similarly 
increased following serine 133 phosphorylation by protein kinase A 
(Nichols etal, 92).
I.B.Ib DNA Binding
c-Jun DNA binding activity is directly regulated through phosphorylation, c- 
Jun is phosphorylated at three carboxy-terminal sites : threonine 231, 
serine 243 and serine 249, located immediately adjacent to the DNA 
binding domain in the A2 region (Bohman et al, 89; Boyle et al, 91). An 
additional site lies within this cluster: threonine 239, but does not appear 
to be phosphorylated in vivo (Lin et al, 92). All three sites are 
phosphorylated in non-stimulated cells but upon exposure to TPA or 
certain transforming oncogenes, including activated Ha-ras, v-Sis and v- 
Src, two sites are rapidly dephosphorylated (Binetruy et al, 91; Smeal et 
al, 92), and there is a subsequent increase in DNA binding activity (Boyle 
et al, 91). Casein kinase II has been shown to phosphorylate threonine 
231 and serine 249 in vivo. Serine 243 is not phosphorylated by Casein 
kinase II but has been implicated as a potential substrate for the MAP 2 
kinases and MAP Related kinases : ERT and ERK 1&2. Phosphorylation 
of serine 243 increases the reactivity of the remaining sites. Conversly, 
mutation of serine 243 to an alanine, as in v-Jun, has been shown to 
interfere with subsequent phosphorylation events and is believed to 
contribute to the increased oncogenicity of v-Jun relative to c-Jun (Lin et al,
92). Casein kinase II is a constitutively active kinase which is 
predominantly located in the nucleus (Boyle et al, 91). Consequently, it 
has been proposed that activation of c-Jun DNA binding may be controlled
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at the level of a specific phosphatase rather than a specific kinase (Lin et 
al, 92).
In contrast to c-Jun, SRF phosphorylation at serine 103, enhances the 
affinity of the SRF for the SRE (Rivera et al, 93). Transcriptional induction 
of c-fos correlates with a transient phosphorylation of the SRF and an 
enhancement of DNA binding activity. Phosphorylation does not affect the 
ability of the SRF to interact with Elk-1 but may influence other 
protein:protein interactions necessary for the SRF:SRE binding interaction. 
Mechanisms responsible for phosphorylation-induced changes in DNA 
binding activity are poorly understood. It has been suggested that 
allosteric and/or electrostatic changes influence the integrity of the DNA 
binding pocket and thereby alter the affinity of a transcription factor for a 
specific DNA recognition sequence. Alternatively, phosphorylation- 
induced changes may direct specific protein:protein interactions that 
indrectly regulate subsequent DNA binding activity. In vivo footprinting 
data from several immediate early gene promoters has revealed that 
promoter site occupancy is unchanged in response to certain inducing 
stimuli (Herr et al, 94; Herrera et al, 89; Rozek et al, 93). These 
observations would appear to directly contradict the in vitro studies 
described above unless stimulation induces a rapid exchange of factors on 
the gene promoter leaving the overall crude DNA footprint unchanged. 
Alternatively, post-translational modifications affecting DNA binding activity 
may only be significant for the recognition of low affinity DNA binding sites 
and, consequently, not be detected by footprinting analysis (Nichols et al,
92).
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I.B.Ic Sequestration
Regulated cytoplasmic sequestration controls the activity of certain 
transcriptional activators and repressors in eukaryotic cells. Regulation is 
rapid and obviates the need for a mechanism to propagate signals across 
the nuclear membrane. Phosphorylation of the transcription factor itself or 
a cytoplasmic anchor protein can facilitate nuclear translocation and 
subsequent activation. A well documented example of phosphorylation- 
regulated nuclear translocation is provided by the Rel-related family of 
transcription factors which includes NF-xB p50, NF-%B p65, p49 c-Rel, 
RelB and Dorsal (Reviewed in Gilmore, 91). The Rel proteins transactivate 
as homo and heterodimers through sequences related to the NF-%B 
binding site. Inactive proteins are sequestered in the cytoplasm as dimeric 
complexes or as single monomers (Ganchi et al, 93) by a common 
inhibitory protein, l%B (Baeuerle et al, 88). The \%B anchor protein is 
unphosphorylated in the cytoplasm but becomes rapidly phosphorylated in 
response to a variety of stimuli, including phorbol esters and DNA 
damaging agents. Phosphorylation triggers the degradation of l>cB and the 
subsequnt nuclear translocation of NF->cB-related proteins. The 
mechanism is likely to be more complex in vivo but phosphorylation is 
clearly integral to the overall pattern of regulation (Baeuerle et al, 1988; 
Ghosh etal, 90; Sun etal, 93).
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I.B.2. FUNCTIONAL MODIFICATION BY CELLULAR REGULATORY 
FACTORS
I.B.2a Transactivation
Transactivation activity can be modulated by cellular regulatory proteins. 
Co-activators have been identified that bind to specific transcription factors 
and enhance their transactivation function. A TBP associated factor, 
TAF||110, for example, has been shown to form a bridge between the 
RNA polymerase II preinitiation complex and a glutamine rich 
transactivation domain within the cellular transcription factor Sp1 (Gill et al,
94). A nuclear protein, CBP (CREB Binding Protein) has similarly been 
demonstrated to enhance the transactivation activity of CREB. CPB 
exclusively binds to phosphorylated CREB which forms a scaffold for CBP 
enhanced, CRE-dependent gene expression (Chrivia etal, 93). 
Protein:protein interactions have also been reported that mask the activity 
of transactivation domains. In yeast, the transcription of galactose- 
inducible genes is regulated by the interaction between an activator 
protein, GAL4, and a negative regulatory protein, GAL80. Under non­
inducing conditions GAL80 binds to and masks the GAL4 transactivation 
domain. Following induction, GAL80 remains bound to GAL4 but the 
transactivation domain is unmasked to promote transactivation (Leuther et 
al, 92). A similar pattern of regulation has been reported for the cellular 
oncogene MDM2 which binds to an acidic transactivation domain in p53. 
Binding masks the activity of p53 and contributes to the transforming 
function of MDM2 in human soft tissue sarcomas (Oliner etal, 93).
Protein:protein interactions can also indirectly inhibit the activity of adjacent 
transactivation domains. The activity of PH04, a basic-helix-loop-helix
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yeast transactivator, for example, is modulated by the PHO80 repressor. 
PHO80 physically interacts with two independent sites on PH04 to mediate 
transcriptional repression. Neither site overlaps with the PH04 
transactivation domain and repression is presumed to result from an 
indirect masking effect (Jayaraman et al, 94). The PHO4/PHO80 system 
exhibits strong parallels with repression of the c-Jun a1 transactivation 
domain. a1 is flanked by two independent repressor domains: 8 and E, 
both of which are required for full transcriptional repression. The 8 domain 
has been reported to facilitate or stabilize the interaction between a cell- 
type-specific inhibitor and the E domain (Baichwal et al, 92). In addition 
the 8 domain binds to the c-Jun amino-terminal kinase prior to c-Jun 
phosphorylation and subsequent activation (Hibi etal, 93). It remains to be 
seen whether a1 repression is a consequence of masking induced by a 8/E 
/1 interaction.
I.B.2b DNA Binding
The DNA binding activity of cellular transcription factors is modulated by a 
wide variety of regulatory proteins.
Post-translational modifications involving the reduction/oxidation (redox) of 
DNA binding sensitive residues have been reported to regulate the DNA 
binding activity of the AP-1, Myb and NF-kB transcription factor families 
(Abate et al, 90(i); Abate et al, 90(iv); Frame et al, 91; Toledano et al,
91). The AP-1 transcription factors are reversibly reduced on a conserved 
cysteine residue in the basic region. Reduction is mediated by a cellular 
redox/DNA repair enzyme, Ref-1 (Xanthoudakis etal, 94), and is required 
for optimal DNA binding activity of all the Fos and Jun family proteins 
(Xanthoudakis et al, 92(i); Xanthoudakis etal, 92(ii)). The importance of
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redox regulation in vivo is illustrated by the v-Jun oncoprotein, which 
retains a cysteine to serine mutation at the redox sensitive residue and is 
refractory to DNA binding regulation (Maki et al, 87; Nishimura et al, 88). 
The same substitution in c-Fos augments both its DNA binding and 
transforming potential and has consequently been proposed to represent a 
gain of function mutation (Okuno etal, 93).
Direct protein:protein interactions have similarly been reported to alter the 
DNA binding activity of several transcription factors. Inhibitory proteins 
have been identified that recognize specific transcription factors, and bind 
to form complexes with altered or reduced DNA-binding activity. Several c- 
Jun dimerization partners have been reported that alter its DNA binding 
activity in vitro. Jun-interacting factor 1 (Jif-1) binds specifically to the c- 
Jun leucine zipper and down regulates c-Jun DNA binding and 
transactivation through the canonical collagenase TRE (Monteclaro et al,
93). Jif-1 does not show any structural resemblance to known transcription 
factor motifs but is closely related to the product of a putative human 
tumour suppressor gene, QM. JunB, in contrast, is highly related to c-Jun 
but attenuates c-Jun-mediated transactivation of the collagenase gene 
through a small number of amino acid changes within its DNA binding and 
dimerization domains (Deng et al, 93). c-Jun/JunB heterodimers form in 
preference to either homodimer, but have a relatively low affinity for the 
collagenase TRE. It has been proposed that the c-Jun/JunB heterodimer 
binds to a distinct subset of TRE-dependent genes, and thereby regulates 
an alternative pattern of c-Jun-dependent transactivation (Deng et al, 93; 
Ryseck etal, 91).
Other transcription factors whose DNA binding activity is modulated by 
protein:protein interactions include MyoD and the CAAT/enhancer binding 
protein, C/EBP. MyoD and C/EBP dimerize with dominant repressors 
proteins that lack functional DNA binding domains. MyoD is sequestered
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as an inactive heterodimer with Id, a relatively ubiquitous negative 
regulator of helix-loop-helix proteins (Benezra et al, 90), whereas C/EBP 
interacts specifically with a highly homologous repressor, CHOP (Ron et 
al, 92).
I.B.2c Sequestration
The activity of certain transcription factors is regulated through specific 
interactions with cellular regulatory proteins that mediate cytoplasmic 
sequestration in vivo. The glucocorticoid receptor, for example, is 
sequestered in the cytoplasm as an inactive complex with heat shock 
protein 90, hsp90 (Pratt et al, 88). Binding of hsp90 to the hormone 
binding domain is believed to induce an unfolding of the receptor which 
inactiviates its nuclear localization, DNA binding and transactivation 
functions. The conformational change is reversed through hormone 
binding which triggers the* release of hsp90 and the concomitant nuclear 
localization of the glucocorticoid receptor (Picard etal, 88).
I.B.3. FUNCTIONAL MODIFICATION THROUGH DOMAIN 
INTERACTIONS
I.B.3a Intermolecular Interactions
Synnergism between independent transactivation domains has been 
reported to modulate the transcriptional activity of several transcription 
factors in vivo. c-Jun, for example, posesses two transactivation
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domains, Homology Domains (HOB) 1 & 2, that cooperate and are 
functionally interchangeable with HOB-like domains found in other 
transcription factors such as c-Fos and C/EBP (Sutherland et al, 92). 
Synnergistic transactivation domains have also been identified in Sp-1, a 
transcription factor essential for basal and enhancer mediated 
transactivation of certain gene promoters (Dusing et al, 94). Synnergism 
between the glutamine rich transactivation domains of proximally and 
distally bound Sp-1 molecules superactivates Sp-1-dependent transcription 
in vitro (Courey etal, 89).
Antagonistic transactivation domains can similarly modulate transactivation 
activities. CREB transactivation, for example, is repressed by different 
isoforms of the CREB Modulator protein, CREM. CREM proteins bind to 
the CRE as homodimers or as heterodimers with CREB, and thereby 
directly down-regulate CREB transactivation (Foulkes et al, 91 (i); Foulkes 
etal, 91 (ii)).
I.B.3b Intramolecular Interactions
Intramolecular interactions regulate both the transactivation and the DNA 
binding activity of cellular transcription factors. Certain ATF-2-like proteins, 
for example, contain an inhibitory domain in the carboxy-terminus that 
weakens transactivation through a mechanism of intramolecular masking. 
Repression is alleviated through heterodimerization with Fos or Jun 
proteins that provide alternative transactivation domains, or by the 
Adenovirus E1a protein that binds and directly unmasks the ATF-2 zinc 
finger transactivation domain (Chatton etal, 94). In vitro transactivation by 
p53 is similarly regulated by intramolecular interactions. Transactivation is 
mediated through a direct interaction with the TATA-box binding protein,
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TBP, but is modulated by additional activator and repressor domains 
located outwith the TBP binding domain (Liu e ta l, 93).
The DNA binding activity of the c-Ets1 transcription factor is regulated 
through an intramolecular interaction involving the full length c-Ets1 
protein. c-Ets1 DNA binding activity is directed by the conserved "ets 
domain" but repressed in the context of full length c-Ets1. The importance 
of this regulatory mechanism is demonstrated by the v-Ets1 oncoprotein 
whose DNA binding activity is refractory to intramolecular constraints (Lim 
etal, 92). Intramolecular interactions have an opposing effect on the DNA 
binding activity of JunD. Amino terminal sequences modulate the DNA 
binding activity of JunD but, unlike c-Ets1, increase the affinity of JunD for 
its specific DNA binding sites (Hirai etal, 90).
I.B.4. FUNCTIONAL MODIFICATION THROUGH DNA ORGANIZATION
Structural re-organization of the DNA has been associated with the DNA 
binding activity of several transcription factors in vitro (Kerppola et al, 93; 
Van der Vliet etal, 93). c-Jun homodimers and c-Jun/c-Fos heterodimers, 
for example, bind to the same DNA consensus site but bend the DNA in 
opposite orientations (Kerppola etal, 91). Bending introduces the potential 
for cooperativity between widely spaced DNA bound factors and can 
contribute to transcriptional repression and activation. YY1, for example, 
is a ubiquitously expressed protein that exhibits functional flexibility as a 
transactivator. Flexibility is dependent on a relatively degenerate DNA 
binding specificity coupled with an ability to induce DNA bending 
(Reviewed in Hahn, 92). In vitro experiments have shown that alterations 
in promoter topology are sufficient for YY1-dependent transactivation and
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repression, and suggest that under certain conditions direct interactions 
with the basal transcriptional machinary are not required (Natesan et al,
93).
I.B.5. FUNCTIONAL MODIFICATION THROUGH DISPLACEMENT AND 
REPLACEMENT
Activation and repression from a single gene promoter can be mediated in 
vitro through the direct replacement of activating factors with repressors. A 
direct antagonism between YY1 and the SRF, for example, has been 
described at the c-fos SRE. YY1 competes with the SRF for binding to the 
SRE and induces a concomitant repression of c-fos transcription in vitro 
(Gualberto et al, 92). A similar pattern of regulation has been reported at 
the proximal TRE-like site in the c-jun promoter. Overexpression of under- 
phosphorylated, inactive CREB displaces endogenous TRE binding 
factors from the proximal junTRE and represses serum- and TPA-induced 
expression of c-jun (Lamph etal, 90).
The contribution made by displacement and replacement to the regulation 
of transcription in vivo is less well defined. Direct factor replacement is 
difficult to monitor and may account for the apparently identical in vivo 
footprints observed for some induced and non-induced immediate early 
gene promoters (Herr et al, 94; Herrera et al, 89; Rozek et al, 93). The 
best evidence to support qualitative differences in promoter site occupancy 
in vivo is provided by differentiation model systems. Two independent 
nuclear factors, for example, have been shown to compete for a 
conserved 28-base pair element in the skeletal actin gene promoter 
(Walsh et al, 87). Muscle actin promoter factor 1 (MAPF1) is the
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predominant binding activity in nuclear extracts from non-muscle cell types, 
whereas a distinct binding activity, MAPF2, is detected in differentiated 
skeletal and cardiac muscle cells (Walsh et al, 88). MAPF1- or MAPF2- 
containing nuclear extracts produce identical footprints over the 28-base 
pair conserved element but skeletal actin is restricted to MAPF2- 
expressing cells, suggesting a functional association between MAPF2 
DNA binding and skeletal actin expression in vivo..
I.B.6. QUANTITATIVE MECHANISMS TO MODIFY FUNCTION
I.B.6a Dimerization
Heterodimerization expands the DNA binding potential and transactivation 
activity of individual transcription factors. Dimers between c-Jun and 
members of the Jun, Fos and CREB/ATF gene families, for example, 
exhibit independent DNA binding and transactivation activities (Hai et al, 
91; Kerrpola et al, 93; Macgregor et al, 90; Ryseck et al, 91). The 
proportion of any one dimer has been proposed to reflect the relative 
abundance of each constituent protein present within the cell (Kovary et al,
92). Consequently, dimerization provides a regulatory mechanism that is 
sensitive to changing cellular environments. The Rel-related family of 
transcription factors, for example, dimerize and transactivate through NF- 
xB-related elements in vitro. Strong transactivation is mediated through 
NF-xB p50/NF-%B p65 heterodimers and NF-%B p65 homodimers, 
whereas weak transactivation is mediated through NF-%B p50 homodimers
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(Ganchi et al, 93). The relative proportions of each dimer is presumed to 
contribute to the overall transactivation of NF-%B-dependent genes in vivo. 
Evidence to support a role for dimerization in the regulation of transcription 
in vivo is provided by erythropoiesis. NF-E2 is an erythroid-specific 
transcription factor which binds as an NF-E2 / Maf heterodimer to AP-1 -like 
sites in the promoters of erythroid-specific genes (Andrews et al, 93; 
Kataoka et al 94). The small Maf proteins lack canonical transactivation 
domains but are capable of dimerization and DNA binding (Kataoka et al,
94). Consequently, Maf homodimers supress transcription through NF-E2 
binding sites. Unlike NF-E2, the Maf proteins are ubiquitously expressed, 
albeit at markedly different levels, in specific cell types (Andrews et al, 93). 
From this observation it has been proposed that the relative concentration 
of Maf proteins acts as a sensitive switch by which erythroid-specific gene 
expression is controlled (Igarashi et al, 94)
I.B.6b Squelching
The transactivation of sequence-specific transcription factors is enhanced 
through direct interactions with components of the basal transcriptional 
machinary and/or specific accessory factors (section I.B.2). Over 
expression.of transactivation domains can repress this effect through non­
productive protein:protein interactions (Angel et al, 89; Gill et al, 88; 
Oehler et al, 92). This phenomenon is described as Squelching and is 
predominantly dependent on functional transactivation domains. 
Transcription factors lacking a DNA binding domain (Angel et al, 89) or 
possessing an unrelated DNA binding domain (Gill et al, 88) are not 
compromised in their ability to titrate factors required for productive 
transcription.
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The specificity of squelching interactions is challenged by domain swap 
experiments whereby one transactivation domain is replaced by an 
unrelated domain (Oehler etal, 92). c-Jun mutants, lacking an intact DNA 
binding domain, for example, have been shown to repress c-Jun 
transactivation in yeast (Angel etal, 89). Repression is mimicked by other 
acidic transactivation domains such as JunB, GAL4 and VP16, but not by 
unrelated transactivation domains present in the steroid receptor family of 
transcription factors (Angel et al, 89; Oehler et al, 92). These 
observations have prompted a classification of transactivation domains 
according to their ability to interact with similar components of the basal 
transcriptional machinary (Lin et al, 91; Tasset et al, 90). Acidic 
transactivation domains, for example, are functionally interchangeable 
and, consequently, have been shown to repress several non-specific 
genes in vitro that are recognized targets of independent acidic 
transactivators in vivo (Gill etal, 88).
The ability to repress transactivation when overexpressed may be an 
important regulatory mechanism in vivo. The rapid and transient 
expression of immediate early genes, for example, could be regulated by 
a concentration-dependent switch in gene expression. One example of 
concentration-dependent transregulation in vivo is provided by the yeast 
transactivator, GAL4. At high concentrations Gal4 exhibits a repressor 
function that, in contrast to its ability to transactivate, is independent of 
DNA binding activity. This, together with the requirement for intact acidic 
transactivation domains, suggests that Gal4-mediated repression is 
directed by a squelching mechanism that is essential for the activity of 
Gal4 in vivo (Gill etal, 88).
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I.B.7. FUNCTIONAL MODIFICATION THROUGH TRANSCRIPTIONAL 
CROSS TALK
Interactions between transcription factors from unrelated gene families 
facilitate the integration of independent signal transduction pathways and 
expand and refine the overall transcriptional response. This process has 
been described as "transcriptional cross talk". Some of the consequences 
of transcriptional cross talk for gene regulation are described below.
I.B.7a Consequences of Transcription Cross Talk For Gene 
Regulation In Vivo
1. Expansion of DNA Binding Potential
Heterodimerization alters the sequence specificity of DNA binding 
transcription factors in vitro and in vivo. c-Jun/c-Fos heterodimers , for 
example, bind to the canonical TRE whereas heterodimers between c-Jun 
and ATF2, exhibit a greater affinity for the ATF/CREB (CRE) consensus 
sequence (Hai etal, 91).
More detailed analyses have demonstrated the importance of flanking 
residues for the optimum binding activity of sequence-specific transcription 
factors (Ryseck et al, 91). The Maf-related proteins, for example, were 
isolated on the basis of their homology to the product of the v-Maf 
oncogene, but also exhibit a weak homology over the DNA binding 
domain with members of the AP-1 and ATF/CREB transcription factor 
families (Kataoka etal, 93). MAF proteins homodimerize through a leucine 
zipper domain and bind 13- or 14-bp palindromic sequences containing the 
TRE or CRE consensus site. Maf heterodimers between c-Fos and c-Jun
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exhibit alternative binding specificities that are distinct from both Maf 
homodimers and Jun/AP-1. The differences reside in unique flanking 
sequences surrounding the TRE and CRE consensus sites and serve to 
expand the repertoire of DNA binding sites available to the Maf 
transcription factor family (Kataoka etal, 94).
2JptegratiQn of Independent Signal T ransduction Pathways
Transcriptional "cross talk" facilitates the integration of independent signal 
transduction pathways in vivo. Well characterized examples of this type of 
regulation are provided by tissue-specific and differentiation-dependent 
patterns of gene expression.
- Tissue-Specific Gene Expression
Antigen-dependent activation of T-lymphocytes leads to the immediate 
early expression and secretion of the cytokine, IL-2. Expression of IL-2 is 
regulated through the integration of at least two independent signalling 
pathways that have been proposed to cooperatively activate the Rel and 
AP-1-like components of NF-AT, the Nuclear Factor of activated T cells 
(Jain et al, 92; Nolan et al, 94). Antigen-dependent activation can be 
mimicked in vitro by treatment of T cells with a PKC agonist and a calcium 
ionophore. Calcium is proposed to stimulate the nuclear translocation of 
pre-existinig cytoplasmic NF-AT (Rel) which then combines with a PKC- 
and calcium-induced nuclear subunit representing newly synthesized AP-1 
(Jain et al, 92; Su et al, 94). Nuclear NF-AT binds to two regulatory 
elements in a 300bp enhancer region upstream of the transcriptional 
initiation site of IL-2. The AP-1 component is believed to stabilize the NF- 
AT:DNA interaction and thereby enhance subsequent IL-2 transactivation.
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Functional synnergy has similarly been reported between IL-6 and IL-1 in 
association with several physiological responses in vivo, including 
immunoglobulin secretion and the acute-phase response in T-cell 
activation (Brasier et al, 90; Hirano et al, 90). IL-1 and IL-6 activate the 
expression of NF-xB p65 (Osborn et al, 89) and C/EBPb (Poli et al, 89) 
repectively. NF-xB and C/EBP synnergistically regulate gene expression 
through C/EBP DNA binding sites in vivo (Stein etal, 93(i)). Synnergism is 
dependent on a direct physical interaction between NF-xB and C/EBPb 
that stimulates the DNA binding activity of C/EBPb and enhances 
transactivation through an additional NF-xB transactivation domain. It has 
not been determined whether the cross coupling of NF-xB and C/EBP 
observed in vitro is relevent to the signal integration of IL-1 and IL-6 
reported in vivo.
- Differentiation-Specific Gene Expression.
The integration of two independent signalling pathways is proposed to 
regulate myogenesis in vivo. MyoD, a member of the helix-loop-helix 
group of transcription factors, is a key regulator in the process of 
myogenic differentiation, and is capable of activating many muscle- 
specific genes (Weintraub etal, 91 (ii)). Overexpression of c-Jun and v-Jun 
in immature myoblasts has been reported to suppress muscle-specific 
gene expression and inhibit terminal differentiation (Bengal et al, 92; 
Grossi et al, 91; Su et al, 91). Inhibition is a consequence of a direct 
physical interaction between the helix-loop-helix domain of MyoD and the 
c-Jun leucine zipper. c-Jun inhibition of myogenesis is mediated through 
the repression of MyoD responsive promoters and is refractory to 
differentiating-inducing stimuli . Similarly, induction of AP-1 responsive 
genes by activated c-Jun and c-Fos is inhibited by MyoD expression
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(Bengal et al, 92). These observations suggest that the interaction 
between MyoD and c-Jun regulates the integration of two antagonistic 
signalling pathways important for myoblast proliferation and myogenic 
differentiation in vivo.
An alternative mechanism of transcriptional cross coupling has been 
reported to regulate the switch between osteoblast proliferation and 
differentiation. The osteocalcin gene is repressed in proliferating 
osteoblasts through an AP-1 binding site within the gene promoter. 
Differentiation stimuli, such as Vitamin D3, bind to an overlapping 
hormone response element (HRE) thereby inducing a concomitant 
displacement of Jun/AP-1 binding factors. Competitive binding to the HRE 
has been proposed to regulate the osteoblast response to independent 
proliferation and differentiation signalling pathways (Owen et al, 90; 
Schule e ta l90(i)).
3. Integration Through Common Signal Transduction Pathways
Several independent families of transcription factors are activated by 
common inducing stimuli. Cross talk between co-activated factors can 
result in functional synnergism in vivo. The NF->cB and AP-1 transcription 
factor families, for example, are related to structurally distinct oncogenes 
but are co-induced in response to growth factors, mitogens, tumour 
promoters, and DNA damaging agents (Reviewed in Angel et al, 91; 
Baeuerle et al, 91). NF-%B and AP-1 independently recognize distinct 
enhancer motifs but have recently been reported to cooperatively 
transactivate gene expression through NF-%B and AP-1 DNA binding sites. 
The functional synnergism is dependent on intact NF-%B and AP-1 
transactivation domains, and is proposed to result from a physical
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interaction between the bzip domains of c-Jun and c-Fos and the rel 
homology domain of NF-%B (Stein etal, 93(ii)).
I.B.7b Mechanisms of Transcriptional Cross Talk In Vivo
- DNA Involvement
Transcriptional cross talk is mediated through protein:protein interactions 
between unrelated transcription factor families. Auxiliary protein:DNA 
interactions may or may not contribute to the functional activity of different 
protein complexes in vivo. Transcriptional cross talk between Jun/AP-1 
and members of the steroid hormone receptor gene family, for example, 
results in a mutual repression of their respective transactivaiton activities 
(Desbois et al, 91; Jonat et al, 90; Schule et al, 90(ii); Yang-Yen et al,
91). Auxiliary protein:DNA interactions have not been detected and 
repression is proposed to result from a direct protein: protein interaction 
that inhibits the DNA binding activity of both components (Schule et al, 
90(ii); Yang-Yen et al, 91). Jun/AP-1-mediated expression of the 
collagenase gene, for example, is repressed by glucocorticoids through a 
direct interaction between the DNA binding domain of the glucocorticoid 
receptor and the c-Jun leucine zipper (Jonat et al, 90; Schule et al, 90(ii)). 
The DNA binding domain of the Retinoic Acid Receptor or the Thyroid 
Hormone Receptor can physically substitute for the Glucocorticoid 
Receptor in AP-1-associated collagenase gene repression, suggesting 
that the important feature of mutual repression is not to recognize a 
specific DNA sequence but to achieve a specific overall structure (Desbois 
etal, 91; Yang-Yen etal, 91).
For other transcription factors, the effects of transcriptional cross talk are 
absolutely dependent on auxiliary protein:DNA interactions. The
38
interaction between monomers of Elk-1 and SRF dimers for example 
precipitates Elk-1 DNA binding activity and thereby enhances 
transactivation of the SRF ternary complex through phosphorylatable 
residues on Elk-1 (Hipskind et al, 91; Marais et al, 93). The DNA binding 
activity of NF-xB is similarly enhanced in electrophoretic mobility shift 
assays in the presence of c-Fos or c-Jun proteins. The bzip region of c- 
Fos and c-Jun is required for the enhanced DNA binding activity in vivo, 
and for the physical interaction between NF-xB and AP-1 in vitro (Stein et 
al, 93(ii». A similar mechanism of transcriptional cross talk has been 
reported between NF-xB p65 and C/EBP. NF-xB physically interacts with 
the C/EBP protein in vitro and thereby enhances the affinity of C/EBP for 
its cognate DNA binding site (Stein et al, 93(i». The electrophoretic 
mobility shift of the C/EBP:DNA complex is unaltered in the presence of 
NF-xB but this may simply reflect the constraints of the electrophoretic 
mobility shift assay which does not account for DNA bending, transient 
interactions or dissociations during electrophoresis (Stein etal, 93(i)).
- Auxiliary Factors
The functional domains directing the effects of transcriptional cross talk are 
commonly identical to those required to mediate the physical interaction 
(Stein etal, 93(i); Stein e ta l93(ii». Consequently, it has proved difficult 
to establish the structure of many functional protein complexes in vivo. 
The nature of the physical interaction may be further complicated by 
contributions from auxiliary proteins. The hormone bound glucocorticoid 
receptor, for example, has been shown to interact with c-Jun and c-Fos 
monomers (Yang-Yen et al, 90(i», and with specific AP-1 dimers 
(Diamond et al, 90) in vitro, but cannot be detected in either complex in 
vivo (Diamond et al, 90). This may be the consequence of an intrinsic
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dimer instability or reflect a requirement for auxiliary factors that are 
essential for the functional activity of the protein complex but preclude its 
detection in vivo .
Auxiliary factors may also provide an explanation for the cell-type-specific 
effects and antigenic profiles of certain protein complexes in vivo. AP-1- 
mediated collagenase expression, for example, is repressed in HeLa cells 
in the presence of dexamethasone. A parallel effect is not observed in 
NIH3T3 cells which are presumed to lack essential cell-type-specific 
auxiliary proteins (Jonat etal, 90). Expression of the IL-2 gene is induced 
in activated T cells by a multiprotein complex containing NF-AT and an AP- 
1 -related component. c-Fos and c-Jun directly enhance the DNA binding 
activity of NF-AT through an adjacent TRE binding site within the IL-2 
promoter (Jain et al, 92). AP-1-containing oligonucleotides specifically 
inhibit the binding of NF-AT to its cognate motif, but neither c-Fos nor c- 
Jun-specific antisera completely disrupt the protein complex in vitro, 
suggesting that alternative AP-1 dimers or auxiliary factors contribute to 
the NF-AT complex in vivo (Boise etal, 93; Jain etal, 92).
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CHAPTER 1.C. - INTRODUCTION 
c-JUN TRANSACTIVATION AND TRANSFORMATION.
I.C.1 c-JUN - TRANSACTIVATION AND CELL GROWTH
Cell growth is regulated through the transactivation and transrepression of 
growth promoting and growth attenuating genes. In different cell types, c- 
Jun expression has been associated with both the onset and the cessation 
of cell growth. This, together with the ability of c-Jun to transactivate gene 
expression, has led to the proposal that it functions as a dual regulator of 
growth in vivo.
c-Jun Transactivating Function
c-Jun transactivation has been associated with the expression of growth 
promoting and growth attenuating genes.
Early reports describing the kinetics of c-jun expression demonstrate a 
direct correlation between growth promotion and the onset of c-jun 
expression: c-jun mRNA is rapidly and transiently induced in response to 
serum growth factors and tumour promoters (Lamph et al, 8 8 ; Quantin et 
al, 8 8 ; Ryder et al, 8 8 ; Ryseck et al, 8 8 ); the mRNA and protein levels 
are markedly repressed in quiescent NIH3T3 fibroblasts (Pfarr et al, 94); 
and elevated c-jun expression is associated with Go/G1 transitions (Kovary 
et al, 91; Ryseck et al, 8 8 ; Zwiller et al, 91). The relationship between c- 
jun expression and growth promotion has been further substantiated by the
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increase in AP-1-dependent transactivation commonly observed in growth 
stimulated cells. De-regulated expression of human c-Jun, for example, 
induces cellular transformation of primary REFs in association with 
activated Ha-ras. Transformation correlates with an up-regulation of AP-1- 
dependent gene expression and is reversed by a dominant negative 
mutant of c-Jun lacking a functional amino terminal transactivation domain 
(Schutte et al, 89). The same mutant has been shown to repress the 
transactivation of several oncoproteins including c-Fos and c-Jun (Lloyd et 
al, 91), and to repress AP-1-dependent transactivation in two malignant 
epidermal cell lines, thereby inhibiting their sub-cutaneous tumour 
formation in nude mice (Domann etal, 94).
In other cell types c-Jun expression has been associated with growth 
cessation. Stimulation of Balb/c keratinocytes with TGF-B1, for example, 
induces a repression of cell growth and a concomitant activation of c-jun 
expression (Ginsberg etal, 91). A similar reversal of c-jun expression has 
been associated with certain in vivo differentiation pathways. F9 and P19 
embryonal carcinoma cells exhibit a high proliferative potential in the 
absence of c-jun expression, but exit from the cell cycle and rapidly 
express c-jun in response to differentiation stimuli (de Groot et al, 90(i); de 
Groot et al, 90(ii)). In addition, an inverse correlation has been observed 
between the cellular transformation of F9 embryonal carcinoma cells and 
AP-1-dependent transactivation (Havarstein et al, 92). This correlation 
suggests that, in specific cell types, c-jun expression is associated with 
the regulation of growth attenuating genes. In support of this hypothesis, 
overexpression of c-Jun (or c-Fos) has been shown to reduce the 
tumourigenic and metastatic potential of high metastatic cell lines through 
an induction of MHC class 1 gene expression (Yamit-Hezi et al, 94). An 
inverse correlation between AP-1-dependent transactivation and cellular 
transformation has similarly been reported in c-Jun- and v-Jun-expressing
42
primary CEF cultures (Hartle et al, 92; Havarstein et al, 92; Wong et al, 
92), leading to the proposal that c-Jun functions as a tumour suppressor 
gene in specific cell types, activating the expression of growth attenuating 
genes under normal growth conditions.
Transactivation of growth attenuating and growth promoting genes would 
clearly enable c-Jun to function as a dual regulator of cell growth in vivo. 
The evidence described above supports this proposal and suggests that 
each regulatory function is restricted to particular cell types, presumably 
due to the presence or absence of additional AP-1 transcription factors and 
cell-type-specific accessory proteins.
- c-Jun Transrepression Function
Transrepression provides an alternative interpretation of the results 
decribed above. Evidence associating c-Jun with a transrepressor activity, 
however, has not been widely reported, and is mainly confined to 
analyses of the v-Jun oncoprotein. v-Jun, for example is a poor 
transactivator in primary CEFs but a strong inducer of in vitro 
transformation and in vivo tumourigenesis (Bos et al, 90; Wong et al, 92). 
This has led to the proposal that v-Jun mediates transformation of primary 
CEFs through a passive inhibition of growth attenuating genes (Hartle etal, 
92; Havarstein etal, 92; Wong et al, 92; section I.C 2.). Active inhibition 
of growth promoting genes has similarly been associated with the v-Jun 
oncoprotein. The metastatic potential of a mouse papilloma cell line, for 
example, was reduced through an overexpression of v-Jun. Metastatic 
suppression correlated with a specific repression of the AP-1-dependent 
stromalysin gene required for the invasion of the basement membrane by 
malignant epithelial tumours (Tsang etal, 94).
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These observations suggest that transrepression is a specific function of 
the v-Jun oncoprotein that might contribute to the differential transforming 
activities of v-Jun and c-Jun in vitro and in vivo. This interpretation is not 
favoured by the results presented in one report. In this investigation 
overexpression of murine c-Jun was associated with a reversal of the 
transformed phenotype in primary REFs co-transfected with c-Myc and 
activated Ha-ras (Ginsberg et al, 91). Repression was dependent on a 
domain immediately ajacent to the basic region and did not require the 
leucine zipper or amino-terminal transactivation domains. A novel 
mechanism of transrepression was proposed. Curiously, this domain is 
essential for c-Jun-induced growth promotion in CEFs (Hartl et al, 92), 
which exhibit an inverse correlation between Jun transactivation and 
transformation (Hartl et al 92; Havarstein et al, 92; Wong et al, 92). 
Consequently this previously uncharacterized domain may be involved in 
c-Jun-dependent transrepression of both growth promoting (REFs) and 
growth attenuating (CEFs) genes, and thereby contribute to the specific 
growth regulatory functions of c-Jun in different cell types.
I.C.2. MECHANISMS OF JUN-INDUCED CELLULAR 
TRANSFORMATION
I.C.2a Qualitative and Quantitative Changes in Gene Expression
Overexpression of c-Jun and v-Jun has been proposed to induce cellular 
transformation through aberrant gene expression (Castellazzi et al, 90; 
Castellazzi et al, 91; Schutte et al, 89). c-Jun and v-Jun transactivate
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gene expression through AP-1/TRE regulatory elements (Angel et al, 8 8 (i); 
Bohmann et al, 89; Chiu et al, 89). In accordance with this, a direct 
correlation has been observed between AP-1-dependent transactivation 
and the co-transformation of primary REFs by c-Jun and activated Ha-ras 
(Alani etal, 91). Transformation of primary REFs was not abolished in the 
presence of c-Jun/GCN4 or c-Fos/GCN4, which exclusively homodimerize 
to transactivate AP-1-dependent genes (Oliviero et al, 92). Consequently, 
quantitative changes in AP-1-regulated gene expression may be sufficient 
to mediate the cellular transformation of specific cell types in vitro (Oliviero 
etal, 92). In vivo tumourigenesis, however, is exclusively associated with 
high levels of the v-Jun oncoprotein and presumably requires additional 
qualitative mutations not present in the c-Jun protein. Overexpression of 
c-Jun and JunB, for example, is associated with third stage dermal 
fibrosarcomas but is not sufficient to induce a fully transformed phenotype 
(Bossy-Wetzel et al, 92). Similarly, primary CEFs exhibit a partially 
transformed phenotype in the presence of high c-Jun expression, but are 
incapable of forming tumours in nude mice (Wong etal, 92).
The structural mutations present in v-Jun are located in the carboxy and 
amino-terminal regions of the protein and are described below. They have 
been proposed to relieve v-Jun from DNA binding and transcriptional 
regulation, thereby facilitating v-Jun-mediated tumourigenesis in vivo 
(Figure 1.1).
- 6  deletion
The 5 domain is essential for the transcriptional regulation of c-Jun. It is 
recognized by the Jun-amino-terminal kinase, JNK, which phosphorylates 
c-Jun at serines 63 and 73 in response to various inducing stimuli (Hibi et 
al, 93). The v-Jun oncoprotein lacks an intact 6  domain (Maki et al, 87;
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Nishimura etal, 8 8 ; Figure 1.1). Consequently, v-Jun does not present a 
binding site tor JNK and has been proposed to express an intrinsically 
weaker transactivation activity than the c-Jun protein (Hibi et al, 93). The 
consequences of this are complex and cell-type dependent. In avian cells, 
for example, c-Jun is believed to transactivate growth attenuating genes, 
thereby effecting an an inverse correlation between transactivation and 
transformation (Havarstein etal, 92; Lloyd et al, 91); whereas in REFs, 
the reverse is true (Alani et al, 91; Lloyd et al, 91). If v-Jun transactivation 
is intrinsically weaker than c-Jun, owing to the lack of JNK regulation, 
transformation of both cell types would ensue through the poor 
transactivation of growth attenuating (CEFs) or growth promoting (REFs) 
genes. In support of this hypothesis, it has been reported that c-Jun is a 
more potent oncogene than v-Jun in the REF co-transformation assay 
(M.Birrer - personal commun.), and that v-Jun is a poor transactivator in 
CEFs (Havarstein etal, 92).
In other cell types v-Jun has been reported to transactivate gene 
expression more strongly than c-Jun (Baichwal et al, 90; Bohmann et al,
89). Enhanced transactivation is directly associated with the absence of 
the 6  domain (Bohmann et al, 89), which is proposed to act as a 
transcriptional repressor in c-Jun by mediating an interaction between a 
cell-type-specific inhibitor (I) and the c-Jun E domain (Baichwal et al, 92). 
In support of this hypothesis, competition analysis has demonstrated 
super-transactivation in the presence of exogenous full length c-Jun 
protein, that is presumed to result from a Jun-mediated titration of a cell- 
type-specific inhibitor (Baichwal et al, 90). Enzymatic or allosteric 
mechanisms could mediate an E/I/8  interaction in vivo. JNK clearly binds 
to a domain that overlaps with the 8  domain (Hibi et al, 93) and 
consequently may be masked by the E/I interaction. However, v-Jun is 
slightly super-transactivated in the presence of c-Jun, supporting the
46
proposal that the E/I interaction exerts a negative transcriptional effect 
even in the absence of a productive JNK/Jun interaction (Baichwal et al,
90).
The relevence of these observations in vivo is not clear. The experiments 
described above were exclusively performed with c-Jun and v-Jun 
homodimers, although studies to detect c-Jun homodimers in vivo have 
not been successful (Kovary et al, 91; Kovary et al, 92). In addition, when 
c-Jun/c-Fos heterodimers were used in the titration analysis no super­
transactivation was observed, suggesting that the heterodimer is not 
subject to this additional level of control (Baichwal et al, 90). Thus, cell- 
type-specific inhibition of c-Jun transactivation may be confined to c-Jun 
homodimers and provide a regulatory mechanism by which c-Jun 
homodimeric transactivation is suppressed and transformation of specific 
cell types, such as primary CEFs, mediated (Castellazzi et al, 90; 
Castellazzi et al, 91; Wong et al, 92). By this analogy, additional 
qualitative changes in gene expression, associated with v-Jun-mediated 
tumourigenesis in vivo, would presumably depend on the weaker, but 
constitutively active, v-Jun-specific transactivation domain.
- C-Terminal Point Mutations
Two point mutations in the carboxy terminus of v-Jun have been reported 
to directly affect its DNA binding activity in vitro. The serine to 
phenylalanine mutation at serine 243 converts v-Jun into a constitutively 
active DNA binding protein, no longer inhibited by casein kinase II 
phosphorylation (Lin et al, 92). The cysteine to serine mutation in the v- 
Jun DNA binding domain, represents a gain of function mutation that 
relieves v-Jun from Redox regulation (Abate et al, 90(iv)). Both mutations 
have been proposed to activate v-Jun DNA binding and are presumed to
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contribute to its transforming activity in vitro and in vivo (Abate et al, 90(i); 
Lin etal, 92).
An additional effect of the carboxy-terminal mutations may be to alter the 
spectrum of DNA binding sequences recognized by v-Jun-containing homo 
and heterodimers. Preferential recognition could be mediated directly 
through differential binding affinies, or indirectly through a unique subset 
of v-Jun dimerization partners. In support of this proposal, in vivo viral 
and cellular Jun complexes have been reported to interact differentially 
with a variety of AP-1 and CREB-like target sequences (Hadman et al, 93) 
and in vivo tumourigenesis requires both carboxy-terminal mutations in the 
v-Jun oncoprotein (Wong et al, 92). The 6  domain, in contrast, 
contributes to the latency of tumour development but is otherwise 
dispensible for tumourigenesis. These observations suggest that the 
carboxy-terminal mutations direct the expression of an overlapping but 
distinct subset of target genes, essential for v-Jun-dependent 
tumourigenesis in vivo (Wong et al, 92). Alternative subsets of c-Jun and 
v-Jun-specific target genes could mediate their differential transforming 
effects in vivo and in vitro (Castellazzi et al, 90; Castellazzi et al, 91; 
Wong et al, 92), and provide an explanation for the distinct morphologies 
exhibited by c-Jun and v-Jun transformed fibroblasts (Pfarr et al, 94; 
section III.B.2b).
I.C.2b. Concentration-Dependent Changes in AP-1 Regulated Gene 
Expression
Overexpression of c-Jun (or v-Jun) is sufficient for the induction of cellular 
transformation in primary CEFs (Bos et al, 90; Hartle et al, 92; Havarstein 
et al, 92). This contrasts with the proposed tumour suppressor effects of c-
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Jun in non-transformed CEF cultures (Hartle et at, 92; Havarstein et al,
92), and suggests that c-Jun mediates growth promotion and growth 
attenuation in a concentration-dependent manner. Concentration- 
dependent gene expression has been observed for many cellular 
transcription factors, including c-Jun (Schneikert et al, 91), and is often 
associated with the phenomenon of squelching (Gill et al, 8 8 ; section
I.B.6 b). c-Jun has been reported to interact with components of the basal 
transcriptional machinary (Kraft; in press), and with transcriptional co­
activators (Oehler et al, 92), suggesting that it may be capable of 
mediating squelching effects at high concentrations in vivo. Alternatively, 
concentration-dependent changes in gene expression may be mediated 
through the formation of different AP-1 dimers. The spectrum of AP-1 
dimers detected in vivo is thought to be determined by the relative 
concentrations of each constituent protein (Kovary et al, 92). c-Jun/Fra2 
heterodimers, for example, are the predominant AP-1 DNA binding 
activity detected in exponential and quiescent CEFs (Nishina et al, 90; 
Suzuki et al, 94). In the presence of high exogenous c-Jun or v-Jun, the 
dimerization eqilibrium is proposed to shift in favour of c-Jun or v-Jun 
homodimers (Hughes et al, 92). The consequences of this for Jun- 
mediated cellular transformation are not known, but it may be significant 
that different AP-1 dimers exhibit independent transactivation activities and 
preferentially bind distinct subsets of target regulatory sequences (Deng et 
al, 93; Ryseck eta l, 91; Suzuki et al, 91). If preferential recognition 
includes c-Jun- and v-Jun-specific non-consensus AP-1-regulated target 
sequences, then this may provide an explanation for the apparent inverse 
correlation between Jun-mediated cellular transformation and AP-1- 
dependent transactivation in primary CEFs (Hartle et al, 92; Havarstein et 
al, 92), and the differential effects of c-Jun and v-Jun on cellular 
transformation in vitro.
CHAPTER II - METHODS and MATERIALS.
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CHAPTER II - METHODS
II.A. CELL CULTURE
ll-A.1. CELL GROWTH AND PREPARATION
Primary cultures of CEF cells were prepared as described by Tato et a l 
Cells were maintained in DM EM supplemented with 10% tryptose 
phosphate broth, 1 0 % newborn calf serum, 2 % heat inactivated chicken 
serum (56°C for 2hrs), and 2mM glutamine, in humidified 37°C 
incubators containing 5% (v/v) C0 2 - Confluent cultures were passaged 
approximately 1:5 every 2-3 days. For a T25 tissue cultue flask, the 
growth medium was aspirated and the cells washed with 5ml PBS. 5ml of
0.25% trypsin in CT buffer (see Materials) was slowly added and then 
aspirated off to leave a thin film. The culture flasks were left at room 
temperature until the monolayer could be detatched by gentle agitation. 
The cells were resuspended in growth medium and reseeded at an 
appropriate density. Cultures were maintained in this manner for no longer 
than 4 weeks or 7 subcultures.
Quiesced cultures were prepared as follows. Growth medium was 
aspirated from subconfluent flasks and the cells washed twice in DM EM. 
For a T25 flask, 5ml of DMEM supplemented with 0.2% newborn calf 
serum and 2mM glutamine was added, and the culture maintained at 
37°C for 48hrs. Under these conditions the cultures reached confluence 
but then underwent a complete cessation of growth, as measured by 
uptake of tritiated thymidine (Dr A. Catling; personal commun.).
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II.A.2. STORAGE
Confluent cultures of CEFs were trypsinized as described, and
resuspended in DM EM supplemented with 40% fetal calf serum at 1-2 
x10? cells/ml. An equal volume of DMEM containing 20% DMSO was 
added dropwise to the cells over approximately 2min. The cells were 
divided into 1ml aliquots in 1-2ml Nunc cryotubes and frozen well insulated 
at -70°C. After 1-2 days individual tubes were transferred to liquid 
nitrogen for long term storage.
II.A.3. TRANSFECTION AND G418 SELECTION 
II.A.3a Collagen
All CEF transfections and clonal expansions were performed on
collagenated tissue culture dishes. Dishes were coated in 1 mg/ml collagen 
in 1 % acetic acid, for 2-5min, and then drained and air dried.
II.A.3b Transfection and Selection
Secondary CEFs were seeded at 3x105/T25 flask or 8x105/90mm dish 
and incubated at 37°C overnight. A Calcium Phosphate precipitate was 
prepared as follows:
1. 10ug of SFCV based plasmid (Figure 3.6) in 10ul TE buffer 
(10mM Tris HCI, 1mM EDTA, pH 8.0 ), was mixed with 2ug
RCAN (1 mg/ml in TE) as a helper virus, and 240ul 0.2x SSC
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(20x stock is 175.3g NaCI, 88.2g tri sodium citrate per litre) in a 
sterile plastic bijoux.
2. 35ul of 2M CaCl2  was added and the contents gently mixed.
3. 250ul of 2x HEBS ( 2x HEBS is 274mM NaCI, 10mM KCI, 1.4mM 
Na2 HPO4 .7 H2 0 , 11mM glucose, 38mM HEPES, pH 7.1) was 
added and the mixture allowed to stand at room temperature for 
30min.
The overnight cultures were washed in 5ml PBS and refed with 5ml of 
growth medium. The resulting precipitate was added dropwise with gentle 
mixing to the medium, and the cultures incubated at 37°C for 4hrs. After 
4hrs the medium was aspirated and the cells washed in 3ml growth 
medium. The cultures were shocked in 1ml HEBS-glycerol (1x HEBS with 
15% glycerol) for 4min at room temperature and then washed as before. 
5ml of growth medium was added and the cells incubated at 37°C for 4-6 
days until confluent. The cultures were split 1:2 and G418 added to a final 
concentration of 1 mg/ml. Selection continued in this way for 14-21 days. 
This resulted in the death of mock transfected cultures and uniform 
infection, as judged by western blot analysis and cell morphology.
Virus particles were harvested from 90mm dishes of uniformly-infected 
cultures. The growth medium was aspirated and the cells washed twice 
with DMEM. The cultures were fed with complete growth medium 
supplemented with 1 % DMSO and reincubated for 4hrs (5ml medium) or 
overnight (10ml medium) at 37°C. The media was collected and filtered 
through a 0.22um sterile filter to remove any detatched cells. Virus 
particles were stored for long term use at -70°C.
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II.A.4. VIRAL INFECTION AND SOFT AGAR CLONING ASSAYS
II.A.4a Viral Infection
Soft Agar Assays were used as an indicator of anchorage indepent growth. 
Primary CEFs were subcultured 1:6 on 60mm dishes and incubated 
overnight at 37°C until approximately 70% confluent. The cells were 
washed in sterile PBS and fed with 4ml of growth medium supplemented 
with 2 ug/ml polybrene. 1 ml of overnight virus collection was added to the 
medium and the contents gently mixed. The cultures were incubated at 
37°C until confluent and then expanded into two T75 flasks for seeding 
into soft agar.
II.A.4b Soft Agar Assay
0.72% base agar plates were prepared by mixing 43ml of sterile 2.5% 
Difco bacto-agar with 81ml of hard agar mix (described below) at 44°C. 
The base agar was poured into 60mm dishes at 4ml/dish and left to set at 
room temperature. The dishes were equilibrated in a 37°C incubator 
before overlaying.
Virally-infected cells were diluted to the desired concentration (1 0 ^, 1 0 ^, 
105/ml) in growth medium and diluted with an equal volume of 0.72% 
base agar mix, maintained at 44°C. The base plates were overlayed with 
2ml of the soft agar/cell mix and allowed to set at 4°C. The dishes were 
incubated in a humidified 37°C incubator containing 5% CO2  (v/v), and 
fed every 3-4 days with 2ml of soft agar. The assays were typically 
performed in triplicate with colonies appearing 14-21 days after seeding.
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Hard Base Agar (0.72%) DM EM x2
DM EM x2 50ml 10x DM EM 40ml
Tryptose phosphate 1 0 ml Sodium bicarbonate 2 0 ml
Foetal calf serum 1 0 ml Sodium pyruvate 4ml
Chicken serum (HI) 2 ml distilled water 160ml
Penicillin (50U/ml) 0.5ml
Streptomycin (50ug/ml) 0.5ml
Glutamine (200mM) 1 ml
Folic acid (0.8%) 1 ml
MEM Vitamins 100x 1 ml
Sodium bicarbonate 5ml
2.5% agar 43ml
Soft Agar Colonies were picked for screening and a second round of 
cloning approximately 21 days after seeding. Individual colonies were 
picked with a one way valve mouth pipette into 500ul of growth medium in 
a 24 well dish, and disseminated with repeated pipetting. After overnight 
incubation any remaining non-adherent cells were further disseminated 
through a 23G needle. The cultures were fed and expanded into 90mm 
dishes over 1 -2 weeks. Virus was collected for a second round of soft agar 
cloning and lysates prepared for western blot analysis (section II.D.3).
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II.A.5. IMMUNOFLUORESCENCE 
II.A.5a Indirect Immunoflourescence
Sterile 13mm diammeter coverslips were coated in poly-L-lysine 
(13.2ug/ml distilled H2 O ) and incubated at 37°C overnight. Dried 
coverslips were transferred into 24 well dishes and seeded with 2 x1 0 ^ 
cells in 500ul growth medium at 37°C overnight. The cells were fixed in 
10Oul of 3.3% paraformaldehyde (see below) for 15min, and then 
permeablized three times in 10Ou! of PBS/0.5% Triton X-100 for 10min. 
Permeabilized cells were incubated with 50ul of anti c-Jun specific antisera 
(see section II.E.2), diluted 1:100 or 1:500 in PBS/0.5% Triton X-100, in a 
humidified dark environment to prevent cellular dessication. The cells 
were washed three times in 50ul PBS/0.5% Triton X-100 for 5min and 
incubated as described above with 50ul of GAR FITC, diluted 1:100 in 
PBS/0.5% Triton X-100. After three washes in PBS/0.5% Triton X-100 and 
three rinses in sterile PBS, the coverslips were mounted in antifade (2.5% 
DABCO in 50:50 glycerol/PBS), and sealed with nail varnish on 
microscope slides. The slides were stored in the dark at 4°C for up to 6  
months.
All manipulations were performed at room temperature and followed by 
two washes in sterile PBS unless otherwise stated.
3.3% Paraformaldehyde
Heat 3.3g of paraformaldehyde and 100ml sterile PBS to 70°C in a
fume cupboard.
Dissolve with drops of 1.0M NaOH.
Cool on ice and pH to 7.3 with 1.0M NaOH.
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II.B. RECOMBINANT DNA TECHNIQUES
I1.B.1. BACTERIAL HOST CELLS FOR TRANSFORMATION 
II.B.Ia Growth Conditions
E. coli strain DH1 was obtained from D. Crouch. Strain DH5a was 
obtained as competent cells from Life Technology Industries. Host cells 
and derivatives were grown at 37°C with good aeration in L-broth 
supplemented with 1 0 0 ug/ml ampicillin.
1I.B.1 b Competent Cells
2.5ml of an overnight culture of DH1 was diluted with L-broth to 250ml in a 
2L flask, and grown until the absobance at 600nm reached 0.3 (1cm path 
length, L-broth blank). The cell suspension was cooled on ice and 
centifuged at 8,000 rpm for 8 min at 4°C in a Sorvall GS3 rotor. The log 
phase cells were collected as a pellet and washed twice in 100ml 0.1 M 
NaCI, 5mM MgCl2 . The cell pellet was collected by centrifugation as 
described above and carefully resuspended in 50ml 100mM CaCl2 , 5mM 
MgCl2 - The suspension was incubated on ice for 20min and then 
centrifuged as before. The supernatant was decanted and the cell pellet 
resupended in 10ml 100mM CaCl2 , 5mM MgCl2 , 15% glycerol. The 
suspension of competant cells was divided into 0 .1 -1 .0 ml aliquots on dry 
ice and stored at -70°C.
All solutions were sterilized and maintained at 4°C before use.
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II.B.Ic Transformation of Bacterial Hosts DH1 and DH5a
E. coli strains DH1 and DH5a were routinely used to propagate cloned and 
commercially obtained plasmids. 25-50% of ligation mix or 10-50ng of 
plasmid DNA was added to a precooled eppendorf tube and stored on ice. 
10Oul or 200ul of competent DH5a or DH1 cells respectively were thawed 
on ice and then mixed gently with the DNA of interest. The mixture was 
incubated on ice for a further 30-45min and then heat shocked at 42°C for 
2min to allow DNA uptake. 800ul of prewarmed L-broth was added and 
the cell suspension incubated at 37°C for 60min to induce expression of 
the antibiotic resistance marker. 10Oul was plated on agar plates (1.5% 
agar in L-broth) supplemented with the appropriate antibiotic. The 
remaining 900ul of cell suspension was gently centrifuged for 10sec and all 
but 10Oul of the supernatant drawn off. The cell pellet was resuspended in 
the remaining 10Oul and plated out as before. The agar plates were 
incubated inverted at 37°C overnight to allow colony formation.
II.B.Id Glycerol Stocks
E. coli transformants of interest were stored as glycerol stocks for future 
use. 500ul of a stationary phase L-broth culture was mixed gently with an 
equal volume of glycerol in a sterile plastic 1 -2 ml nunc cryotube and stored 
at -70°C. A sterile plastic loop was used to retrieve cells as and when 
required.
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II.B.2. BACTERIAL HOST CELLS FOR PHAGE PROPAGATION
II.B.2a Growth conditions
E Coli strain WL87 was obtained from V. Fincham. Host cells were grown 
at 37°C with good aeration in L-broth supplemented with 10mM MgS0 4  
and 0.4% maltose. Stationary phase plating bacteria were recovered by 
bench top centrifugation at 3000rpm for 5min, and resuspended at 
approximately 1 0 8  cells/ml (1 ODgoo = 8x10 8  cell/ml) in sterile 1 0 mM 
MgSC>4 . Plating bacteria were stored at 4°C for up to 48hrs. Glycerol 
stocks were prepared as described in section II.B.Id and stored at -70°C.
II.B.2b Phage Quantitation
Caesium chloride preparations of bacteriophage X (section II.B.6 bi) were 
titred onto stationary phase WL87 cultures to estimate the concentration of 
intact phage particles present. Serial dilutions of bacteriophage X were 
made into TMN buffer (10mM Tris-HCI, pH 7.5, 0.1 M NaCI, 10mM MgCI2) 
and 10ul of each dilution adsorbed to 0.2ml plating bacteria at 37°C for 
20min. Sterile top agar (7.5% agar in L-broth supplemented with 10mM 
MgS0 4 > was melted in a boiling water bath and cooled to 47°C. 3.0ml 
was added to each adsorption mix and the contents plated out onto 
100mm agar plates (15% agar in L-broth supplemented with 10mM 
MgS0 4 ). After overnight incubation plates were scored for individual 
plaque forming units.
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II.B.2c Packaging and Adsorption
An appropriate amount of phage lambda ligation mix was packaged using 
the Gigapack II Plus Packaging Extract Kit according to the manufacturer's 
instructions. The packaging mix was serially diluted and plated out as 
described above. An optimum dilution was replated in proportionally 
bigger volumes on 2 0 x2 0 cm dishes for screening.
II.B.2d Screening Bacteriophage X Libraries
Nitrocellulose filter lifts were made in triplicate from 20x20cm dishes using 
a series of needle marks to align the membranes. Filters were washed in 
denaturation buffer (section II.B.8 ) for 30-60sec and then in neutralization 
buffer (section II.B.8 ) for 5min. They were rinsed in 5x SSC (20x SSC is 
175.3g NaCI, 88.2g NaOH in 11 distilled water, pH 7.0) for 5min and blot 
dried. The membranes were fixed at 80°C for 2hrs and screened as 
described in section II.B.8 . Autorads were aligned by the original needle 
marks and used to identify positive plaques. These were picked as soft 
agar plugs with a blunt ended pasteur pipette. Plugs were transferred into
1.0ml TMN buffer supplemented with a drop of chloroform in a sterile 
universal. After elution at room temperature for 1-2hrs, the phage 
particles were titrated as before and plated onto 1 0 0 mm agar dishes for 
secondary screening. Minipreparation phage DNA was prepared from 
positive secondary plaques (section II.B.6 bii) and digested with an 
appropriate enzyme for Southern Blotting analysis (section II.B.8 )
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II.B.3. RESTRICTION DIGESTS AND SIZE SEPARATION OF DIGESTED 
FRAGMENTS
II.B.3a Restriction Digests
Restriction digests were performed under buffered conditions using 
commercially obtained buffers specific for the enzyme of choice. 1-10 U of 
restriction enzyme per ug of DNA was added, depending on the enzyme 
used and the number of restriction sites present. The total volume of 
enzyme did not exceed one tenth of the final digestion volume. Typically, 
1 -2ug plasmid DNA was digested in a volume of 20ul for 1 -2hrs at 37°C. 
Larger quantities of DNA were digested in proportionally greater volumes. 
Genomic DNA was digested overnight in the presence of maximal 
concentrations of enzyme and 1 .OmM spermidine. Occasionally a second 
aliquot of enzyme was required for complete digestion of genomic DNA. 
Double digests were performed sequentially or as a single reaction 
depending on the buffering conditions specified by the manufacturer. 
Digests were terminated by the addition of one tenth gel loading buffer 
(50% sucrose w/v, 1.5% bromophenol blue w/v).
II.B.3b Size Separation of Digested Fragments
(i) Aaarose Gel Electrophoresis
DNA Restriction fragments were resolved on non-denaturing agarose gels. 
Resolution was dependent upon the DNA fragments of interest and the 
agarose concentration used, but for most purposes a 0.7% agarose gel 
was sufficient. Gels were prepared by heating powdered agarose in an 
appropriate volume of TAE buffer (10x TAE is g/l 48.44g tris, 27.22g 
sodium acetate, 7.5g EDTA ; pH 7.8 with glacial acetic acid) until all the
60
particles had dissolved. The solution was cooled to approximately 50°C 
and ethidium bromide added to a final concentration of 0.5ug/ml. The 
contents of the flask were poured into a gel cast and allowed to set at room 
temperature. The well former was removed and the gel installed in an 
electrophoresis tank containing TAE buffer. Samples for electrophoresis 
were mixed with one tenth volume of gel loading buffer and pipetted 
through the TAE buffer into the wells. 1ug of molecular weight standards 
(materials) were treated in the same manner. The samples were resolved 
by electrophoresis towards the anode and visualized by ethidium bromide 
staining. A UV sourse was shone from below to illuminate the gel and a 
permanent record made onto polaroid film.
(ii) Sucrose Gradient Centrifugation
Sucrose gradient centrifugation was used to enrich for a specific population 
of restriction fragments within a total digest pool. Breifly, 250-500ug of 
genomic DNA was digested according to conditions established for a 
previous pilot reaction, and an aliquot analysed on a 0.4% agarose gel for 
correct size distribution. The DNA was extracted and resuspended in 500- 
10OOul of 1xTE buffer. A 10-40% sucrose gradient was mixed in a gradient 
former according to Manniatis and decanted into a 13.2ml Beckman 
polyallomer tube. The DNA sample was heated to 6 8 °C for 10min, cooled 
to 20°C and loaded gently onto the gradient. The tubes were spun in a 
Sorval TH641 rotor at 25,000rpm at 20°C for 16hrs. 0.5ml fractions were 
recovered from the top of the gradient downwards using a slow speed 
peristaltic pump. 1 0 ul of each sample was diluted with 2 0 ul of distilled 
water and electrophoresed on a 1.0% agarose gel. Fractions containing 
the fragment of interest were identified by southern blotting (section II.B.8 ) 
and the DNA extracted for bacteriophage X cloning.
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II.B.4. ELUTION. EXTRACTION AND QUANTITATION OF DNA
II.B.4a Elution
(i) Agarose Gel
DNA fragments were excised from agarose gels under longwave uv 
illumination (300-360nm) to minimize DNA damage, and eluted using 
geneclean. This was carried out according to the manufactures 
instructions (Materials).
lii) Law Melting Point Agarose Gel
DNA fragments for oligolabeling (section II.B 8 ) were excised from 1% low 
melting point agarose gels as described above. The restriction digest was 
designed such that the band of interest contained at least 250ng of DNA. 
The gel slice was transferred to a sterile eppendorf tube and distilled water 
added to a final concentration of 3.0ml/gram gel slice. The eppendorf was 
heated to dissolve the agarose and the contents divided into aliquots for 
storage at -20°C.
(iii) Acrvlamide Gel.
DNA fragments of less than 500bp in length were resolved on 10% 
polyacrylamide gels (section II.D.7a). Polyacrylamide gels were stained in 
0.5ug/ml ethidium bromide for 30min at room temperature and the band 
excised as described above. The gel slice was cut up and the DNA eluted 
overnight at 37°C in no more than 400ul of polyacrylamide gel elution 
buffer (0.5M NH40Ac, 0.01 M MgOAc, 0.1 mM EDTA, 0.1% SDS). The 
acrylamide was removed by centrifugation and the DNA ethanol 
precipitated for further analysis.
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II.B.4b Extraction with Organic Solvents and Ethanol Precipitation
DNA samples were extracted with chloroform and/or phenol to remove 
contaminants such as restriction enzymes, nucleases and detergents, 
that can interfere with subsequent DNA manipulations. Typically the initial 
extraction was performed in an equal volume of phenol/chloroform. 
Phenol/Chloroform was prepared by mixing equal volumes of 1M Tris-HCI, 
pH 8.0 equilibrated phenol and chloroform/isoamyl alcohol (24:1) 
immediately before addition to the DNA sample. After addition the 
aqueous and organic phases were mixed thoroughly by vortexing and then 
separated by centrifugation in a bench top microfuge for 2 min at 
14,000rpm. This extraction was repeated if necessary. The aqueous 
phase was transferred into a fresh tube with an equal volume of chloroform 
(chloroform/isoamyl alcohol, 24:1) and the sample vortexed and 
centrifuged as before. This was repeated one more time to remove any 
traces of phenol from the upper aqueous phase. After the final extraction 
the aqueous phase was collected for ethanol precipitation.
Ethanol precipitation was used to collect and concentrate DNA samples, 
and to separate them from traces of salt, sucrose, and other solute 
contaminants. The aqueous solution of DNA was gently mixed with one 
tenth volume of 3M Sodium Acetate, pH5.2, and 2-2.5 volumes of ice cold 
ethanol. The sample was stored overnight at -20°C or alternatively placed 
on dry ice for 10-20min, to precipitate the DNA. Yeast tRNA was added to 
facilitate precipitation if the sample contained concentrations of less than 
10ug/ml DNA. Precipitated DNA was recovered by centrifugation in a 
bench top microfuge at 14,000rpm for 1 0 -2 0 min at room temperature or 
4°C. Precipitates were washed in a large volume of 70% ice cold ethanol 
to remove any traces of salt, air dried, and resuspended in an appropriate 
volume of TE buffer.
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ll.E3.4c Quantitation of DNA by Spectrophotometric Analysis
The concentration of DNA preparations was calculated from their 
absorbance at 260nm. Typically an appropriate dilution of a DNA solution 
was made into TE buffer and the absorbance of the sample read at 260nm 
and 280nm against a blank of TE. The readings were made in a quartz 
cuvette with a path length of 1cm. An A2 6 O ° f 1-0 was taken as being 
equivalent to a concentration of 50ug/ml plasmid or genomic DNA and 
30ug/ml oligonucleotide. The chemical purity of the DNA sample was 
determined by the ratio of absorbance at 260nm and 280nm. A ratio of
I.8-2.0 indicated that the DNA solution was essentially pure. Preparations 
with a ratio of significantly less than 1.8 were purified further by extraction 
and precipitation.
II.B.5. ENZYME MODIFICATION
ll.E3.5a Dephosphorylation of 5'termini
Calf Intestinal Alkaline Phosphatase was used to dephosphorylate 5'termini 
after restriction endonuclease digestion. Phosphatase reactions were 
performed under buffered conditions with 1U of enzyme essentially 
according to the method outlined in Maniatis. Phosphatased DNA was 
extracted twice with phenol/chloroform and ethanol precipitated as 
described in section II.B.4b.
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II.B.5b 5’ Phosphorylation of 5' Termini
5' phosphorylation of 5' termini was used to label DNA probes for 
electrophoretic mobility shift assays. Briefly, 200ng of double stranded 
oligonucleotides was phoshorylated in a final volume of 20ul kinase buffer 
(100mM Tris-HCI, pH 8.0, 10mM MgCl2, 7mM DTT ) with 2 units of 
polynucleotide kinase and 25-50 uCi (y-32p) a t p  (3000Ci / mmol). The 
reaction was allowed to proceed at 37°C for 30min.
II.B.5c Ligation of DNA Fragments
DNA fragments were ligated over a range of molar concentrations to 
determine the optimal conditions for ligation. Reactions were performed in 
small volumes, typically 10-20ul. For a 20ul reaction the following 
components were assembled on ice:
10-20ng linearized phosphatased vector DNA
2-10 fold molar excess of purified DNA insert
4ul 5x ligation buffer (250mM Tris-HCI,pH7.8, 50mM MgCl2 , 100mM
DTT, 5mM ATP, 250ug/ml BSA)
Distilled water to 18ul 
2.0ul T4 DNA Ligase
The ligation was mixed gently and allowed to stand at room temperature 
for 30min before overnight incubation at 4°C. Optimum ligation conditions 
were determined by visual inspection of pre and post ligation samples on 
agarose gels. Successful ligations were used to transform bacterial hosts 
immediately or stored at -20°C for future use.
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II.B.6. DNA PREPARATION
II.B.6a Preparation of Plasmid DNA
li) Plasmid Minipreparations
Small-scale preparations of plasmid DNA were prepared according to an 
unpublished method of Dr D.Crouch.
Solutions
Lvsis Solution 25mM Tris-HCI, pH 8.0
10mM EDTA, pH 8.0 
50mM glucose
Alkaline/SDS 2M NaOH
1.0% SDS
Single bacterial colonies were picked into 2.0ml L-broth supplemented with 
the appropriate antibiotic and grown up overnight. 1.5ml was transferred 
to an eppendorf tube and the bacteria collected by centrifugation at 
6000rpm for 1min in a bench top microfuge. The bacteria were 
resuspended in 200ul lysis solution and lysed with 400ul alkaline / SDS on 
ice for 5min. 300ul of 3.0M sodium acetate pH 4.8 was added and the 
solution mixed thoroughly by vortexing. Chromosomal DNA was 
precipitated on ice for 5-10min and recovered by centrifugation at high 
speed for 5min in a bench top microfuge. 500ul of supernatant was 
transferred into a fresh eppendorf tube and the plasmid DNA precipitated
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on dry ice in the presence of an equal volume of isopropanol. The 
precipitate was centrifuged as before and reprecipitated from 0.3M sodium 
acetate pH 5.2 and 2.5 volumes of ethanol. The pellet was resuspended in 
75ul 1x TE and used at 5.0ul per restriction endonuclease digestion. 
Digestions also included a final concentration of 1 .Omg/ml RNAse A.
(ii) Large Scale Preparation of Plasmid DNA
Large scale preparations of plasmid DNA essentially followed a 
modification of the method outlined above. A 500ml overnight culture was 
harvested by centrifugation in a Sorvall GS3 rotor at 4,000rpm for 10min at 
4°C. The bacterial pellet was resuspended in 10ml of lysis solution and 
allowed to stand at room temperature for 5min before the addition of 20ml 
alkaline/SDS. The solution was mixed well and incubated on ice for 10min 
to ensure complete bacterial cell lysis. 15ml of 3M potassium acetate 
pH4.8 was added and the lysates incubated for a further 5min on ice. The 
chromosomal DNA precipitate was recovered by centrifugation at 
8,000rpm for 10min at 4°C. The supernatant was filtered through a double 
thickness of fine gauze and precipitated in 0.6 volumes of iso-propanol at 
room temperature for 15min. The bacterial DNA pellet was collected by 
centrifugation in a Sorvall SS34 rotor at 10,000rpm for 15min at room 
temperature. Precipitates were drained thoroughly and resuspended in 
8.0ml TE in a sterile plastic universal. Exactly 7.0g caesium chloride was 
added and the universal placed at 37°C until all the particulate matter had 
dissolved. 500ul of ethidium bromide was added and the solution 
transferred to a polycarbonate ultracentrifuge tube. Tubes were balanced 
to within 0.1 g and centrifuged at 40,000rpm for 40-48hrs at 20°C in a 
Sorvall T1270 rotor. Plasmid DNA was carefully syringed from the gradient 
with a 19G needle and extracted twice with an equal volume of butanol to 
remove the ethidium bromide. The DNA was dialysed overnight against a
67
large volume of TE buffer and then ethanol precipitated and resuspended 
in TE at 0.5-1 mg\ml. Large scale plasmid preparations were stored at 4°C 
or -20°C.
II.B.6b Preparation of Bacteriophage X DNA
(i) Large Scale Preparation
Step gradient solutions
CsCI/ q 1.3: 20.3g CsCI dissolved in 44.7ml TMN
TMN q 1.5: 34.0g CsCI dissolved in 41.0ml TMN
Bacteriophage X DNA was prepared essentially according to the protocol 
outlined in Manniatis (Maniatis et al, 78; Yamamoto et al, 70). 2-3ml of 
phage particles were purified on a caesium chloride step gradient prepared 
from 5ml of q1.5 CsCI and 4.5ml of q1.3 CsCI in 14ml Beckman cellulose 
nitrate centrifuge tubes. The gradients were balenced to within 0.1 g with 
TMN buffer and spun at 20,000rpm for 2hrs at 4°C in a Sorvall TH641 
rotor. Phage particles were syringed from the gradient with a 21G needle 
and stored at 4°C in caesium chloride or dialysed against 21 of TMN buffer 
overnight. Dialysed bacteriophage particles were treated with 50ug\ml 
proteinase K for 60min at 37°C in the presence of 20mM EDTA, pH 8.0 
and 0.5% SDS. The DNA was extracted in phenol/chloroform and ethanol 
precipitated. Precipitates were collected by spooling and washed in 70% 
ethanol. Phage particles were resuspended in TE buffer at 0.5mg\ml and 
stored at -20°C.
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(ii) Bacteriophage X MiniDreparation
Single, well isolated plaques were picked into 50ul of TMN buffer and 
adsorbed to 50ul of WL87 plating bacteria for 20min at 37°C. 10ml of L- 
broth supplemented with 10mM MgSC>4 was added and the cultures 
incubated at 37°C with agitation for 6-8hrs until cell lysis was evident. 
Phage particles were extracted from the cultures as outlined above 
(Maniatis et al, 78; Yamamoto et al, 70) but in proportionally smaller 
volumes and excepting the dialysis step. Precipitated DNA was 
resuspended in 10Oul of TE and digested at 20ul per reaction with 
1 .Omg/ml RNAse A.
II.B.6c Preparation of Genomic DNA
(i) Preparation of undigested Genomic DNA 
Solutions
TNE buffer 10mM Tris-HCI
400mM NaCI 
2mM EDTA, pH 8.2
Lvsis Buffer 40ug/ml proteinase K
0.5% SDs 
TNE buffer
Cells (-5x107) in T175 flasks were washed twice in PBS and lysed in 5.0ml 
lysis buffer at 37°C for 30min. The viscous contents were scraped into 
15ml falcon 2059 tubes and incubated at 37°C overnight. The solution
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was extracted twice in phenol/chloroform and once in chloroform. Each 
extraction was centrifuged at 5000rpm for 5min in a Sorvall HB4 rotor. The 
aqueous phase was transferred into a fresh tube using a wide bore pipette. 
Genomic DNA was then ethanol precipitated with 0.3M sodium acetate at 
room temperature. Precipitates were collected at the end of a sealed 
pasteur pipette and rinsed thoroughly in 70% ethanol. Excess ethanol was 
removed by air drying and the DNA dissolved in 1-2ml TE/T175 flask at 
room temperature overnight. Genomic DNA was stored at 0.5-1 mg/ml in 
TE at 40C.
(ii) Preparation of DNase 1 Treated Genomic_DNA
Preparation of DNase 1 treated genomic DNA was essentially according to
Stewart e ta l, with modifications made for CEF cell culture.
Solutions
Permeabilization solution 
(pH 7.5 with NaOH)
15mM Tris-HCI, pH 7.5
15mM NaCI
5mM MgCI2 
300mM Sucrose
60mM KCI
0.5mM EGTA
Lvsis solution 50mM Tris-HCI, pH 8.0 
20mM EDTA, pH 8.0
1.0% SDS
DNase 1 Storage Buffer 20mM sodium acetate, pH 6.5
5mM CaCI2
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0.1 mM PMSF 
50% (v/v) glycerol
Secondary CEFs were plated at approximately 5 x10® cells per 90mm dish 
and incubated overnight at 37°C. Cells were washed twice in PBS and 
drained thoroughly. DNase 1 (2mg/ml in storage buffer) was diluted over a 
range of concentrations (10-100ug/ml) in permeabilization buffer 
supplemented with 0.2% NP40 and 0.5mM B-Mercaptoethanol. 2.0ml of 
each dilution was layered onto a single monolayer and the cells incubated 
at room temperature for 3.5 min. The solution was aspirated off and 
replaced with 1.0ml of lysis solution. Proteinase K was added to 200ug/ml 
and the contents scraped into a sterile capped eppendorf tube and 
incubated overnight at 37°C. After a single extraction in 1.5ml phenol, 
nucleic acids were precipitated twice from 0.25M ammonium acetate and 2 
volumes ethanol. The pellet was rinsed in 70% ethanol, air dried, and 
resuspended in TE at 0.5-1 mg/ml.
II.B.6d Preparation of Oligonucietides
Tritylated oligonucleotides were synthesized on an Applied Biosystems 
model 381A DNA synthesizer. The oligonucleotide was eluted from the 
column in 2.0ml of concentrated ammonia (29%) for 1.5hrs at room 
temperature. The solution was transferred to a sealed glass vial and 
incubated overnight at 55°C. The deprotected oligonucleotide was passed 
through an oligonucleotide purification cartridge according to the 
manufacturers instructions (see materials). Full length oligonucleotides 
were dried down under vacuum and resuspended in TE at 1 .Omg/rnl.
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II.B-7. DOUBLE STRANDED DNA SEQUENCING
Double stranded sequencing was used to sequence avian c-jun genomic 
DNA and cloned derivatives thereof. The DNA was prepared and 
sequenced according to an unpublished method of Dr D. Crouch. 50ul of 
RNase A treated minipreparation plasmid DNA or 2.5ug of plasmid DNA (in 
50ul TE) was mixed with 30ul of 2.5M NaCI / 20% PEG and incubated on 
ice for 1 hr. DNA precipitates were recovered by centrifugation at 
14,000rpm for 15min in a bench top microfuge and washed in 70% 
ethanol. Air dried pellets were resuspended in 16.0ul TE and alkali 
denatured in 0.2M NaOH for 30min at 37°C. The DNA was precipitated on 
dry ice from 0.3M sodium acetate, and 2 volumes of ethanol. The pellet 
was washed as before and resuspended in 20ul TE. 7.0ul of this 
preparation was mixed with 2.0ul sequencing reaction buffer (USB 
Sequenase Kit) and 1.0ul primer (25ng/ul) and annealed for 30min at 
37°C. Sequencing reactions were then carried out using the USB 
Sequenase Kit according to the manufacturers instructions. The reactions 
were resolved as described in section II.C.3.
II.B.8. SOUTHERN BLOT ANALYSIS
10-20ug of genomic DNA was digested with an appropriate enzyme and 
resolved by agarose gel electrophoresis. Gels were washed with gentle 
agitation for 1 hr at room temperature in 200ml denaturation buffer (1.5M 
NaCI, 0.5M NaOH). The buffer was changed twice over this period. After 
rinsing briefly in water to remove traces of alkali, gels were gently agitated 
in 200ml of neutralisation buffer (1.5M NaCI, 0.5M Tris-HCI, pH7.5) for 
40min at room temperature.
72
Gel transfer to Hybond N(fp) membrane was effected by capillary action in 
20x SSC buffer. Transfer and subsequent fixation by UV cross linking, 
were performed according to the manufacturer's instructions. Membranes 
were sealed in 100ml of prehybridization buffer (6x SSC, 0.5% SDS, 5X 
Denhardts, 100ug/ml denatured salmon sperm DNA), and incubated at 
65°C in a shaking water bath for 2-4hrs. DNA probes were oligolabelled 
using commercially available kits from Pharmacia and Boehringer. 
Radiolabelled probes were separated from unincorporated nucleotides 
through Biorad Biospin 30 columns according to the manufacturer's 
instructions. Probes were denatured at 95-100°C for 2-5min and coooled 
on ice immediately prior to hybridization. Hybridization was carried out in 
sealed boxes in a minimal volume of prehybridization fluid supplemented 
with 10mM EDTA and the denatured oligolabelled probe. Boxes were 
incubated overnight in a shaking water bath at 65°C. Membranes were 
washed to high stringency according to the manufacturer's instructions, 
blot dried to remove excess fluid, and subjected to autoradiography at - 
70°C.
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II.C. RNA ANALYSIS
II.C.1. TOTAL RNA EXTRACTION AND QUANTITATION
Total RNA was harvested from confluent CEF cell monolayers grown in the 
presence and absence of serum growth factors. A T175 flask was lysed in 
10ml RNAzol solution and the contents transferred to a 15ml polypropylene 
falcon 2059 tube. RNA extraction was then carried out according to the 
manufacturer's instructions. Washed precipitates were air dried and 
resuspended in sterile distilled water. The concentration of total RNA 
preparations was measured spectrophotometrically as described in section 
II.B.4c. The spectrophotometer was calibrated using a blank of sterile 
distilled water. An A260 of 1.0 was taken as being equivalent to 40ug/ml of 
RNA. RNA preparations were stored at 1 .Omg/ml at -20°C and at -70°C.
II.C.2. PREPARATION OF ANTISENSE RNA PROBES
The transcription vector pSPT19 was used to generate antisense cjun 
riboprobes for RNase protection analysis. pSPT19 contains diametrically 
opposed SP6 and T7 transcription promoter sequences, separated by a 
multiple cloning site. JF4 c-jun cDNA, was subcloned into pSPT19 in the 
SP6 orientation by Dr E. Black (Figure 2.1). pSPT19/JF4(SP6) was 
linearized in the absence of RNase A, at a single Bgl II site prior to 
transcription. The linearized template was extracted sequentially with 
phenol/chloroform, and chloroform, and precipitated in 2 volumes of 
ethanol and 0.3M sodium acetate. The DNA pellet was air dried and
Figure 2.1
A plasmid map to illustrate the structure of pSPT19/JF4. pSPT19 /JF4 
contains an EcoRI fragment spanning an avian c-jun cDNA cloned into the 
transcription vector, pSPT19 (Figure 5.3). The cDNA contains ~ 25bp of 
5' untranslated leader sequence and ~300bp of 3' untranslated 
downstream sequences.
Figure 2.2
A plasmid map to illustrate the structure of pHSV-Bgal. pHSV-Bgal, used 
as an internal control for transfection efficiency, is derived from the lacZ- 
containing plasmid pCH110 (Hall et al, 83). Transcription of the lacZ gene 
is driven by the HSV-2 IE-5 promoter obtained from pLW2 (Gaffney et al, 
85).
PSPT19/JF4 (SP6)
(4 .2kbp )
Bgl11
FIGURE 2.1
H ill
FIGURE 2.2
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resuspended at 1.0mg/ml in sterile distilled water. Stock solutions were 
stored at -20°C.
For a single in vitro transcription reaction the following components were 
mixed on ice in a final volume of 20ul:
1-2ug linearized DNA template
4ul 5x transcription buffer (200mM Tris-HCI, pH 7.5, 30mM MgCI2, 
10mM Spermidine, 50mM NaCI)
1 ul RNasin
5mM GTP:ATP:UTP
100uCi (a-32P) CTP (800Ci/mmol)
2ul T7 RNA polymerase
The reaction was incubated at 37°C for 30-60min. 0.5mg/ml RNase free 
DNase 1 was added and the incubation continued for a further 10-15min. 
RNA was extracted sequentially in phenol, phenol/chloroform, and 
chloroform. The aqueous phase was passed through a Pharmacia Nick 
Column according to the manufacturer's instructions. 10Oul fractions were 
collected into STE buffer (10x STE is 100mM Tris-HCI, pH 8.0, 1.0M NaCI, 
10mM EDTA, pH 8.0) and 1.0ul of each counted in 5.0ml Ecoscint. The 
hottest fraction was retained as a probe for subsequent RNase protection 
analysis. A second smaller peak represented unincorporated radioactive 
nucleotides.
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I1.C.3. RNase PROTECTION ANALYSIS
Solutions
80% FAB 80% deionized formamide
400mM NaCI 
40 mM PIPES, pH 6.4 
1mM EDTA
Digest Buffer 10mM Tris-HCI, pH 7.6
5mM EDTA, pH 8.0 
0.3M NaOAc, pH 7.0 
40ug/ml RNase A 
150 U/ml RNase T1
30ug of total cellular RNA was mixed with approximately !o® cpm of 
antisense riboprobe in a sterile eppendorf, and dried down under vacuum 
spinning at room temperature. The pellets were resuspended in 20ul FAB 
and incubated in a water bath at 85°C for 5min. The temperature of the 
bath was slowly reduced to 50°C and the hybridization continued 
overnight. 300ul of digestion buffer was added and the samples incubated 
at 30°C for 60min to digest single stranded RNA. 2.5ul proteinase K 
(10mg/ml) and 3.2ul 20% SDS was then added for 15min at 37°C to 
terminate the digestion. Double stranded RNA was extracted sequentially 
with 5-20ug of carrier yeast tRNA, in phenol/chloroform (x1) and 
chloroform (x2). Two volumes of ethanol was added and the RNA 
precipitated on dry ice for 30min. The pellet was washed in 70% ethanol, 
air dried, and resuspended in 5ul loading buffer (95% formamide, 20mM 
EDTA, 0.05% Bromophenol Blue, 0.05% Xylene Cyanol FF). Controls
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containing the digested or the non-digested riboprobe alone were included 
in each experiment to illustrate the extent of digestion and to compare the 
migration of the full length riboprobe relative to the hybridized counterpart. 
A 1 kb DNA ladder was 5’ end labelled (section II.B.5b) to size the 
protected fragments. Reactions were resolved on 6% denaturing 
acrylamide gels (see below) at a constant 40W for 2hrs. Gels were fixed 
for 10-20min in 10% methanol, 10% acetic acid in water and dried down 
before autoradiography at room temperature.
Gel Mix - 75ml in distilled water
30% Acrylamide-bis (19:1 ; seq. grade) 15ml
Urea 31.5g
10XTBE buffer 7.5ml
(g/l; 108 tris base, 9.3 EDTA, 55 boric acid)
10% ammonium persulphate 450ul
TEMED 75ul
II.C.4. NUCLEAR RUN-OFF ANALYSIS 
II.C.4a Nuclei Extraction
Solutions
Hypotonic Buffer 10mM Tris-HCI, pH 7.5
10mM KCI
1.5mM MgCl2
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Glutamate Buffer 125mM Potassium glutamate
(stored at -20°C) 100mM Hepes, pH 8.0
5mM MgCl2 
2mMM DTT 
1mM EGTA 
40% Glycerol
Confluent CEF cells in T175 flasks were washed in ice cold PBS and 
trypsinized in 12.5ml 0.25% trypsin in CT buffer. 2x T175 flasks were 
harvested into 12.5ml newborn calf serum in a 50ml falcon tube. Any 
remaining cells were collected in a further 12.5ml ice cold PBS. The cells 
were recovered by bench top centrifugation at 1000rpm for 5min and 
washed in 50ml ice cold PBS. Cells were pelleted as before and 
resuspended in 5.0ml Hypotonic Buffer in a dounce homogenizer. The 
cells were dounced 2-3x to obtain an even suspension and a further 15- 
20x in the presence of 5.0ul Triton X-100 to promote cell lysis. Nuclei were 
harvested in a Sorvall HB4 rotor at 2000rpm for 10min at 4°C. Opaque 
pellets were resuspended in 0.5ml ice cold glutamate buffer in a sterile 
eppendorf tube. Nuclei were harvested for a second time at 3000rpm for 
30-60sec in a bench top microfuge, and the supernatant carefully 
aspirated to approximately 40ul. Pellets were vortexed briefly to 
resuspend the nuclei and stored at -70°C for several months.
II.C.4b Immobilization of DNA to Nitrocellulose Filters
Plasmid DNA was immobilized on nitrocellulose membranes using a Biorad 
Bio-Slot Microfiltration Apparatus. 10ug of DNA was diluted to 80ul in TE 
buffer, and alkali denatured in 0.4M NaOH, 10mM EDTA, pH 8.0 at 100°C 
for 10min. The samples were neutralized in an equal volume of 2.0M
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ammonium acetate, pH 7.0, and transferred to nitrocellulose according to 
the manufacturer's instructions. The membrane was fixed under vacuum 
at 80°C for 2hrs and prehybridized as described in section II.B.8. 
Individual filters were transferred to sterile plastic bijouxs containing a 
minimal volume of hybridization fluid (section II.B.8) and hybridized as 
described below.
II.C.4c Run-Off Assay
Nuclei from 4 T175 flasks were thawed on ice and mixed with the following 
components in a sterile eppendorf tube:
12ul 32p-UTP (240 uCi, 800 Ci/mmol)
0.5ul 1.0M creatine phosphate in 10mM Hepes, pH 8.0 
(stored in aliquots at -70°C)
1.2ul 2.0mg/ml creatine kinase in glutamate buffer 
1 .Oul nucleotide triphosphate solution 
(50mM ATP, 25mM GTP, 25mM CTP)
Nuclear runoff reactions were incubated in a 37°C water bath for 15min. 
RNA was extracted according to the manufacturer's instructions, in 800ul 
of RNAzol and 400ul of chloroform. Precipitates were washed in 70% 
ethanol, air dried, and resuspended in 90ul 0.5% SDS, 1 .OmM EDTA, pH 
8.0. 10ul of 3M NaOH was added to degrade the RNA to approximately 
100bp fragments, and the tubes incubated on ice for 10min. 10Oul of 
0.48M HEPES was added to neutralize the sodium hydroxide and the 
samples assayed for TCA precipitable radioactivity. Typically 2.0ul of 
labelled extract was mixed with 5.0ul of a 10mg/ml solution of yeast tRNA, 
and 83ul of sterile distilled water in a precooled eppendorf tube. Ice cold
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TCA was added to a final concentration of 10% and the tube incubated on 
ice for 1 hr. Precipitates were collected on Whatman GF-C filters and 
washed extensively in ice cold 10% TCA. Filters were washed with 95% 
ethanol, dried thoroughly and counted in 5.0ml Ecoscint. An eqivalent 
amount of TCA precipitable radioactivity was added directly to each 
parallel nitrocellulose filter in hybridization fluid. The filters were hybridized 
in a shaking water bath at 65°C for 48-72hrs and then washed to high 
stringency according to the manufacturer's instructions. Filters were rinsed 
twice in 1x SSC and incubated with 10ug/ml RNAse A in 20ml 10mM Tris- 
HCI, pH 7.5, 5mM EDTA, pH 8.0, 0.3M NaCI, in a 37°C shaking water 
bath for 30min. After a final wash in 1x SSC at 65°C for 15min, the filters 
were blot dried and subjected to autoradiography at -70°C.
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II.D. PROTEIN ANALYSIS 
II.D-1- PROTEIN EXTRACTION
II.D.1 a Preparation of Non-Denatured Nuclear Protein Extracts
Nuclear protein extracts for footprinting analysis (section II.D.6a) were 
prepared from normal and ASV 17-infected CEF stocks essentially 
according to O'Prey etal.
Group A Inhibitors - 100x stocks (-20°C).
50mM PMSF in isopropanol 
50mM Benzamidine
1.0M sodium butyrate
1.0M B-glycerophosphate 
1 .OmM sodium orthovanadate, pH 8.0 (20x stock)
Group B Inhibitors - 1000x stocks (-20°C).
1 .Omg/ml Leupeptin 
1 .Omg/ml Aprotinin in PBS 
1 .Omg/ml Bestatin in PBS 
1 .Omg/ml Pepstatin A in methanol
E5Q 50mM (NH4)2S04
20mM Hepes, pH 7.9
5mM MgCl2
0.1 mM EDTA, pH 8.0
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0.1% (v/v) Brij 35 
20% (v/v) glycerol 
1 mM DTT (add fresh)
Storage Buffer 50mM NaCI
20mM Hepes, pH 7.9 
5mM MgCl2 
20% (v/v) glycerol 
1mM DTT (add fresh)
CEF cells were grown to confluence in 10 roller bottles (-10^0 cells) and 
detatched with sterile glass beads. The nuclei were harvested according 
to the published protocol and resuspended in 7.0ml TMS (5mM Tris-HCI 
pH 7.5, 2.5mM MgCl2 , 125mM sucrose) in a sterile 30ml Corex tube. 0.1 
volumes of 4M NaCI was added dropwise, with stirring, and the solution 
centrifuged in a Sorvall SS34 rotor at 17,000rpm for 15min at 4°C. The 
supernatant was ultracentrifuged in a Sorvall T1270 rotor at 35,000rpm for 
60min at 4°C. Solid ammonium sulphate was added to 3.4g/7.5ml, and 
the supernatant left on ice for 30min. The precipitate was pelleted in a 
Sorvall SS34 rotor at 15,000rpm for 20min, and redissolved in 3.0ml E50 
buffer. Nuclear protein preparations were dialysed overnight against 11 of 
storage buffer in ready prepared BRL dialysis tubing washed sequentially 
in distilled water and TMS. The crude protein extract was cleared by 
ultracentrifugation in a Beckman TL-100 rotor at 35,000rpm for 60min at 
4°C. The supernatant was divided into aliquots on dry ice and stored at - 
70°C.
All manipulations were carried out at 4°C in solutions containing Group A + 
B inhibitors.
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ll.D.lb Preparation of Non-Denatured Whole Cell Extracts
Whole cell extracts were prepared for Electrophoretic Mobility Shift assays 
essentially according to the method of Marais et al. Typically, CEF cells 
were grown to confluence in 150mm dishes and lysed in 300ul lysis buffer 
(20mM Hepes, pH 7.9, 5mM EDTA, 10mM EGTA, 5mM NaF, 0.1ug/ml 
okadaic acid, 10% glycerol, 1mM DTT), containing 0.4M KCI, 0.4% 
Triton X-100 and protease inhibitors as follows : 5ug/ml pepstatin A, 1mM 
benzamidine, 50ug/ml PMSF. The crude extract was cleared in a bench 
top microfuge at 14,000rpm for 15min and the protein concentration 
estimated essentially according to the method of Bradford et al. 1 ul of 
extract was diluted to 500ul or 1ml in distilled water and mixed with an 
equal volume of Coomassie protein reagent. The absorbance reading at 
595nm was taken in a plastic cuvette with a path length of 1cm. The 
spectrophotometer was calibrated using a lysis buffer blank. Protein 
concentrations were read off a standard curve constructed from dilutions of 
bovine serum albumin under the same assay conditions. Extracts were 
divided into aliquots and stored at -70°C.
All manipulations were carried out at 4°C sterile eppendorf tubes.
II.D.Ic Preparation of Denatured Whole Cell Extracts
Denatured whole cell extracts were routinely prepared from confluent T25 
flasks for western blot analysis (section II.D.3). Monolayers were washed 
in ice cold PBS, drained thoroughly, and lysed in 500ul sample buffer 
(50mM Tris-HCI, pH 6.8, 30% glycerol, 2.5% SDS, 2% B-
mercaptoethanol). Lysates were sonnicated to shear any genomic DNA 
present and cleared in a bench top microfuge at 14,000rpm for 10min at 
4°C. The extracts were stored at -70°C.
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II.D.2. PREPARATION OF POLYCLONAL c-JUN-SPEClFIC ANTISERA
II.D.2a Expression and Purification of T7 expressed c-Jun
A T7 RNA polymerase expression system was adopted to prepare 
sufficient quantities of c-Jun protein for rabbit immunizations and 
subsequent antibody production. The system was developed by Dr E. J. 
Black essentially according to Studier et al. Plasmid pRK 171 and pLys S 
cells were kindly provoded by Dr F.W. Studier for this purpose, c-jun was 
expressed in pLys S cells from a T7 promoter within the pRK 171 plasmid, 
after induction of T7 RNA polymerase by IPTG. Briefly a 21 culture of cells 
grown to an ODgoo ° f 0.3-0.5 in L-broth supplemented with 100ug/ml 
ampicillin and 25ug/ml chloramphenicol, was induced with 0.4mM IPTG at 
37°C for 3-5hrs. The cells were harvested in a Sorvall GS3 rotor at 
4000rpm for 10min at 4°C and resuspended in 20ml 50mM Tris-HCI, pH 
7.5, 5mM EDTA. The suspension was quick frozen in dry ice and then 
rapidly thawed at 37°C to lyse the cells. 1.4ml 5M NaCI was added 
dropwise with stirring at 4°C. 1.5ml Triton X-100 was added and the
solution sonnicated for 5sec three times to shear any genomic DNA. 
Proteins were recovered in a Sorvall SS34 rotor at 15,000rpm for 10min at 
4°C. The pellet was washed in 10mM Tris-HCI, pH 7.5 and resuspended 
in 2.0ml 20mM Tris-HCI, pH 7.5, 1mM EDTA, 2mM DTT, 0.1% Triton X- 
100 for long term storage at -20°C.
II.D.2b Immunization
1ml of full length c-Jun protein suspension was emulsified with 3ml of 
Freunds Complete Adjuvant for immunization of two New Zealand White 
rabbits at 4 independent subcutaneous sites. Secondary immunizations
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were performed at day 14 and day 21, using Freunds Incomplete 
Adjuvant. The rabbits were test bled before (pre-immune) and after each 
successive immunization. 5ml of blood was transferred into a sterile 
universal and left to clot at 4°C. The serum was decanted and spun in a 
bench top centrifuge at 1000rpm for 5min to remove any remaining intact 
red blood cells. Aliquots were stored at -20°C and then tested over a 
range of concentrations against control western blot lysates as described 
below. After two successive specific positive reactivities the animal was 
sacrificed and the serum divided into aliquots for long term storage at - 
70°C. Thawed aliquots were stored at 4°C in the presence of 0.025% 
azide.
II.D.3. WESTERN BLOTTING 
II.D.3a Sodium dodecyl sulphate Polyacrylamide Gel Electrophoresis
Sodium dodecyl sulphate Polyacrylamide Gel Electrophoresis (SDS- 
PAGE) was adopted to separate proteins according to their apparent 
molecular weight. Gels were resolved by electrophoresis essentially 
according to Laemlli et al, using a Biorad Protean II apperatus. For 
western blots gels were typically 9% with respect to acrylamide. A stock 
solution containing 29.2% (w/v) acrylamide, 0.8% bis-acrylamide was 
used to prepare the resolving gels as follows:
ml
30:0.8 Acrylamide-bis 
1M Tris-HCI, pH 8.8 
distilled water
12.0
15.0
12.3
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10% SDS 0.4
10% ammonium persulphate 0.305
TEMED 0.02
The gel mix was pipetted between two glass plates and overlayed with 
water saturated butan-2-ol. After polymerization the overlay was poured 
off and the gel surface washed extensively with distilled water. Excess 
water was removed with a sheet of 3mm Whatman filter paper, and the 
comb inserted before the stacking gel was poured. The stacking gel 
contained the following components:
ml
30:0.8 Acrylamide-bis 3.2
1M Tris-HCI, pH 6.8 2.5
distilled water 14.0
10% SDS 0.2
ammonium persulphate 0.2
TEMED 0.02
After polymerization the comb was removed and the gel transferred to a 
gel tank. Both reservoirs were filled with 1x running buffer (10x stock, g/l 
tris base, 30, SDS, 10, glycine, 144, in distilled water, pH8.3). The wells 
were flushed through with running buffer and bubbles removed from the 
lower surface of the plate before the samples were loaded.
50ul of lysate (section II.D.Ic) from a confluent T25 flask was resolved with 
an aqual amount of protein (by Coomassie brilliant blue staining) from the 
same culture maintained under different growth conditions or from an 
alternative culture of interest. The samples were denatured at 100°C for
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3-7min prior to loading, and resolved at a 200-250V tor 2hrs or 30V 
overnight with pre-stained protein molecular weight standards.
II.D.3b Electroblotting
Proteins were transferred from acrylamide resolving gels to Hybond ECL 
nitrocellulose membranes using a CAM LAB Semi Dry Blotter according to 
the manufacturer's instructions. Briefly, the resolving gel was equilibrated 
in 1x transfer buffer (60mM tris, 50mM glycine, 1.6mM SDS, 20% (v/v) 
methanol) for 15min at room temperature. Six pieces of Whatman 3MM 
paper and one piece of membrane were rinsed in transfer buffer and 
placed on the blotter, membrane uppermost. The gel was placed on top 
of the membrane and covered with six more pieces of rinsed Whatman 
3MM paper. Air bubbles were removed and transfer effected at full power 
for 45-60min. Molecular weight marker positions were highlighted and the 
membrane stored at room temperature in a sealed box.
II.D.3c ECL detection
Enhanced Chemiluminescence (ECL) is a light-emitting-non-radioactive 
method for detecting immobilized specific primary antibodies conjugated 
with horse radish peroxidase (HRP)-linked secondary antibodies. Light 
emission is generated by the HRP/hydrogen peroxide catalysis of luminol 
to an excited oxidated state. This reaction is dramatically enhanced in the 
ECL system by chemical enhancers such as phenols, and can be 
detected by a short exposure to blue-light sensitve autoradiography film. 
Hybond-ECL nitrocellulose membranes were blocked overnight at 4°C in 
Tris-buffered-saline-Tween (10mM Tris-HCI, 150mM NaCI, 0.05% 
Tween-20 - pH 8.0) containing 5% Marvel. ECL detection reactions were
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then carried out according to the manufacturer's instructions. The primary 
antibody was diluted as required in TBS-T / 5% Marvel. The HRP-linked 
secondary antibody was diluted 1:5000 as above, and washes were 
performed in TBS-T alone.
Membranes were stripped for subsequent analysis in 100ml of 62.5mM 
Tris-HCI, pH 6.8, 2% SDS, 100mM B-mercaptoethanol, at 55°C for 
30min. The blots were washed repeatedly at room temperature in TBS-T 
and stored as before.
II.D.4. IN VITRO TRANSLATION AND IMMUNOPRECIPITATION 
II.D.4a In Vitro Translation
Sense RNA templates for in vitro translation reactions were prepared as 
described in section II.C.2. 1-2ul of invitro transcription reaction was
translated in the presence of 35s labelled methionine and 35ul of Promega 
rabbit reticulocyte lysate according to the manufacturer's instructions. The 
products were divided, and 5ul diluted in 20ul SDS sample buffer for 
Sodium dodecyl sulphate Polyacrylamide Gel Electrophoresis (section 
II.D.3a). Samples were resolved on a 9% acrylamide/SDS gel with 
prestained molecular weight markers and detected by flourography of the 
dried gel. Co-translations were performed as above with 1-2ul of each 
input RNA template added per reaction.
II.D.4b Immunoprecipitations
RIPA buffer 10mM Tris-HCI, pH 7.4
0.15M NaCI
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1% NP40
1% Sodiun deoxycholate 
0.1% SDS 
0.5% aprotinin
20-25ul of invitro translation reaction was diluted, under non-denaturing 
conditions, to 500ul in RIPA buffer and gently shaken with 5ul of primary 
antibody at 4°C for 1 hr. 40ul of PAS (50% Protein A Sepharose/sterile 
PBS slurry) was added to bind immunoglobulin, and the samples 
incubated for 1 hr as before. Precipitates were washed twice in RIPA buffer 
and resuspended in 50ul SDS sample buffer. The samples were 
denatured at 100°C for 3-7min and spun briefly to remove the PAS before 
resolving on a 9% acrylamide SDS gel as above.
II.D.5. DNA TRANSIENT TRANSFECTION AND CAT EXPRESSION 
ASSAYS
II.D.5a Transient Transfection
Virally-infected or control CEF stocks were plated 16hr prior to transfection 
at 3x10^ cells per 60mm dish or 8x10^ cells per 90mm dish. Cells were 
transiently transfected by liposome mediated transfer using DOTAP 
according to the manufacturer's instructions. The quantities of DNA 
included in each transfection are outlined in Table 5A. After 4-5hrs 
incubation the transfection mix was aspirated and the cells washed twice 
with DMEM. Dishes were refed with growth medium (60mm dish) or 
quiescing medium (90mm dish), and incubated for a further 40-44hrs. 
Quiesced cell cultures were washed twice in DMEM and serum stimulated
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for 60min in complete growth media before all the cultures were harvested 
for CAT analysis.
II.D.5b CAT assay
Transient transfections were washed in ice cold PBS and scraped into 1ml 
PBS in a precooled eppendorf tube. Cells were harvested in a bench top 
microfuge at 6000rpm for 2min. The pellets were resuspended by 
vortexing in 200ul 0.25M Tris-HCI, pH 7.8, and the cells lysed by repeated 
freezing and thawings. Nuclei were harvested in a bench top microfuge at 
14,000rpm for 2min and collected for Hirts analysis (section II.D.4c). The 
supernatant was assayed for protein concentration by Bradford analysis 
(section II.D.Ib). 20ug of protein was diluted to 180ul with 0.25M Tris-HCI, 
pH 7.8 and incubated at 60°C for 7min to inactivate endogenous 
proteases (Fromm et al, 85). 20ul of a 1:10 C  ^4-chloramphenicol : acetyl 
CoA mix was added and the tubes incubated at 37°C for 30-60min. 
Chloramphenicol and the mono and diacetoxy products were solubilized in 
300ul of ethyl acetate, by vortexing at 4°C for 10-15sec. The products 
were extracted in a bench top microfuge at 14,000rpm for 2min, and 250- 
280ul of the organic phase dried down under vaccum by centrifugation at 
room temperature. Samples were taken up in 20ul of ethyl acetate and 
spotted, by repeated applications, at the origin of a thin layer 
chromatography sheet. Chromatograms were transferred to an 
equilibrated tank and run in chloroform/methanol (95:5 v/v) until the front 
was approximately 5cm from the top of the sheets. After removal from the 
tank chromatograms were air dried and subjected to autoradiography.
The percentage conversion of chloramphenicol was calculated directly by 
aligning the exposed X-ray film with the translucent chromatogram over a 
light source. Spots corresponding to chloramphenicol or to the aceylated
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products were excised and transferred into separate scintillation vials for 
counting in 5ml Ecoscint.
II.D.5c B- Galactosidase Assay
pHSV-Bgal was kindly provided by J. O'Prey (Figure 2.2) and was used as 
an internal control to standardize for transfection efficiency in CEF cells. 
The levels of B-galactosidase activity were quantified by the catalytic 
conversion of colourless ONPG to yellow o-nitrophenol. Typically, 30-60ul 
of cell lysate was incubated with 0.5ml solution 1 and 0.1ml solution 2 (see 
below) at 37°C for 30-90min or until a yellow colour change was apparent. 
The reaction was stopped with 0.25ml 1M sodium carbonate and an 
absorbance reading taken at 420nm in a plastic cuvette with a path length 
of 1cm
II.D.5d Hirts Supernatants
Hirts Supernatants measure the concentration of plasmid DNA within a cell 
population and were used as a control to standardize for transfection 
efficiency between different cell types. Briefly, cell pellets were 
resuspended in 200ul TE buffer and mixed on ice for 5min with 200ul TSE 
(1% SDS, 5mM Tris-HCI, pH 8.0, 10mM EDTA). 10Oul of 3M potassium
Solution.!
60mM Na2HP04 
40mM NaH2P04 
10mM KCI 
1mM MgCl2
50mM B-mercaptoethanol
Solution 2 
60mM Na2HP04 
40mM NaH2P04 
2mg/ml ONPG
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acetate, pH 4.8 was mixed in gently and the tubes incubated for a further 
10min on ice. Chromosomal DNA precipitates were collected in a bench 
top microfuge at 14,000rpm for 10min. The supernatants were extracted 3 
times in phenol/chloroform and precipitated with 0.3M sodium acetate and 
2.5 volumes of ethanol. Precipitates were recovered by centrifugation and 
resuspended in 36ul TE buffer. The DNA was digested with an approprate 
enzyme and analysed by Southern Blotting (section II.B.8).
II.D.6. PROTEIN:DNA INTERACTIONS
II.D.6a Footprinting Analysis
(i) Labelling Plasmid for Footprintina
Footprinting probes were prepared by 5' end labelling of DNA restriction 
fragments with T4 polynucleotide kinase and (*y-32p) ATP, and isolated by 
secondary restriction according to Plumb et al.
Labelled fragments were resolved on a non-denaturing 8% 
acrylamide/TBE gel in sample buffer (10x TBE, 20% glycerol). Gels were 
exposed wet and the released fragment located by aligning the exposed X- 
ray film. Bands were excised and eluted as described in section II.B.4a. 
Precipitates were resuspended in 10Oul storage buffer (50mM NaCI, 
20mM Hepes, pH 7.9, 5mM MgCl2, 0.1 mM EDTA, 20% glycerol, 1mM 
DTT, 0.1 mM EGTA, 0.1 mM CaCl2 ), and assayed for TCA precipitable 
activity as outlined above in section II.C.4c.
(ii) DNase 1 Footprint Protection Assays
DNase 1 footprint protection assays were performed in 10Oul storage 
buffer (see above), in the presence of 6ug poly(dl-dC):(dl-dC), 1 ul end-
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labelled restriction fragment and up to 80ul (30ug) nuclear protein extract 
(section II.D.1 a). DNA binding reactions were incubated on ice for 60- 
90min and then partially digested with DNAse 1 (20-200ug/ml in storage 
buffer) at room temperature for 15-30sec. Digestions were terminated in 
10Oul STOP buffer for 30min at 37°C and proteinase K then inactivated at 
90°C for 2min. Nucleic acid was extracted sequentially in phenol (x1) and 
chloroform (x2) and precipitated in 10ul 5M LiCI and 600ul ethanol. 
Precipitates were washed in 95% ice cold ethanol, air dried, and 
resuspended in 10ul loading buffer (95% Formamide, 20mM EDTA, 
0.05% Bromophenol Blue, 0.05% Xylene Cyanol FF). 2-5ul of each 
sample was denatured at 100°C for 3-5min and resolved on a 6 % 
denaturing acrylamide gel (section II.C.3) with markers prepared from 
double stranded sequencing reactions of the same DNA.
STOP buffer -1.5ml
1.3ml 100mM Tris-HCI, pH 8.0 / 10mM EDTA
70ul 10% SDS
60ul Proteinase K (1 Omg/ml)
15ul yeast tRNA (1 Omg/ml)
38ul 4M NaCI
II.D.6b Electrophoretic Mobility Shift Assay
(i) Preparation of Double Stranded Oligonucleotide Probes 
5ug of paired single stranded oligonucleotides were diluted in annealing 
buffer (67mM Tris-HCI, pH 7.3, 13mM MgCl2 , 6.7mM DTT, 1.3mM 
Spermidine, 1.3mM EDTA) to a final volume of 10Oul. The annealing 
reaction was heated for 2min at 100°C and then cooled slowly to room 
temperature. 2 0 0 ng of double stranded oligonucleotide was end-labelled
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as described in section II.B.5b, and separated from unincorporated 
nucleotides using a Biorad Biospin 30 column according to the 
manufacturer's instructions. 2ul was assayed for TCA precipitable activity 
as outlined in section 1I.C.3.
(ii) Gel Mobility Shift Assay 
Solutions
1Qx Binding Buffer 
100mM Hepes, pH 8.0 
2mM EDTA 
0.94M NaCI 
1mM PMSF 
1 mg/ml BSA 
40% Glycerol
4% Acrylamide Gel 
8 ml 30% Acrylamide/bis 
(19:1 seq. grade)
6 ml 10XTBE buffer 
46ul distilled water 
500ulAmmonium persulphate 
50ul TEMED
Binding reactions were performed in a volume of 30ul distilled water in the 
presence of 5-1 Oug whole cell extract (section II.D.1 b), 1x binding buffer, 
0.5ug poly(dl-dC):(dl-dC), 5mM DTT, and 2ul end labelled oligonucleotide 
(2x10 ^ cpm). Reactions were incubated on ice for 30min and resolved at 
4°C on a 4% non-denaturing acrylamide gel in TBE running buffer for 2- 
3hrs at 150V. Samples were loaded between two marker tracks (0.05% 
bromophenol blue and Xylene Cyanol FF in 2% glycerol/TBE) to monitor 
the electrophoresis. Gels were fixed for 15-30 min in 10% methanol, 10% 
acetic acid in water, and dried, before autoradiography at -70°C. 
Modifications to this procedure were made for competition and supershift 
analysis. Cold binding reactions were assembled with 1 -2ul of antibody or 
50ng of a specific cold competitor in a final volume of 28ul. After
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incubation on ice tor 30min, 2ul end labelled oligonucleotide (2 x 1 0 ^  cpm) 
was added and the samples incubated for a further 30min before 
electrophoresis as described above.
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CHAPTER II.E. - MATERIALS
II.E.1. ANTISERUM
Rabbit anti-Fra-2 (PEP-2) NBS Biologicals 
Hatfielf, UK.
Donkey anti-rabbit IgG, 
alkaline phosphatase conjugate
Promega
Southampton, UK.
Rabbit anti-murine Jun B 
Rabbit anti-murine Jun D
A gift of Dr. R Bravo
Rabbit anti-human RSRF-C4 A gift of Dr. R. Treisman
Goat anti-rabbit FITC Europath Ltd.
Bude, Cornwall, UK.
Rabbit anti-TrpE-v-Jun (CASTOR) A gift of Dr T Oehler 
Inst.fur Genetik und Tox. 
Postfach 3640 
7500 Karlsruhe, Germany.
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Rabbit anti-c-Fos Laboratory stocks 
(Dr. D.A.F. Gillespie and 
Dr. A. Darling)
Rabbit anti-gag 5202 A gift of Dr R.N Eisenman 
FHCRC, Seattle 
Wa. 98104, USA
Rabbit anti-bzip c-Jun 948/4 Laboratory stocks 
(Dr. D.A.F. Gillespie)
Rabbit anti-avian c-Jun 730/5 Laboratory stocks 
(A. Kilbey)
Normal rabbit serum Laboratory stocks
II.E.2. BACTERIAL HOSTS
E. coli host strains DH1 and WL87 were obtained from laboratory stocks 
held by Dr D. Crouch (DH1) and V. Fincham (WL87). E. coli DH5a was 
obtained as a competant strain from Life Technology Industries, Paisley, 
Scotland.
II-E.3. CELLS
CEF were prepared as described from White cross Brown Leghorn chicken 
embryos supplied by Wickham Laboratories, Hants., UK.
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pLys S cells, used for the expression preparation of T7 expressed c-Jun 
(section II.D.2a), were a gift from F.W. Studier and held as laboratory 
stocks by Dr E. Black.
1I.E.4. RABBITS
New Zealand White Rabbits supplied by Harlin Olac UK. Ltd., were used 
for immunization and subsequent polyclonal antisera preparation.
II-E.5. CHEMICALS
Supplier - Amersham International PLC.. Avlesburv. UK- 
Amplify
(ct-3 2 P)dCTP 3000Ci/mmlo
(ct-3 2 P)CTP 800Ci/mmol
(a-3 2 P)UTP 800Ci/mmol
(Y-3 2 P)ATP 3000Ci/mmol
14C Chloramphenicol 50-62 mCi/mmol
14C protein molecular weight markers
ECL Western Blot immunodetection reagents
Supplier- BDH Chemicals Ltd.. Poole. Dorset. UK,
All organic solvents (AnalaR grade) were obtained from BDH unless 
otherwise stated. The following compounds were also obtained from BDH 
(AnalaR, Biochemical or Electran grades):
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Acrylamide Magnesium chloride
Ammonium acetate Magnesium sulphate
Ammonium persulphate Maltose
Ammonium sulphate NaH2P04. 2H20
Aqueous ammonia PEG 6000
bis-Acrylamide Potassium acetate
B-mercaptoethanol Potassium chloride
Calcium chloride Sodium acetate
D-glucose Sodium carbonate-anhydrous
Disodium HPO4 JH 2 O Sodium chloride
Disodium HPO4 .2 H2 O Sodium citrate
DMSO SDS
EDTA Sodium fluoride
Glycerol Sodium hydroxide
Glycine Sodium orthvanadate
Hydrochloric acid Tris
Lithium chloride Xylene cyanol
Magnesium acetate
Supplier - BioRad Laboratories. Hemel Hempstead. UK. 
TEMED
Supplier - Boehringer Mannheim UK Ltd.. Lewes. East Sussex. 
Caesium chloride
Calf intestinal alkaline phosohatase
DOTAP transfection reagent
Klenow fragment E.coli DNA polymerase
100mM Nucleotide triphoshates (ATP, CTP, GTP, UTP)
Proteinase K
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RNase A
Supplier - James Burrouah Ltd.. Witham. Essex. UK.
Ethanol
Supplier - Flow Laboratories. UK.
Vitrogen 100 purified collagen
Supplier - CP Laboratories. Bishop's Stortford. Herts. UK.
Sheared salmon sperm DNA
Supplier - Difco Laboratories.
BactoAgar
Supplier - Imperial Laboratories (Eur.) Ltd.. West Portwav. Hants. UK. 
Vitrogen 100-Collagen
Supplier - Koch Light Ltd.. Haverhill. Suffolk. UK.
Isoamyl alcohol
Supplier - Life Technology Industries. Paisley Scotland.
All DNA modifying enzymes and appropriate buffer concentrates were 
obtained from Life Technology Industries unless otherwise stated. The 
following reagents were also obtained from Life Technology Industries.
Agarose (ultrapure grade) 
Bacteriophage X (Hill digested) 
Bacteriophage
10x DM EM concentrate 
DNA ladder (1 kb)
DNase 1 (RNase free)
Foetal calf serum 
Folic acid (USP grade)
G418 (powder)
200mM Glutamine 
1M HEPES
Low melting point agarose 
MEM 100x vitamins 
Newborn calf serum 
Okadaic acid
2x MEM concentrate, phenol red free 
Prestained protein molecular weight markers 
7.5% sodium bicarbonate 
100mM sodium pyruvate 
Sucrose (enzyme grade)
Trypsin
Tryptose phosphate broth 
Urea
Supplier - National Diagnostics. Manville. New Jersey. USA. 
Ecoscint A
Supplier - New England Nuclear. Duoont UK Ltd.. Stevenage 
35s-methionine
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Supplier - Pharmacia Ltd.. Milton Kevnes. Bucks. UK.
T4 pelynucleotide kinase 
Yeast tRNA
Supplier - Pierce and Warriner UK Ltd.. Chester. UK.
2 mg/ml albumin standard 
Coemassie protein reagent
Supplier - Promega. Southhampton UK.
RNasin (40,000U/ml)
SP6  RNA polymerase (20,000U/ml)
T7 RNA Polymerase (20,000U/ml)
Rabbit reticulocyte lysate - methionine
Supplier - Rathburn Chemicals Ltd.. Walkerburn. Scotland.
Phenol ( water saturated)
Supplier - Safeway supermarket - Glasgow.
Non-fat milk powder ("Marvel")
Supplier - Severn Biotech. Ltd.. Kidderminster. UK.
30% w/v Acrylamide - bis acrylamide (19:1)
RNAzol
Supplier - Sigma Chemical Co.. Poole. Dorset. UK.
Acetyl co-A Freunds incomplete adjuvant
Activated charcoal HEPES
Ampicillin IPTG
Aprotinin Leupeptin
B-glycerophosphate
B-oestradiol ONPG
Benzamidine Paraformaldehyde
Bestatin Pepstatin A
Brij 35 (30% w/v) Phosphocreatine
Bromophenol Blue PIPES
BSA (fraction V) PMSF
Calf Thymus DNA Poly(dl-dC):(dl-dC)
Coomassie Brilliant Blue Polybrene
Creatine phosphokinase Poly-L-Lysine
Cycloheximide Potassium glutamate
DABCO Protein A Sepharose
Denhardt's Potassium glutamate
DTT RNase T1
EGTA Sodium butyrate
Emetine Spermidine
Ethidium bromide Triton X-100
Formamide Tween 20
Freunds complete adjuvant 
1I.E.6. KITS
Supplier - Bio 101 Inc.. Stratech Scientific. Luton UK. 
Geneclean kit
Supplier - Boehrinqer Mannheim. Lewes UK. 
Random Primed DNA Labelling kit
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Supplier - Cruachem Ltd.. West of Scotland Science Park. Glasgow. 
Oligonucleotide Purification Cartridges and reagents
Supplier - Pharmacia LKB Biotechnologies. Milton Keynes. UK, 
Oligolabelling kit
Supplier - Stratagene. La Jolla. CA. USA.
Gigapack II Plus Packaging Extract
United States Biochemical. Cleveland. Ohio. USA.
Sequenase version 2.0 kit
II-E.7. COLUMNS. MEMBRANES. PAPER. TLC PLATES AND X-RAY 
JEiLM
Supplier - Ammersham International PLC. Avlesburv. UK.
Hybond ECL nitrocellulose membrane 
Hybond N(fp) nylon membrane 
Hyper film - MP
Supplier - Anderman Co. Ltd.. Kingston-uoon-Thames. England. 
Schleicher and Schuell nitrocellulose membrane
Supplier - Biorad Laboratories. Hemel Hempstead. UK.
Biospin 30 columns
Supplier - CAMLAB.. Cambridge. UK.
20x20 Polygram Silica Gel TLC plates
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Supplier - Eastman Kodak Co.. Rochester. NY. USA.
Duplicating film (DUP-1)
X-ray film (XAR-5)
Supplier - Fuji Photo Film Co. Ltd.. Japan.
X-ray film (RX)
Supplier - Life Technology Industries. Paisley. Scotland.
Dialysis tubing
Supplier - Pharmacia LKB Biotechnologies. Milton Kevnes UK.
Nick Columns
Supplier - Sartorius GmbH.. Epsom. Surrey. UK.
Dialysis bags
Supplier - Whatman International Ltd.. Maidstone. UK.
GF-C filters
3MM chromatography paper
II.D.8 . PLASMIDS AND BACTERIOPHAGES
Vector Reference Source
pSPT19 Boehringer Mannheim UK
Ltd.Lewes, East Sussex.
pSPT19/
c-fos
Dr. D.A.F. Gillespie 
Laboratory stocks
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pSPT19/
JF4 (SP6 )
pSPT19/
JF11 (SP6 )
pSPT19/ 
vJun (T7)
pS PT19/ Dugaiczyk et al,
GAPDH (SP6 ) 1983. Biochem.
22(7): 1605-1613
pSPT19/
1.5cJ (T7)-clone 5
pSPT19/
CJ400 (T7)
pSPT19/ 
cJfp (T7)
pSPT19/
c-jun (SP6 )-clone A 
pSPT19/
cjun (T7)-clone K
pSPT19/ 
cJ3' (T7)-clone I
Dr. M. Grove 
Laboratory stocks
Dr. D.A.F. Gillespie 
Laboratory stocks
Dr D.A.F. Gillespie 
Laboratory stocks
Dr. D.A.F. Gillespie 
Laboratory stocks
A. Kilbey
Laboratory stocks
A. Kilbey 
Laboratory stocks
A. Kilbey
Laboratory stocks 
A. Kilbey
Laboratory stocks 
A. Kilbey
Laboratory stocks 
A. Kilbey
Laboratory stocks
106
pSPT19/
A69 cJun (T7)
pSPT19/
A69 vJun (T7)
PAT Twig & Sherratt
(1980). Nature 
283:216-218
PAT/ pB1
pCAT-Basic
pCATb-cJ-400
PUCBM21
pUCBM21/
cJ-400
pSFCV-LE Fuerstenberg et al,
(sa+) (1990). J. Virol
64(12): 5891-5902
Dr D.A.F. Gillespie 
Laboratory stocks
Dr D.A.F. Gillespie 
Laboratory stocks
Dr E. Black 
Laboratory stocks
Dr D. Crouch 
Laboratory stocks
Promega
Southampton, UK.
A. Kilbey
Laboratory stocks
Boehringer Mannheim UK 
Ltd. Lewes, E. Sussex.
A. Kilbey 
Laboratory stocks
Dr M. Zenke 
Inst, for Mol. Pathol. 
A-1030 Wien.
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A69 PC/SFCV
A69 PV/SFCV
RCAN Hughes et al,
(subgroup A) (1987). J. Virol
61(10): 3004-3012
pG5BCAT Lillie & Green
(1989). Nature 
338: 33-44
pSG424 Sadowski & Ptashne
(1989). NAR 17(18): 
7537
pSG424/ Cousens et a l,
Vmw65 (1989). EMB0 8 (8 ):
2337-2342
pRc/RSV
pRC/RSV / 
CJ-3
pRc/RSV / 
VJ-0
Dr D.A.F. Gillespie 
Laboratory stocks
Dr. D.A.F. Gillespie 
Laboratory stocks
Dr D. Crouch 
Laboratory stocks
Dr C. Goding 
Mairie Curie Res. Inst. 
London, UK.
Dr. Colin Goding 
(as above)
Dr Colin Goding 
(as above)
Invitrogen Corp.
San Diego, CA. USA.
Dr I. Morgan
Cell Tech, Slough, UK.
Dr I. Morgan 
(as above)
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pRc/RSV / 
VJ-1
Dr. I. Morgan 
(as above)
pHSV-B Gal Hall et a l, (1983) 
J-Mol-Appl-Genet 2(1) 
101-109
Dr D.J. Chester 
Laboratory stocks
V.Fincham 
Laboratory stocks
II.E.9. RESEARCH SUPPLIES. MISCELLANEOUS
Supplier - Beatson Institute Central Services 
L-broth 
Penicillin 
Sterile CT buffer
Sterile distilled water 
Sterile PBS 
Streptomycin
NaCI 6.0g
trisodium citrate 2.96g
tricine 1.79g
phenol red 0.005g
distilled water 700ml
pH 7.8
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II.E.10. TISSUE CULTURE AND BACTERIOLOGICAL PLASTICWARE
Supplier - Alpha Labs. Eastleigh. Hamps.. UK.
eppendorf tubes 
Supplier - A/S Nunc. Roskilde. Denmark.
T25, 75, and 175 tissue culture flasks 
1 and 2ml Nunc cryotubes
Supplier - Becton Dickinson Labware. Oxford. UK.
60 and 90mm tissue culture dishes 
Tissue culture roller bottles 
50ml falcon tubes
12ml Polypropylene falcon 2059 tubes 
19G and 21G sterile syringe needles 
2 0 0 ml sterile filtration unit
Supplier - Bibbv Sterilin Ltd.. Stone. Staffs.. UK.
60 and 90mm bacteriological dishes 
Sterile plastic bijoux containers 
Sterile plastic universal containers
Supplier - Costar Corporation. High Wvcombe. Bucks.. UK.
24 well tissue culture dish
Supplier - Duoont UK Ltd.. Stevenage Herts.. UK.
Polycarbonate ultracentrifuge tubes
Supplier - Gelman Sciences. Northampton. UK.
Sterile 0.2um filter Acrodisc
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II.E.11. Water
Distilled water for the preparation of buffer stocks was obtained from a 
Millipore MilliRO 15 system. Water for protein, enzyme, and 
recombinantDNA procedures was further purified on a Millipore MilliQ
system to18M/cm
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CHAPTER III - RESULTS 
ANALYSIS OF c-JUN EXPRESSION AND AUTO- 
REPRESSOR ACTIVITY 
III.A. c-yun EXPRESSION
III.A.1. TRANSCRIPTIONAL REGULATION
- Total Cellular c-iun mRNA
c-jun has been described as an immediate early gene. To investigate 
whether the kinetics of avian c-jun expression conform to that of other 
immediate early genes, subconfluent cultures of primary CEFs were 
serum deprived for 48hrs, and subsequently fed with serum-containing 
medium over an 8 hr period (section II.A.1.). Total cellular RNA was 
prepared at different time intervals and the amount of yl/n-specific transcript 
determined by RNase protection analysis using a y'a/7-specific riboprobe 
(section N.C.3.). A GAPDH-specific riboprobe was used in parallel RNase 
protection assays to control for loading (Figure 3.1 B).
As shown in Figure 3.1 A, c-jun mRNA was rapidly and transiently induced 
in response to serum growth factors, /un-specific transcripts were barely 
detectable in serum deprived cultures, but increased significantly after 
30mins serum stimulation (lanes 3-4). The levels remained elevated for up 
to 60mins serum stimulation (lane 5) and decreased thereafter (lanes 6 , 8  
& 9). The decline was gradual relative to the rapid induction, with c-jun-
FIGURE 3.1A
RNase Protection analysis of total mRNA prepared from serum stimulated 
and exponentially growing CEFs. 0.1 mM Emetine was included in the 
growth medium of cultures represented by tracks 6 , 12 & 13. 20ug of total 
RNA was hybridized to 106  cpm of labelled antisense riboprobe. The 
riboprobe was synthesiszed from Bgl11 linearized pSPT19/JF4 (SP6 ) 
(Figure 2.1), and includes approximately 150bp of c-jun specific 3' 
untranslated sequence. The broken arrow denotes the undigested 150bp 
antisense c-jun riboprobe. Complete digestion of the non-hybridized probe 
is illustrated in lane 2. The solid arrow indicates the protected 75bp c-jun 
mRNA fragment.
3 4 5 6 7 8 9 10 11 12 13
Serum (hrs) - 0.5 1 2 2 4 8 + + + 2.0
Emetine + _ _ _ lhr 3hr _
(0.1mM)
Confluent + + + + + + + +
Exponential + + +
FIGURE 3.1 B
RNase Protection analysis of 2ug of RNA samples 3-11 hybridized against 
a 481 bp chicken GAPDH anti-sense riboprobe. The riboprobe was 
prepared from Apa1 linearized pSPT19/GAPDH (SP6 ) (Figure 5.3). The 
431 bp protected fragment is indicated by a solid arrow. A 0.01 x dilution of 
the input riboprobe is denoted by a broken arrow.
A.
1 2 3 4 5 6 7 8 9 10 11 12 13
B.
3 4  5 6  7 8 9  10 11
Bgl 11
<  -
c -ju n 3 L 17
Antisense Riboprobe 
150bp <
c-jun m RNA
75bp
FIGURE 3.1
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specific transcripts persisting above background for at least 8 hrs (compare 
lane 9 with lanes 3 & 10). This pattern of expression was disrupted in the 
presence of a protein synthesis inhibitor. Addition of 0.1 mM Emetine to the 
2 hr serum-induced cultures dramatically increased the levels of c-jun 
mRNA (compare lanes 6  & 7). Superinduction was similarly observed in 
exponential CEF cultures, grown in the presence of 0.1 mM Emetine. 
Under these conditions, y'u/7-specific transcript levels increased 
proportionally with the period of Emetine incubation (compare lanes IQ- 
12).
Rapid and transient kinetics of expression, together with superinduction in 
the presence of protein synthesis inhibitors, are typical of other immediate 
early genes and clearly characterize c-jun as a member of this class of 
transciption factors.
- de-novo Transcription
The levels of total cellular mRNA are determined by transcriptional and 
post-transcriptional regulatory mechanisms. To examine the contribution 
of de novo transcription to the serum induction of c-jun mRNA, 
transcription of the c-jun gene was measured in treated and untreated cells 
by the nuclear run off assay (section II.C.4.). yun-specific transcripts were 
detected using a plasmid encoding the v-jun gene; positive and negative 
controls were provided by GAPDH and pSPT19 sequences respectively 
(Figure 5.3).
As shown in Figure 3.2, c-jun transcription was detected at low levels in 
serum deprived CEFs. A rapid, but modest, increase in transcription was 
observed in response to serum stimulation. The increase was insufficient 
to account for the corresponding induction of c-jun mRNA, and peaked at 
an earlier time point following serum stimulation (compare Figure 3.2 &
FIGURE 3.2.
Runoff Analysis of nuclei prepared from serum deprived and serum 
stimulated CEF cultures. Approximately equal amounts of TCA 
precipitable radioactivity were included in each hybridization reaction. 
Plasmid DNAs were alkali denatured and immobilized onto nitrocellulose 
filters using a Bio-Slot Microfiltration apperatus. 5ug of plasmid DNA was 
immobilized per slot, and the filters fixed under vacuum for 2hrs at 80°C. 
Hybridization proceeded for 72hrs in a final volume of 1.8ml. The filters 
were washed under high stringency and exposed overnight at -70°C. 
Negative and positive controls were provided by pSPT19 and pGAPDH 
respectively. pSPT19/v-Jun and pSPT19/c-Fos were included to compare 
the rate of c-jun and c-fos transcription at the point of cell lysis.
Details of each plasmid are outlined in Figure 5.3
SERUM STIMULATION (min)
pSP T19
v-Jun
c-Fos
c-Myc
G APD H
0 10 45
FIGURE 3.2
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3.1). The decrease in c-jun transcription was similarly rapid. Basal levels 
of transcription were observed just 45mins after serum stimulation, when 
c-jun mRNA was persisting at maximum levels.
The kinetics of c-jun expression paralleled those of another immediate 
early gene, c-myc, but were quite distinct from the rapid and dramatic 
kinetics observed during the serum induction of c-fos (Figure 3.2).
1ILA.2. TRANSLATIONAL AND POST-TRANSLATIONAL 
REGULATION
. --Translational Regulation
To examine the relationship between c-jun transcription and c-Jun 
translation, serum deprived cultures of primary CEFs were serum 
stimulated over a 6 hr period, and lysed under denaturing conditions for 
western blot analysis. Whole cell protein extracts were resolved on 9% 
SDS-acrylamide gels, and p39 c-Jun visualized using two independent c- 
Jun-specific polyclonal antisera. 730/5 was raised against bacterially 
expressed c-Jun protein (section II.D.2); CASTOR was raised against a 
75kD trpE-vJun fusion protein and recognizes epitopes within both v-Jun 
and human and avian c-Jun (Angel et al, 8 8 (i); Dr. T. Oehler; personal 
commun.).
Figure 3.3A and 3.3B represent parallel western blots probed for p39 c-Jun 
expression with CASTOR (3A) or 730/5 (3B). As shown in Figure 3.3A, 
p39 c-Jun was expressed at high levels in serum deprived CEF cultures, 
exhibiting virtually no increase in expression in response to serum 
stimulation. The CASTOR antibody expresses a higher affinity for p39 c- 
Jun than 730/5 (compare "exp" lanes in Figure 3.3A and 3.3B).
FIGURE 3.3
Western Blot analysis of denatured whole cell protein extracts, prepared 
from serum deprived and serum stimulated CEF cultures. Approximately 
equivalent concentrations of protein were resolved on a 9% 
SDS/acrylamide gel and electroblotted onto ECL nylon membrane using a 
CAM LAB Semi-Dry Blotter. The proteins were visualized by ECL 
detection, with a 1:2000 dilution of CASTOR (3.3A) or a 1:4000 dilution of 
730/5 (3.3B). Normal CEF extracts and ASV17 (v-Jun) and MC29 (v-Myc) 
transformed CEF extracts were included as controls. p65 gag v-Jun is 
denoted by a light arrowhead; and p39 c-Jun by a solid arrowhead.
Antibody specificities are outlined in figure legend 3.16.
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Consequently, saturating concentrations of CASTOR may mask subtle 
changes in c-Jun expression. In support of this hypothesis, modest 
increases in p39 c-Jun were detected using 730/5, with maximal 
expression detected approximately 3hrs after serum stimulation (Figure 
3.3B).
The serum-induced expression of p39 c-Jun never exceeded the levels 
detected in normal exponentially growing cultures, and peaked at late time 
points after serum stimulation (Figure 3.3A and 3.3B). The magnitude and 
kinetics of the translational response contrasted with the corresponding 
induction of c-jun mRNA (Figure 3.1 A), c-jun mRNA exhibited the most 
dramatic changes in expression in response to serum stimulation, with 
maximum levels detected within just 30mins (compare lanes 3 & 4 with 
lanes 3 & 10). At late time points after serum stimulation, when c-Jun 
protein levels were at their peak, c-jun-specific transcripts were in decline, 
owing to the rapid and transient nature of the transcriptional reponse 
(compare Figure 3.3B & 3.1 A).
- Post-translational Modification
At very early time points after serum stimulation, a ladder of additional 
bands was rapidly and transiently detected by the CASTOR antibody 
(Figure 3:3A). The ladder was not detected by 730/5, suggesting that it 
represented alternative c-Jun-reactive proteins that transiently appeared at 
the expense of endogenous p39 c-Jun (compare Figure 3.3A & 3.3B).
It has been proposed that post-translational modifications to pre-existing 
proteins initiate the rapid transcriptional response of immediate early 
genes (Reviewed in Angel et al, 91). To investigate whether the additional 
c-Jun-reactive proteins were the products of post-translational 
modifications, the analysis was repeated in the presence of a protein
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synthesis inhibitor. As shown in Figure 3.4, the c-Jun-reactive ladder was 
not abolished in the presence of 10ug/ml cycloheximide, and therefore, 
did not represent newly synthesized Jun proteins. Infact addition of 
cycloheximide accentuated the appearance of the ladder, shifting it in 
favour of the higher molecular weight species. This was particularly 
apparent at later time points after serum stimulation when the c-Jun- 
reactive ladder had collapsed (lane 5). Under these conditions, addition of 
cycloheximide induced a reappearance of the c-Jun-specific bands that 
mimicked their initial rapid detection in response to serum stimulation 
(compare lanes 6 & 3).
III.B. AUTO-REPRESSION
III.B.1. v-JUN-DEPENDENT AUTO-REPRESSION
Expression studies identified c-jun as an immediate early gene (section
111.A.). One characteristic of several immediate early transcription factors is 
an ability to negatively regulate their own gene promoters (Grignani et al, 
90; Sassoni-Corsi et al, 88). To investigate whether Jun exhibits an 
equivalent auto-repressor function, endogenous c-Jun protein levels were 
examined in primary CEFs infected with the ASV17 transforming retrovirus. 
ASV17 expresses high levels of the retrovirally transduced v-Jun 
oncoprotein (Bos et al, 90; Maki et al, 87). v-Jun is expressed as a 65kD 
gag-Jun fusion protein and is, therefore, readily distinguishable from p39 
c-Jun by molecular weight (Figure 1.1).
FIGURE 3.4
Western Blot analysis of denatured whole cell protein extracts, prepared 
from serum deprived and serum stimulated CEF cultures. Approximately 
equal concentrations of protein were resolved on a 9% SDS/acrylamide gel 
and transferred to ECL nylon membrane using a CAM LAB Semi-Dry 
Blotter. The proteins were visualized, by ECL detection, with a 1:2000 
dilution of CASTOR. Parallel dishes were serum stimulated in the 
presence of 10ug/ml cycloheximide (Linial 86) and analysed as above. 
Normal and ASV17 transformed cell extracts were included as controls. 
p65 gag-v-Jun is denoted by a solid arrowhead and p39 c-Jun by a light 
arrowhead.
LANE 1 2 3 4 5 6 7
SERUM 0 5 10 10 30 30 45
(mins)
CHX + +
(10ug/ml)
Antibody specificities are outlined in figure legend 3.16.
ASV17 CEF 1 2 3 4 5 6 7
FIGURE 3.4
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As shown in Figure 3:5, endogenous c-Jun protein was virtually 
undetectable in the presence of p65 gag-v-Jun. Wild type levels of 
endogenous c-Jun were expressed by equivalent v-Myc transformed 
cultures, suggesting that the down-regulation represented a specific effect 
of the v-Jun oncoprotein rather than a secondary consequence of cellular 
transformation.
III.B.2. C-JUN-DEPENDENT AUTO-REPRESSION
p65 gag-v-Jun was created through a non-homologous recombination 
event between retroviral gag sequences and the endogenous c-jun gene. 
The resulting gene is expressed at high levels from the retroviral LTR, and 
contains a number of structural mutations in the coding and non-coding 
sequences (Figure 1.1). To investigate whether repression of endogenous 
c-Jun represents a direct effect of the qualitative mutations in v-Jun, 
retroviral vectors were constructed to facilitate equivalent overexpression 
of c-Jun and v-Jun proteins (Figure 3.6). Specifically, gag-c-jun and gag- 
v-jun fusion sequences were created by PCR and inserted into the 
replication defective, drug-selectable, avian retrovirus SFCV-LE 
(Fuerstenberg et al, 90). The partial gag sequences were included to 
induce a size difference between exogenous and endogenous Jun proteins 
that would be evident on SDS/acrylamide gels.
III.B.2a Physical Properties of gag-c-Jun and gag-v-Jun Fusion 
Proteins
To confirm the predicted molecular weights of the gag-c-Jun and gag-v- 
Jun fusion proteins the DNA segments created by PCR were subcloned
FIGURE 3.5
Western Blot analysis of denatured whole cell protein extracts, prepared 
from normal and transformed CEF cultures. Transformed cell extracts 
were prepared from v-Jun (ASV17) and c-Myc ( RCAN-c-Myc) infected 
chicken fibroblasts. Approximately equal concentrations of protein were 
resolved on a 9% SDS/acrylamide gel and transferred onto ECL nylon 
membrane using a CAM LAB Semi-Dry Blotter. The proteins were 
visualized by ECL detection, with a 1:4000 dilution of 730/5. p65 gag-v- 
Jun is denoted by a solid arrowhead and p39 c-Jun by a light arrowhead.
Antibody specificities are outlined in figure legend 3.16
CEF ASV17 RCAN
c-MYC
FIGURE 3.5
FIGURE 3.6
PC and PV/SFCV contain partial gag-c-jun (PC) or gag-v-Jun (PV) 
sequences amplified from the PC and PV retroviral vectors (constructed by 
D.A.F. Gillespie). PCR primer "a" was designed against a specific 
retroviral gag sequence, and tagged with a 5' Hindlll restriction 
endonuclease site and an adjacent ATG initiation codon contained within a 
Kozak consensus sequence. The antisense PCR primer "b" was specific 
for c-jun 3' coding sequences, and was tagged with an antisense EcoRI 
restriction endonuclease site. PC and PV Hindlll - EcoRI fragments 
encompass 67 amino acids of partial gag p19 and p10 sequences, fused 
in frame to the full length c-jun or v-jun coding regions respectively. The 
amplified product was cloned into the avian replication defective retroviral 
vector, pSFCV-LE (Fuerstenberg et al, 1990), at the appropriate 
restriction endonuclease sites. c-Jun or v-Jun sequences are denoted by 
a shaded box; and partial retroviral gag sequences by a hatched box. The 
splice donor (SD) and splice acceptor (SA) sites are identified as shown 
and the spliced transcript indicated by a dotted arrowhead. Translation of 
the gag-c-Jun and v-Jun sequences is directed from the internal ATG 
inserted in PCR primer "a".
For invitro transcription and sequencing analysis, the Hindlll - EcoRI gag- 
c/v-jun fragment was subcloned directly from pSFCV-LE into the polylinker 
of the invitro transcription vector, pSPT19. The orientation of the Hindlll 
and EcoRI restriction sites, within the pSPT19 polylinker, directs sense 
transcription from the T7 RNA polymerase promoter (Figure 5.3).
PC/PV
&*U1
pSFCV - LE
PC/PV - SFCV
SD SA
  ->
FIGURE 3.6
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from SFCV into plasmid pSPT19 for in vitro translation analysis (see Figure 
3.6). As shown in Figure 3.7A, c-Jun and v-Jun were expressed as 47kD 
and 44kD proteins respectively, in the presence of reticulocyte lysate. The 
additional 8kD corresponds to the predicted molecular weight of the 67aa 
gag sequence fused in frame to both full length proteins (Figure 3.6). A 
ladder of retarded bands was observed for the gag-c-Jun fusion protein. 
This was reminiscent of the electrophoretic mobility shift reported for in 
vitro translated c-Jun (but not v-Jun), that was shown to result from 
phosphorylations of c-Jun in reticulocyte extract (Black e ta !, 91).
To determine whether the gag-Jun fusion proteins behaved normally with 
respect to dimerization, the DNA segments were cotranslated in the 
presence of c-Fos, and the products immunoprecipitated with anti-Jun- 
(730/5) or anti-Fos- (388/4) specific antisera. 730/5 reacts specifically with 
c-Jun and v-Jun proteins, whereas 388/4 recognizes epitopes specific to 
c-Fos and Fos-Related Antigens. In accordance with this 703/5 
immunoprecipitated the gag-Jun fusion proteins (Figure 3.7B: compare 
lanes 2 & 3 and lane 1), whereas 388/4 specifically immunoprecipitated c- 
Fos (Figure 3.7C: compare lane 1 and lanes 2 & 3). 388/4 also
precipitated co-translated gag-c-Jun (lane 5) and gag-v-Jun (lane 4), 
indicating that heterodimerization had occured under these conditions. 
The extended ladder of c-Jun-specific in vitro translated proteins was not 
immunoprecipitated by 388/4, suggesting that c-Fos heterodimerizes with 
only a proportion of modified c-Jun proteins (compare lanes 5 in Figure 
3.7A and 3.7C). The converse immunoprecipitation, in the presence of 
730/5, was less conclusive as p55 c-Fos migrates as a weak 
heterogenous band and is, consequently, not readily detectable in c- 
Jun/c-Fos co-translations (Figure 3.7A: lanes 1, 4 & 5).
FIGURE 3.7
In vitro translations and cotranslations of p47 gag-c-Jun,(blue arrowhead) 
p44 gag-v-Jun (black arrowhead) and p55 c-Fos (green arrowhead).
Full length jun and fos sequences were subcloned, in the antisense 
orientation, into plasmid pSPT19 for in vitro transcription and subsequent 
in vitro translation (Figures 3.6 & 5.3). In vitro transcripts were 
synthesized from the T7 RNA polymerase promoter encoded by pSPT19.
P l a s m i d
s e q u e n c e s :
c-Fos
(p55)
gag-cJ
(p47)
gag-vJ
(p44)
In vitro translations and cotranslations were performed in a final volume of 
50ul. 5ul of each reaction was removed prior to immunoprecipitation and 
the translated products resolved on a 9% acrylamide/SDS gel (3.7A). The 
remaining volume was equally divided, and immunoprecipitated against 
5ul 730/5 (3.7B) or 5ul 388/4 (3.7C). p47 gag-c-Jun is denoted by a blue 
arrowhead; p44 gag-v-Jun by a black arrowhead and p55 c-Fos by a 
green arrowhead.
Antibody specificities are outlined in figure legend 3.16.
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These results confirmed that proteins of the predicted molecular weight 
were encoded by the gag-jun fusion genes, and that both fusion proteins 
behaved normally with respect to in vitro heterodimerization with c-Fos.
III.B.2b Biological Effects of c-Jun and v-Jun Fusion Proteins
To investigate and compare the biological consequences of high c-Jun and 
v-Jun expression, primary CEFs were co-transfected with PC or PV/SFCV 
and RCAN DNA, and incubated in the presence of G418 to select for 
uniformly-infected cultures (section II.A.3). G418 resistant cultures were 
maintained in normal growth medium to examine their growth rate and 
cellular morphology; and lysed under denaturing conditions to quantifiy the 
levels of exogenous c-Jun or v-Jun expression.
- Cellular Growth Rate
The growth rate of PC and PV/SFCV transfectants was measured under 
normal growth conditions, over six consecutive days. As shown in Figure 
3.8, PV/SFCV-transfected and ASV17-transformed cells grew more 
rapidly than non-transfected or vector-transfected (SFCV) CEFs. 
PC/SFCV-transfected CEFs grew at an intermediate rate between the fully 
transformed ASV17-infected cultures and the normal CEF controls.
- Cellular Morphology
The cellular morphology of PV and PC/SFCV transfected CEFs was quite 
distinct (Figure 3.9). PV/SFCV transfected cultures exhibited a 
transformed morphology typical of ASV17-transformed CEFs. The cells 
were elongated and retractile, and at high densities piled up in swirling
FIGURE 3.8
Growth curves of PC and PV/SFCV CEF transfectants relative to normal, 
vector transfected and ASV17 transformed CEF controls. Growth was 
measured in normal growth medium and cell numbers correspond to the 
average value of two T25 tissue culture flasks.
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FIGURE 3.9
Morphology of PC and PV/SFCV transfected primary CEFs. A bold 
arrowhead denotes the epithelioid component of PC/SFCV transfected 
cultures. Normal and ASV17 transformed primary CEFs were included as 
controls. All cultures were examined at an equivalent passage.
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patterns. PC/SFCV transfected cultures exhibited a unique morphology 
that was distinct from normal (CEF/SFCV) and p65 gag-v-Jun-transformed 
(ASV17-CEF) CEFs. The newly selected cultures contained a mixture of 
fibroblastic and epithelioid-like-cells. With continued passage, the 
epithelioid-like-cells assumed a greater proportion of the culture and 
exhibited a tendency to slough off into the growth medium at high 
densities. Floating cells could be transferred into low serum-containing 
medium, and sustained under these conditions for several passages 
(Figure 3.9 - lower panel).
- Exogenous Jun Protein Expression
The expression and subcellular localization of the exogenous Jun proteins 
was examined by indirect immunofluorescence staining, using an antibody 
specific for c-Jun and v-Jun proteins (730/5). The staining pattern of PC 
and PV/SFCV transfected CEFs was compared to that of normal and 
ASV17-transformed CEF cultures.
As shown in Figure 3.10, exogenous and endogenous Jun proteins were 
predominantly localized to the nucleus. This confirmed their function as 
nuclear transcription factors, and demonstrated that nuclear translocation 
of c-Jun and v-Jun was not disrupted by retroviral gag sequences. The 
intensity of nuclear staining was approximately comparable between PC 
and PV/SFCV transfected cultures, and a culture of ASV17-transformed 
CEFs. A control culture of normal CEFs exhibited a markedly reduced 
intensity of nuclear staining. The pattern of immunological staining was 
specific to c-Jun and v-Jun proteins as parallel reactions using the 
flouresceine-linked secondary antibody alone exhibited little or no 
background fluorescence (Figure 3.10 - lower panel).
FIGURE 3.10
Indirect Immunfluorescence staining of PC and PV/SFCV transfected 
CEFs. Transfected monolayers were fixed in paraformaldehyde and 
incubated at room temperature with a 1:100 dilution of 730/5. c-Jun and v- 
Jun specific staining was visualized using a 1:100 dilution of GARFITC. 
Normal and ASV17 transformed CEFs were included in the analysis as 
controls. Non-transfected CEFs were incubated with GARFITC alone to 
control for non-specific immunofluorescence staining.
Antibody specificities are outlined in figure legend 3.16.
CEF ASV17/CEF
RBRB
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FIGURE 3.10
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These results demonstrated that exogenous c-Jun and v-Jun were 
expressed to equivalent levels in PC and PV/SFCV transfected CEFs, and 
that the levels of expression paralleled that of p65 gag-v-Jun in ASV17- 
transformed CEFs and exceeded that of endogenous c-Jun in normal 
CEFs.
To quantitate the levels of gag-c-Jun and gag-v-Jun expression more 
accurately, PC and PV/SFCV transfected cultures were lysed under 
denaturing conditions, and the whole cell protein extracts examined by 
western blot analysis. As shown in Figure 3.11A, endogenous c-Jun was 
expressed in normal and SFCV transfected cultures but was completely 
absent from ASV17-transformed CEFs. This confirmed previous 
observations (Figure 3.5), and demonstrated that the SFCV vector 
sequences alone did not affect endogenous c-Jun protein expression.
PC and PV/SFCV CEF extracts exhibited low, but detectable, levels of 
endogenous c-Jun. The levels may reflect the persistence of normal CEFs 
within the low passage PC and PV/SFCV transfected cultures, and/or 
demonstrate an inability of the gag-Jun fusion proteins to down regulate 
endogenous c-Jun expression. High levels of exogenous Jun-reactive 
proteins were also detected in the PC and PV/SFCV transfected cultures. 
Candidate gag-Jun fusion proteins of the predicted molecular weight 
(Figure 3.7) represented a small proportion of the total pool of Jun-reactive 
proteins (Figure 3.11 A). The p44 and p47 Jun-reactive species were not 
recognized by a gag-specific antisera (Figure 3.11B), suggesting that they 
represented bona-fide protein products of the retrovirally inserted partial 
gag-v-jun and gag-c-jun sequences.
The vast majority of Jun-reactive proteins detected in PC and PV/SFCV 
transfected CEF extracts migrated with molecular weights of approximately 
68kD and 65kD respectively. p68 and p65 were specific to PC and
FIGURE 3.11
Western Blot analysis of denatured whole cell protein extracts, prepared 
from PC and PV/SFCV transfected primary CEFs. Approximately equal 
concentrations of protein were resolved on a 9% SDS/acrylamide gel and 
transferred to ECL nylon membrane using a CAM LAB Semi-Dry Blotter. 
The proteins were visualized by ECL detection with a 1:4000 dilution of 
730/5 (3.11 A), or a 1:10000 dilution of 5202 (3.11B). Normal and ASV17 
transformed cultures were included as controls, together with an extract 
prepared from SCFV-vector transfected CEFs alone. p68 gag-c-Jun is 
denoted by a broken arrowhead; p65 gag-v-Jun by a solid arrowhead; 
and p39 c-Jun by a black arrowhead. Candidate proteins corresponding to 
p44 gag-v-Jun and p47 gag-c-Jun are denoted by respective green and 
blue arrowheads, in Figure 3.11 A. Gag reactive proteins pr76, p27 and 
p30 gag neo are denoted, in Figure 3.11B, by red, blue and green 
arrowheads respectively (11B). The ~ p42 gag-v-Jun proteolytic fragment 
is denoted by a "b " on Figure 3.11 A.
Antibody specificities are outlined in figure legend 3.16
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PV/SFCV transfected cultures (Figure 3.11 A) and were recognized by anti- 
Jun (730/5) and anti-gag (5202) specific antisera (Figure 3.11A & 3.11B). 
This, together with their similarity in size to the v-Jun oncoprotein, 
suggested that p65 and p68 were the products of a homologous gag 
recombination that mimicked the non-homologous gag-jun recombination 
responsible for the generation of p65 gag-v-Jun (Maki et al, 87). c-Jun and 
v-Jun differ in size by 3kD due to a 27 amino acid deletion in the v-jun 
coding region (Figure 1.1). The 3kD size difference was maintained in the 
recombined gag-Jun fusion proteins, supporting the hypothesis that both 
were the consequence of an identical gene rearrangement. The gag 
sequences involved could have originated from endogenous retroviruses, 
the RCAN helper virus or gag sequences upstream of the neomycin 
resistance gene in SFCV (Figure 3.6). Evidence for endogenous 
retroviruses was provided by the identification of retroviral gag proteins in 
non-transfected normal CEF extracts (Figure 3.11B). The gag antiserum 
also recognized a 30kD protein, specific to SFCV transfected CEFs. p30 
corresponds to the predicted molecular weight of the gag-neo protein 
responsible for conveying G418 resistance in SFCV transfected cells 
(Figure 3.6). The G418 resistance of PC and PV/SFCV transfected CEFs 
suggested that recombination within the PC and PV/SFCV constructs was 
unlikely to represent the sole gene rearrangement, and emphasized the 
importance of alternative retroviral gag sequences in the overall generation 
of the gag-Jun recombinant proteins.
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III.B.2C Transforming Effects of gag-c-Jun and gag-v-Jun Fusion 
Proteins
- Soft Agar Cloning Assays
The cellular morphology and growth rate of PV/SFCV transfected CEFs 
were indistinguishable from ASV17-transformed cell cultures. PC/SFCV 
transfectants, in contrast, exhibited an intermediate phenotype between 
normal and fully transformed CEFs (section III.B.2b). An alternative 
parameter of cellular transformation is the ability to grow in the absence of 
anchorage to a cellular or non-cellular substrate. Anchorage independent 
growth is measured by soft agar cloning analysis and provides a useful tool 
to separate the growth of normal and ASV17-transformed CEFs (Bos et al, 
90). At suitable densities each ASV17-derived soft agar colony represents 
the descendants of a single p65 gag-v-Jun-infected cell. The absence of 
contaminating normal CEFs has made this an ideal system for examining 
the auto-repressor activity of the v-Jun oncoprotein. To investigate 
whether the soft agar cloning assay could be similarly used to study the 
gag-Jun fusion proteins, PC and PV/SFCV transfected CEFs were seeded 
into soft agar and their anchorage independent growth monitored over 2-3 
weeks (section II.A.4b). As shown in Figure 3.12, PC and PV/SFCV 
transfected CEFs formed multiple rapidly growing colonies in soft agar. 
PV/SFCV derived colonies were indistinguishable from ASV17-transformed 
CEF colonies in both their morphology and frequency of appearance. 
PC/SFCV derived colonies, in contrast, appeared at a lower frequency, 
but otherwise resembled their PV/SFCV transfected counterparts. In 
accordance with previous observations, normal and vector-transfected 
CEFs failed to grow in soft agar (Bos et al, 90).
FIGURE 3.12
Soft Agar Cloning analysis of PC and PV/SFCV transfected primary CEFs. 
Control assays are illustrated in the upper panel. The cells were seeded 
into 0.36% top agar, at 10^ 10^ and 10$ per 60mm dish. Cloning assays 
were supported on 0.76% base agar plates and fed every 2-3 days with 
0.36% top agar. The dishes were incubated in a humidified 37°C 
incubator containing 5% CO2  (v/v).
The colony numbers correspond to the average value of three 60mm 
dishes after 14 days incubation. The experiment was performed on three 
separate occasions. Individual soft agar colonies were picked and 
expanded 14 days after seeding.
Cell Numbers 
x105 -
Colonies per 
60mm dish -
Mean Colony 
Numbers
CEF
ASV17 / CEF 207 205 230 214
SFCV/CEF - - - -
PC/SFCV 70 82 89 80
PV/SFCV 218 262 380 286
CEF SFCV/CEF ASV17/CEF
'i
♦ a *
PV/CEF
■ ■ ■
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- Exogenous Jun Protein Expression in Primary Soft Agar Colonies
To investigate the levels of exogenous c-Jun and v-Jun expressed in PC 
and PV/SFCV derived soft agar colonies, individual clones were isolated 
and expanded for western blot analysis. As shown in Figure 3.13A, p68 
gag-c-Jun and p65 gag-v-Jun were expressed at high and approximately 
equivalent levels in colonies derived from PC or PV/SFCV transfected 
CEFs. The levels of expression were comparable to the levels of p65 gag- 
v-Jun detected in equivalent ASV17 derived cultures (Figure 3:13A - right 
hand lane). Gag-Jun fusion proteins of the predicted molecular weight, 
were not detected, supporting the hypothesis that the homologous 
recombination was both stable and advantageous for cellular 
transformation.
Endogenous p39 c-Jun was absent in ASV17, PC/SFCV and PV/SFCV 
derived colonies, irrespective of the growth conditions analysed (Figure 
3.13A). This observation led to the proposal that c-Jun down-regulation 
was a direct consequence of Jun overexpression and not dependent on 
qualitative mutations present within the v-Jun oncoprotein. To test this 
hypothesis further, virus particles were harvested from expanded primary 
soft agar colonies and titred onto exponential cultures of non-infected 
primary CEFs (section II.A.3b). The infected cultures were incubated in 
normal growth medium for 48hrs to permit retroviral integration and 
exogenous gag-Jun protein expression, and then lysed under denaturing 
conditions for western blot analysis. As shown in Figure 3.13B, the levels 
of exogenous and endogenous Jun proteins, in PC- and PV/SFCV- 
infected CEFs, were inversely proportional. Cells infected with the highest 
virus titre (1.0ml of an overnight harvest) expressed the lowest levels of 
endogenous p39 c-Jun, thereby supporting the conclusion that auto-
FIGURE 3.13A
Western Blot analysis of denatured whole cell protein extracts, prepared 
from expanded PC/SFCV, PV/SFCV and ASV17 infected soft agar 
colonies. Expanded colonies were grown under normal (exp) conditions, 
or serum stimulated for 45mins (45+), prior to cell lysis. Approximately 
equal concentrations of protein extract were resolved on a 9% 
SDS/acrylamide gel and transferred to ECL nylon membrane using a CAM 
LAB Semi-Dry blotter. The proteins were visualized by ECL detection with 
a 1:4000 dilution of 730/5. Normal and ASV17 transformed CEF extracts 
were included as controls. The p68 gag-c-Jun fusion protein is denoted by 
a broken arrowhead; the p65 gag-v-Jun fusion protein by a solid 
arrowhead; and p39 c-Jun by a light arrowhead. The protein extract 
corresponding to an expanded ASV17 infected soft agar colony is shown 
in the far right hand lane.
Antibody specificities are outlined in figure legend 3.16
FIGURE 3.13B
Western Blot analysis of denatured whole cell extracts, prepared from 
primary CEFs 48hrs after infection with titred PC/SFCV or PV/SFCV virus 
particles.
1 2 3
~ Virus Titre:
1.0ml O/N culture +
0.1ml O/N culture - +
1.0ml 4hr culture +
Approximately equal concentrations of protein extract were resolved on a 
9% SDS/acrylamide gel and transferred to ECL nylon membrane using a 
CAM LAB Semi-Dry Blotter. The proteins were visualized by ECL 
detection with a 1:4000 dilution of 730/5. p68 gag-c-Jun is denoted by a 
broken arrowhead; p65 gag-v-Jun by a solid arrowhead; and p39 c-Jun 
by a light arrowhead.
Antibody specificities are outlined in figure legend 3.16.
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repression is dose-dependent, and mediated by high levels of c-Jun or v- 
Jun proteins.
- Exogenous Jun Protein Expression in Secondary Soft Aaar colonies
To examine the stability and reproducibility of c-Jun and v-Jun-mediated 
auto-repression, soft agar cloning assays were repeated using PC- and 
PV/SFCV-infected primary CEFs. PC and PV/SFCV retroviral particles 
were harvested from expanded primary soft agar colonies, as described 
above (section II.A.4a). Second round PV and PC/SFCV derived colonies 
appeared at the same rate and frequency as before, and were 
morphologically identical to their first round counterparts (data not shown). 
The levels of p68 gag-c-Jun and p65 gag-v-Jun expression were similarly 
unchanged. Candidate exogenous proteins of the predicted molecular 
weight and endogenous p39 c-Jun, were consistently absent from the 
expanded second round colonies (Figure 3.14A & 3.14B).
From these observations it was concluded that the recombined c-Jun and 
v-Jun proteins were stable and that their overexpression was sufficient to 
down regulate endogenous c-Jun expression in avian cells.
III.C. CONSEQUENCES OF c-JUN DOWN-REGULATION FOR 
AP-1 DNA BINDING ACTIVITY IN ASV17-TRANSFORMED 
CEFS
The functional consequences of c-Jun down-regulation, in ASV17- 
transformed CEFs were investigated by DNA mobility shift assays. An 
oligonucleotide containing the collagenase TRE binding site, was used as
FIGURE 3.14
Western Blot analysis of denatured whole cell protein extracts, prepared 
from expanded secondary soft agar colonies. Virus particles were 
harvested form primary soft agar colonies, PC-1 and PV-2 (Figure 3.13A), 
and titred onto cultures of non-infected primary CEFs. 48hrs after infection 
the cells were seeded into soft agar as described in Figure 3.12. 
Individual secondary colonies were picked and expanded for Western Blot 
analysis on day 14. Approximately equal concentrations of protein extract 
were resolved on a 9% acrylamide gel and transferred to ECL nylon 
membrane using a CAM LAB Semi-Dry Blotter. The proteins were 
visualized by ECL detection with a 1:4000 dilution of 730/5. Figure 3.14A 
and 3.14B illustrate the expression of exogenous c-Jun and v-Jun proteins 
in respective, independent, PC and PV/SFCV derived secondary 
colonies. p68 gag-c-Jun is denoted by a broken arrowhead; p65 gag-v- 
Jun by a solid arrowhead, and p39 c-Jun by a light arrowhead.
Antibody specificities are outlined in figure legend 3.16.
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a probe to compare the AP-1 DNA binding activity in normal and ASV17- 
transformed CEF extracts. As shown in Figure 3.15, normal and ASV17- 
transformed CEFs were characterized by qualitatively and quantitatively 
distinct patterns of collagenase TRE binding activity. A single retarded 
band in normal CEF extracts (band I) was replaced by a weaker doublet in 
ASV17-transformed cells (bands II & III). The doublet was not detected in 
equivalent vector-infected (RCAS) or Src-(CK29) transformed CEF 
extracts, and therefore represented a specific consequence of v-Jun 
overexpression rather than a secondary effect of cellular transformation.
III.C.1. JUN COMPOSITION OF TRE BINDING ACTIVITIES I, II & 111
To investigate the Jun composition of Bands I, II, and III, a panel of 
different polyclonal antisera was included in the in vitro AP-1/TRE binding 
reactions. The reactivity of each antibody is outlined in figure legend 3.16. 
The antibody specificities were confirmed in a parallel series of binding 
reactions using extracts prepared from Swiss 3T3 cells (A kind gift from M. 
Unlu). JunB represents the predominant Jun family protein expressed in 
Swiss 3T3 cells (Kovary et ai, 91; Kovary et al, 92) and, in accordance 
with this, comprised the major AP-1/TRE binding protein detected in vitro 
(Figure 3.16A).
The AP-1 /TRE binding activity detected in normal and ASV17-transformed 
CEF extracts was virtually completely disrupted by two independent c-Jun- 
specific antisera: 730/5 and 948/4 (Figure 3.16A). Parallel reactions in the 
presence of anti-JunB or anti-JunD, had no effect on the migration of 
Bands I, II and III. This pattern of reactivity confirmed the c-Jun-specificity 
of 730/5 and 948/4, and led to the proposal that c-Jun-containing
FIGURE 3.15
Electrophoretic Mobility Shift analysis of collagenase TRE binding 
complexes present within non-denatured whole cell protein extracts, 
prepared from normal and ASV17 transformed CEFs. 10ug of protein 
extract was incubated for 30min on ice, in the presence (+) or absence (-) 
of a 100 fold excess (200ng) of specific cold competitor. 2ul (~ 2x 105 
cpm) of a 5' end labelled, double stranded collagenase TRE probe, was 
added and the contents incubated for a further 30 mins at 4°C. The 
binding reactions were resolved on a 4% non-denaturing acrylamide gel. 
The right hand lanes contain control cell extracts prepared from LA29 Src 
(CK29) and RCAS (vector alone) infected CEFs. DNA binding complexes 
I, II and III are illustrated on the figure. The canonical collagenase TRE 
binding sequence, contained within the synthetic oligonucleotide probe, 
is described above the main figure.
Antibody specificities are outlined in figure legeng 3.16.
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FIGURE 3.16A
Electrophoretic Mobility Shift analysis to compare the composition of 
collagenase TRE binding complexes present within three independent 
whole cell protein extracts. 10ug of non-denatured whole cell extract, 
prepared from Swiss 3T3 cells, normal CEFs and ASV17 transformed 
CEFs, was incubated on ice for 30mins with 2ul of rabbit polyclonal 
antisera. 2ul (~2x 105 cpm) of a 5' end labelled, double stranded 
collagenase TRE probe was added, and the contents incubated for a 
further 30mins at 4°C. The binding reactions were resolved on a 4% non- 
denaturing acrylamide gel. The left hand tracks of each set of six additions 
represent no addition ( -  ) or a 2ul addition of preimmune rabbit antisera ( 
PI ). Complexes I, II and III are denoted on the gel. The Swiss 3T3 and 
normal CEF autoradiographs were exposed for 7hrs and the ASV17/CEF 
autoradiograph for 24hrs.
FIGURE 3.16B
Electrophoretic Mobility Shift analysis to compare the composition of 
collagenase TRE binding complexes present within normal and ASV17 
transformed CEF extracts. 10ug of non-denatured whole cell protein 
extract was incubated in the presence of 2ul of sterile water (--), 2ul 
preimmune rabbit sera (PI), or 2ul of specific polyclonal rabbit antisera, 
for 30mins at 4°C. 2ul (~2x 105 cpm) of a 5' end labelled double stranded 
collagenase TRE probe was added, and the contents incubated at 4°C for 
a further 30mins. The binding reactions were resolved on a 4% non 
denaturing acrylamide gel. Collagenase TRE binding complexes I, II and 
III are denoted on the gel.
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complexes represent the majority, or all, of the AP-1/TRE binding activity 
detected in normal CEFs (Band I).
The nature of the c-Jun-reactive component detected in Bands II and III, 
was complicated by the virtual absence of endogenous p39 c-Jun in 
ASV17-transformed CEFs (Figure 3.5). 730/5 and 948/4 recognize
epitopes that are common to both c-Jun and p65 gag-v-Jun. To 
investigate the specific contribution made by p65 gag-v-Jun, a gag- 
specific antisera (5202) was included in the binding reactions. As shown in 
Figure 3.16B, anti-5202 completely disrupted band II but had no effect on 
the integrity of Band III (or Band I). The parallel antibody reactivities of 
Bands I and III, together with their similar patterns of migration in non­
denaturing acrylamide gels, suggested that both might contain 
endogenous p39 c-Jun. To exclude the possibility of low p39 c-Jun 
expression in a minority of ASV17-transformed CEFs, non-denatured 
protein extracts were denatured in 1x SDS sample buffer and analysed for 
the presence or absence of endogenous c-Jun (section II.D.3). As shown 
in Figure 3.17A, endogenous p39 c-Jun was only detectable in normal 
CEF extracts. Its absence in equivalent ASV17-transformed extracts 
indicated that residual p39 c-Jun was unlikely to represent the c-Jun- 
reactive component of Band III.
III.C.2. Fos/FRA COMPOSITION OF TRE BINDING ACTIVIITIES 
I. II and III
c-Jun transactivates gene expression as a homo or a heterodimer 
(Ransone et al, 89). A major family of Jun dimerization partners is 
represented by the Fos or Fos-related proteins. To investigate their 
contribution to the collagenase TRE binding activity in normal and ASV17- 
transformed CEFs, a Fos/FRA-specific antibody (388/4) was included in
FIGURE 3.17
Western Blot analysis of denatured whole cell protein extracts, prepared 
from normal and ASV17 transformed CEFs. The extracts were originally 
prepared as non-denatured extracts for gel mobility shift analysis and were 
subsequently denatured in SDS sample buffer for western blotting 
analysis. Approximately equal concentrations of protein extract were 
resolved on a 9% SDS/acrylamide gel and transferred to ECL nylon 
membrane using a CAM LAB Semi-Dry Blotter. The proteins were 
visualized by ECL detection with a 1:4000 dilution of 730/5 (Figure 3.17A) 
and a 1:10000 dilution of 5202 (Figure 3.17B). Autorads A and B 
represent the same gel probed sequentially with 730/5 and 5202 after 
stripping in p-mercaptoethanol (Section II.D.3c). Control cell extracts are 
illustrated on the right hand side of the gel. They represent normal and 
ASV17 transformed CEF western blot extracts, and an equivalent extract 
prepared from c-Myc infected primary CEFs (RCAN c-MYC). p65 gag-v- 
Jun is denoted by a solid arrowhead; p39 c-Jun by a light arrowhead; and 
the p42 gag-v-Jun proteolytic fragment by a broken arrowhead.
Antibody specificities are outlined in figure legeng 3.16.
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the in vitro DNA binding reactions. 388/4 was raised against a peptide in 
FBJ-MuSV provirus that spans part of the p55 v-Fos basic region and 
recognizes multiple members of the Fos/FRA gene family (Vosatka et al,
89). As shown in Figure 3.16B, Bands I, II and III were severely 
disrupted by a 2ul addition of 388/4. The pattern of disruption indicated a 
high, and approximately equivalent, presence of Fos/FRA-containing TRE 
binding complexes in both cell types. Complete disruption was never 
observed under these experimental conditions. The residual collagenase 
TRE binding activities was presumed to represent alternative Jun- 
containing complexes with identical mobilities in non-denaturing acrylamide 
gels to their Fos/FRA-containing counterparts.
CHAPTER IV - DISCUSSION m .
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CHAPTER IV - DISCUSSION 
c-JUN EXPRESSION AND AUTO-REPRESSION
IV.A. c-jun EXPRESSION AND REGULATION
IV.A.1. TRANSCRIPTIONAL REGULATION
RNase protection analysis demonstrated that c-jun mRNA was rapidly and 
transiently induced in response to serum growth factors, and 
superinduced in the presence of protein synthesis inhibitors (Figure 3.1 A). 
The kinetics of c-jun expression were characteristic of a class of 
transcription factors described as the immediate early genes. Immediate 
early genes derive their name from viral counterparts which exhibit a 
coordinate and transient pattern of regulation in the absence of ongoing 
protein synthesis (Lau et al, 87). The cellular immediate early genes 
encode transcription factors, such as c-Myc and c-Fos, which have been 
proposed to mediate the conversion of transient cell surface signals into 
long term changes in gene expression (Angel etal, 88(ii».
Regulation of immediate early gene expression is both complex and 
specialized. As shown in Figure 3.2, the serum induction of c-jun 
transcription was modest and transient relative to the corresponding 
induction of c-jun mRNA. The pattern of transcriptional induction was 
insufficient to account for either the large fluctuations in c-jun mRNA, or 
the persistence of yun-specific transcripts at late time points after serum 
stimulation (compare Figure 3.1 A & 3.2). The discrepancies suggest a role
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for post-transcriptional regulatory mechanisms, which have been 
associated with the differential expression patterns of several immediate 
early genes in vivo ( Greenberg etal, 84; Lau etal, 87; Mitchell etal, 86). 
The relative contribution made by post-transcriptional regulation depends 
on the identity of the immediate early gene and the nature of the inducing 
stimulus. Transcriptional repression of c-jun, for example, is delayed in 
the presence of inducing stimuli such as TGF-B (Kim et al, 90) and TNF-a 
(Brenner et al, 89). An equivalent pattern of expression is not associated 
with the c-fos gene, which is predominantly regulated at the level of 
transcription (Greenberg et al, 84; Muller et al, 84; Rahmsdorf et al, 87). 
In accordance with this, c-fos transcription was rapidly and transiently 
induced in response to serum stimulation (Figure 3.2). The kinetics of c- 
fos expression paralleled the reported induction of c-fos mRNA following 
serum stimulation (Greenberg et al, 84) but were distinct from those of c- 
jun (Figure 3.2), suggesting that the c-jun gene is subject to additional 
levels of post-transcriptional regulation under these conditions. 
c-jun- specific post-transcriptional regulatory mechanisms were not 
investigated in this analysis, but the superinduction of c-jun mRNA in the 
presence of protein synthesis inhibitors suggested that productive 
translation was required for the post-transcriptional regulation of c-jun 
mRNA in response to serum stimulation (Figure 3.1 A). In support of this 
hypothesis, ongoing protein synthesis has been associated with mRNA 
stability and transcriptional repression of several immediate early mRNAs 
in vivo, including c-jun (Ryseck et al, 88; Sherman et al, 90). 
Mechanisms responsible for regulating immediate early mRNA stability 
include endonuclease directed degradation through 3' untranslated target 
sequences (Shyu etal, 89; Wisdom et al, 91), and translation-dependent 
degradation through specific instability elements in the coding sequences 
of several immediate early genes (Bernstein et al, 92; Shyu et al, 89;
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Wisdom et al, 91). Repression of immediate early transcription is directed 
through the synthesis of specific repressor proteins. For immediate early 
genes such as c-myc and c-fos, the protein products negatively regulate 
their own promoters thereby mediating exquisitely sensitive mechanisms of 
auto-repression (Grignani etal, 90; Rivera etal, 90).
The translation-dependent mechanisms controlling the levels of c-jun 
mRNA in response to serum growth factors, may include a regulation of c- 
jun mRNA stability and c-jun transcriptional repression. The differential 
contribution of post-transcriptional mechanisms to the serum induction of 
c-jun and c-fos (Figure 3.2), together with the persistence of yun-specific 
transcripts at late time points after serum stimulation (Figure 3.1 A), 
suggests that transcriptional and post-transcriptional regulatory 
mechanisms induce overlapping but sequential patterns of c-jun and c-fos 
expression in vivo. Sequential patterns of gene expression are similarly 
associated with the viral immediate early genes (Lau et al, 87), and are 
presumed to regulate complex and ordered patterns of gene expression, 
analagous to the developmental programme of a complex virus.
IV.A.2. TRANSLATIONAL AND POST-TRANSLATIONAL REGULATION
The rapid and dramatic changes in c-jun mRNA levels, observed in 
response to serum stimulation, did not correlate with the corresponding 
changes in c-Jun protein expression (compare Figure 3.1A & 3.3). c-Jun 
protein was modestly induced under these conditions, attaining maximum 
levels long after the onset of decline in yt//?-specific transcripts. The 
discrepancies in c-jun mRNA and protein expression levels strongly 
supported a role for translational regulation. The relatively invariant levels 
of c-Jun protein detected in response to serum stimulation (Figure 3.3A &
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3.3B), suggested that one function of translational regulation may be to 
maintain relatively consistent levels of c-Jun protein against widely 
fluctuating levels of c-jun mRNA.
The mechanisms governing Jun-specific translational regulation have not 
been elucidated, although an extended GC rich sequence in the 5' 
untranslated region of c-jun mRNA has recently been identified that 
represses c-Jun translation through the formation of highly stable 
secondary structures (A. Sehgal; personal commun.). Further regulatory 
mechanisms are likely, and presumably contribute to the high and 
relatively invarient levels of endogenous p39 c-Jun observed after serum 
stimulation (Figure 3.3). Maintaining a pool of endogenous c-Jun protein 
may facilitate the initial rapid transcriptional response characteristic of 
immediate early transcription factors. Primary immediate early 
transcription is independent of protein synthesis and has been proposed to 
depend on post-translational modifications to pre-existing proteins (Angel 
etal, 88(ii); Reviewed in Angel et al, 91). In support of this hypothesis, a 
ladder of Jun-reactive proteins was transiently detected at very early time 
points after serum stimulation (Figure 3.3A). The ladder comprised 4-5 
individual bands and was not ablated in the presence of a protein synthesis 
inhibitor (Figure 3.4).
Electrophoretic retardations of the c-Jun protein have been reported in 
vitro (Black et al, 91) and in vivo (Pulverer et al, 92), and correlate with 
amino-terminal phosphorylation of c-Jun at serines 63 and 73 (Black et al, 
94; Boyle et al, 91; Lin et al, 92). It has been proposed that 
phosphorylation induces a conformational change that directly or indirectly 
alters the electrophoretic mobility of the c-Jun protein (Black et al, 94; 
Pulverer etal, 92). This proposal is supported by the recently identified c- 
Jun amino-terminal kinase, JNK, that specifically binds to a region in the 
c-Jun transactivation domain and phosphorylates serines 63 and 73.
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Phosphorylation results in the dissociation of the JNK-c-Jun complex, 
presumably through a conformational change (Hibi et al, 93). Stimuli that 
enhance c-Jun amino-terminal phosphorylation also potentiate c-Jun 
transcriptional activation (Binetruy et al, 91; Pulverer et al, 91; Smeal et 
al, 91; Smeal et al, 92). Conversely, substitution of serines 63 and 73 
with non-phosphorylatable leucine or alanine residues severely impairs c- 
Jun transactivation, suggesting that phosphorylation at these sites is either 
necessary for, or potentiates c-Jun transactivation in vivo (Black et al, 94; 
Pulverer et al, 91; Smeal et al, 91). The equivalent mutations in v-Jun 
have no effect on v-Jun transactivation (Black et al, 94). v-Jun is not 
phosphorylated in vitro by kinases that phosphorylate c-Jun (Black et al, 
94; Smeal et al, 91), and does not produce an electrophoretic mobility 
shift when translated in vitro in the presence of reticulocyte lysate (Black et 
al, 91). More recently it has been reported that v-Jun does not contain a 
binding site for JNK, suggesting that it exists in a distinct and potentially 
active conformation (Hibi etal, 93).
The conformational differences between c-Jun and v-Jun may account for 
the differential reactivities of CASTOR and 730/5 against the Jun-specific 
ladder (compare Figure 3.3A & 3.3B). 730/5 was raised against bacterial 
and, presumably, unmodified c-Jun; whereas CASTOR was raised 
against a trpE-v-Jun fusion protein (Angel etal, 88(ii)). If post-translational 
activation of c-Jun is regulated by a conformational change that 
permenently exists in the v-Jun protein, then recognition of the active 
conformation(s) would, predictably, be restricted to the CASTOR 
antibody. The proposed c-Jun-specific conformational change is 
mediated, at least in part, through the recently identified Jun amino- 
terminal kinase, JNK (Hibi et al, 93). JNK was originally identified as a 
cycloheximide stimulated kinase (Edwards et al, 92; Kyriakis et al, 94; 
Mahadevan et al, 91), and, consequently, may account for the enhanced
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electrophoretic mobility shift of the c-Jun ladder in the presence of 
cycloheximide (Figure 3.4). The rapid and transient appearance of the 
ladder (Figure 3.3B) suggests that post-translational modifications to pre­
existing Jun proteins may mediate some aspects of the initial Jun-specific 
transcriptional response, but that ongoing protein synthesis may be 
necessary for more prolonged changes in gene expression.
IV.B. JUN-MEDIATED AUTO-REPRESSION
A subset of immediate early proteins express the ability to negatively 
regulate their own gene promoters (Grignani e ta l, 90; Sassoni-Corsi et al, 
88). To investigate whether Jun exhibits an equivalent auto-repressor 
function, expression of endogenous p39 c-Jun was analysed in ASV17- 
transformed CEFs. As shown in Figure 3.5, detection of endogenous p39 
c-Jun was specifically and completely abolished in the presence of the v- 
Jun oncoprotein.
p65 gag-v-Jun contains a number of structural mutations in the coding and 
non-coding sequences that are not present in the non-transforming proto­
oncogene (Figure 1.1). To investigate their contribution to v-Jun auto­
repression, gag-c-jun and gag-v-jun fusion sequences were inserted into 
the SFCV-LE retroviral vector to facilitate equivalent overexpression of c- 
Jun and v-Jun in primary CEFs (Figure 3.6). The predicted molecular 
weights and dimerization properties of the gag-Jun fusion proteins were 
confirmed by in vitro translation and immunoprecipitation analysis (Figure 
3.7)
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IV.B.1. CHARACTERIZATION OF C-JUN- AND v-JUN-EXPRESSING 
PRIMARY CEFs
PC and PV/SFCV transfected CEFs were characterized in relation to 
normal and ASV17-transformed CEFs, by their growth rate and cellular 
morphology in normal growth medium. As shown in Figure 3.8 and 3.9, 
PV/SFCV transfectants exhibited an indistinguishable phenotype from 
ASV17-transformed CEFs. Early passage cultures expressed low levels of 
a candidate 44kD gag-Jun fusion protein (Figure 3.7A & 3.11 A). With 
continued passage the 44kD protein was replaced by a larger 65kD gag- 
Jun fusion (Figure 3.13A & 3.13B). The molecular weight, nuclear 
distribution and cellular expression of p65 was identical to ASV17 p65 gag- 
v-Jun (Figure 3.13A & 3.10), and may provide an explanation for the 
ASV17-like phenotype of PV/SFCV transfected CEFs.
In contrast to their PV/SFCV transfected counterparts, PC/SFCV 
transfected CEFs expressed a 68kD gag-Jun fusion protein (Figure 3.13A 
& 3.13B). Like p65, p68 rapidly replaced the candidate 47kD gag-c-Jun 
fusion (compare Figure 3.11A & 3.13A), and was predominantly localized 
to the nucleus (Figure 3.10). The size and expression levels of p65 and 
p68 were consistent with a single recombination event linking either v-jun 
(PV/SFCV) or c-jun (PC/SFCV) coding sequences to a common portion of 
the retroviral gag gene (section IV.B.2). Overexpression of p68 gag-c-Jun- 
induced a phenotype that was intermediate between normal and fully 
transformed CEFs (Figure 3.8 & 3.9). The cultures expressed a dual 
morphology of fibroblastic and epithelioid-like cells (Figure 3.9). The small, 
rounded epithelioid-like cells assumed a greater proportion of the culture 
with continued passage, and exhibited sustained growth under low serum 
conditions (Figure 3.9 - lower panel). A similar morphology has been 
reported for high c-Jun-expressing NIH3T3 cells, which also exhibit a
135
slightly elevated growth rate under normal growth conditions (Pfarr et al, 
94). Flow cytometry analysis of NIH3T3 c-Jun overexpressors, 
demonstrated a larger than predicted percentage of abnormally small cells 
in S phase. The overall growth rate of these cells was only slightly 
enhanced, suggesting that c-Jun overexpression accelerates entry into S 
phase but deccelerates exit, due to rate limiting components or negative 
signals.
The c-Jun-specific alterations to growth rate and cellular morphology 
presented in this report, favour a similar Jun-dependent pertubation of the 
cell cycle in primary CEFs. The precise cell cycle target was not 
investigated, but the changes presumably contribute to the partially 
transformed phenotype exhibited by c-Jun-expressing CEFs. To further 
investigate the transformed phenotype of PC and PV/SFCV transfected 
CEFs, cells were examined for their ability to grow in the absence of 
anchorage to a non-cellular substrate. As shown in Figure 3.12, both PC 
and PV/SFCV transfected CEFs were capable of anchorage independent 
growth. PC/SFCV derived soft agar colonies were more diffuse and 
approximately 3 times less frequent than their PV/SFCV and ASV17 
derived counterparts. This correlated with the partially transformed 
phenotype of PC/SFCV transfected CEFs and confirmed the close 
similarity between PV/SFCV transfected and ASV17-transformed CEFs. 
Similar conclusions have been drawn from independent investigations 
analysing the consequences of high c-Jun and v-Jun expression in primary 
CEFs. Overexpression of c-Jun, for example, has been associated with 
an enhanced growth rate, modest anchorage independent growth and a 
lower requirement for exogenous mitogenic stimuli (Bos et al, 90; 
Castellazzi et al, 90). c-Jun overexpressors, however, are not fully 
transformed according to other parameters of cellular transformation such 
as morphology and contact inhibited growth. (Castellazzi et al, 90).
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These observations support the proposal that overexpression of c-Jun is 
sufficient to induce a partially transformed phenotype in primary CEFs. 
The requirement for high levels of c-Jun expression suggests that partial 
transformation is mediated through quantitative changes in c-Jun/AP-1- 
dependent gene expression (Wong et al, 92). Induction and maintenance 
of the fully transformed phenotype is presumed to require additional 
qualitative changes in gene expression that are specific to the v-Jun 
oncoprotein. In support of this hypothesis, v-Jun-mediated cellular 
transformation is dependent on high levels of v-Jun expression, and the 
presence of two amino acid substitutions in the carboxy-terminal region of 
the v-Jun oncoprotein (Figure 1.1). The structural mutations are specific 
to p65 gag-v-Jun and have been proposed to mediate the qualitative 
changes in gene expression necessary for full in vitro cellular 
transformation and in vivo tumourigenesis (Wong etal, 92).
IV.B.2. CONSEQUENCES OF c-JUN AND v-JUN OVEREXPRESSION 
ON ENDOGENOUS c-JUN EXPRESSION
Overexpression of c-Jun and v-Jun was sufficent to induce the cellular 
transformation of primary CEFs (section IV.B.1.). Transformation was 
accompanied by a dramatic and reproducible down-regulation of 
endogenous c-Jun expression that was specific to the expression of 
exogenous Jun proteins and not a secondary consequence of cellular 
transformation (Figure 3.13A & 3.14). The magnitude of the response was 
apparently equivalent in v-Jun- and c-Jun-expressing CEFs (Figure 3.13A), 
suggesting that v-Jun-specific qualitative mutations are dispensible for 
auto-repression in vitro. This interpretation was complicated by the 
appearance of the novel PC and PV gag-Jun fusion proteins which, from
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their antibody reactivities and molecular weights, resembled the products 
of a homologous gag recombination mimicking the final structure of 
ASV17. The conservation and rapidity of the proposed rearrangement 
suggested that specific gag-Jun recombinant proteins present primary 
CEFs with a strong selective advantage over their normal counterparts. 
This proposal is supported by the observation that c-Jun, unlike c-Fos, 
has been captured on only one known occasion through recombination 
with chicken retroviral gag sequences, in spite of a propensity for gag 
rearrangements in vitro ( Bos et al, 90; Reviewed in Curran, 91; Maki et 
al, 87).
The precise nature of the PC and PV/SFCV gene rearrangement was not 
investigated. Without direct sequencing data it remained a possibility that 
qualitative mutations had accumulated in c-Jun that were more significant 
for Jun-mediated auto-repression than any additional recombined gag 
sequences. Evidence from the literature does not favour this 
interpretation. Exogenous c-Jun proteins have consistently been detected 
as discrete bands in SDS gels, migrating according to their predicted 
molecular weight in the absence of endogenous c-Jun expression 
(Castellazzi et al, 90; Castellazzi et al, 91). These observations suggest 
that major structural alterations, such as the 27 amino acid deletion in v- 
Jun, are not required for Jun-dependent auto-repression in vitro. Similar 
conclusions have been drawn using replication defective and drug 
selective retroviral vectors to express high levels of murine c-Jun in 
primary CEFs (Castellazzi et al, 90). Replication defective vectors 
eliminate a contribution from minor, undetectable structural mutations, 
that may accumulate in c-jun during early viral replicative cycles and 
contribute to the auto-repressor function.
These reports, together with the appearance of the PC and PV gag-Jun 
fusion proteins, suggested that the principal function of recombination was
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to juxtapose c-jun or v-jun genes to specific retroviral gag sequences. A 
requirement for specific gag rearrangements was not supported by an 
independent analysis of v-Jun, which identified intact v-jun coding 
sequences and high levels of v-Jun expression as the sole pre-requisites 
for v-Jun-mediated cellular transformation in vitro and in vivo (Bos et al, 
90). Consequently, the principle function of homologous or non- 
homologous recombination, may simply be to facilitate or maximize an 
overexpression of exogenous Jun proteins from the retroviral LTR. The 
precise relationship between cellular transformation and auto-repression is 
not known, but the dose-dependent effects of gag-c-Jun and gag-v-Jun on 
endogenous c-Jun expression (Figure 3.13B), favour this interpretation, 
and correlate with the auto-repressor activities of other immediate early 
genes such as c-myc and c-fos (Grignani et al, 90; Sassoni-Corsi et al, 
88).
IV.C. CONSEQUENCES OF JUN-MEDIATED AUTO­
REPRESSION FOR AP-1 DNA BINDING ACTIVITY IN ASV17- 
TRANSFORMED CELLS
Normal and ASV17-transformed CEF extracts displayed quantitatively and 
qualitatively different patterns of in vitro AP-1 DNA binding activity (Figure
3.15). An oligonucleotide containing the collagenase TRE binding site was 
recognized by a single binding activity (Band I) in normal CEFs and a 
weaker doublet (Band II & III) in their ASV17-transformed counterparts. All 
three binding activities were disrupted by c-Jun-specific antisera (Figure 
3.16A). A contrasting pattern of reactivity was observed using an extract 
prepared from Swiss 3T3 cells. The collagenase TRE binding activity in
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Swiss 3T3 cells was identical to Band I by electrophoretic mobility but only 
partially disrupted by c-Jun-specific antisera. In accordance with the 
published data of Jun family proteins in these cells (Kovary et al, 92), 
JunB represented the major component of AP-1/TRE binding activity 
detected in Swiss 3T3 cell extracts. The differential composition of AP-1 
DNA binding complexes in Swiss 3T3 and CEF extracts confirmed the 
affinity of Jun proteins for the collagenase TRE binding site (Nakabeppu et 
al, 88; Ryseck et al, 91) and suggested that, in contrast to Swiss 3T3 
cells, c-Jun represents the sole or predominant Jun family protein 
expressed in primary CEFs.
The c-Jun-reactive component of Bands II and III was complicated by the 
absence of detectable endogenous c-Jun in ASV17-transformed CEFs 
(Figure 3.5). To distinguish between c-Jun- and v-Jun-specific epitopes, a 
gag-specific antibody (5202) was included in the DNA binding reactions. 
As shown in Figure 3.16B anti-5202 completely disrupted the binding 
activity represented by Band II. The integrity of Band III, in contrast, was 
unaffected by anti-5202. This, together with the absence of endogenous 
p39 c-Jun in parallel denatured extracts (Figure 3.17A), suggested that full 
length p65 gag-v-Jun and residual endogenous p39 c-Jun were unlikely to 
represent the Jun-reactive component of Band III. As an alternative 
explanation, a proteolytic or truncated varient of p65 gag-v-Jun, that lacks 
gag, but retains Jun-specific epitopes may represent the Jun-reactive 
component of Band III. In support of this hypothesis, ASV17-transformed 
CEF extracts contained a 42kD Jun-reactive protein that was not 
recognized in parallel experiments using a gag-specific antibody (compare 
Figure 3.17A & 3.17B). p42 was exclusively detected in ASV17-
transformed CEF extracts and, consequently, may represent a highly 
reproducible fragment of the v-Jun oncoprotein (Figure 3.17A; Bos et al,
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90). If p42 also retains the v-Jun DNA binding domain, then it is 
concievable that it contributes to AP-1 DNA binding activity in vitro.
The antibody reactivities of p42 and p65 (Figure 3.17A & 3.17B) suggested 
that full length and truncated variants of p65 gag-v-Jun represent the Jun- 
reactive components of Bands II and III respectively. The intensity of 
Bands I, II and III was at variance with the relative levels of c-Jun and v- 
Jun expression in normal and ASV17-transformed CEFs (Figure 3.5 &
3.15). p39 c-Jun and p65 gag-v-Jun, however, have been reported to 
express differential affinities for multiple TRE- and CRE-like target 
sequences in vitro (Hadman et al, 93; Hawker et al, 93). Therefore, the 
reduced intensity of Bands II and III may be explained by a replacement of 
high affinity c-Jun-containing complexes with low affinity v-Jun-containing 
alternatives. This explanation would also account for the indistinguishable 
Fos/FRA reactivities of Bands I, II and III (Figure 3.16B), and suggests 
that one functional consequence of endogenous c-Jun repression is the 
complete replacement of c-Jun TRE binding complexes with v-Jun- 
containg equivalents.
IV.D. CONSEQUENCES OF c-JUN DOWN-REGULATION IN 
PRIMARY CEFs
v-Jun- and c-Jun-dependent cellular transformation is apparently restricted 
to avian cells, and is associated with a concomitant down-regulation of 
endogenous c-Jun expression (Castellazzi et alt 90; Castellazzi et al, 91; 
Hughes et al, 92). An equivalent down-regulation in murine fibroblasts (M. 
Unlu; personal commun.) failed to induce a transformed phenotype, 
suggesting that the consequences of c-Jun repression are cell-type-
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dependent. Alternative Jun family members may be responsible for the 
differential effects of c-Jun repression in vivo. It has been reported that the 
Jun family of proteins posess specific but overlapping DNA binding 
affinities, suggesting that, under certain conditions, they are functionally 
interchangeble (Nakabeppu et al, 88; Ryseck et al, 91). A comparison of 
the Jun reactivity of complex I in avian and murine cell extracts, revealed 
that c-Jun was the predominant or only Jun family member expressed in 
primary CEFs (Figure 3.16A). Swiss 3T3 fibroblasts, in contrast, 
expressed additional high levels of JunB, which contributed to the 
endogenous AP-1 DNA binding activity (Figure 3.16A; Kovary et al, 92). 
The differential expression of Jun family proteins in Swiss 3T3 and chicken 
fibroblasts may be critical for the activity of p65 gag-v-Jun. From the 
results described above in section IV.C it is proposed that v-Jun-dependent 
transformation of avian cells is mediated by a complete displacement of 
endogenous AP-1 activity with v-Jun-containing complexes. An analagous 
displacement is presumably prevented in murine cells by additional Jun 
family members, which functionally compensate for the lack of 
endogenous c-Jun activity, thereby inhibiting the transforming potential of 
the v-Jun oncoprotein.
If this interpretation is correct, it would suggest that c-Jun repression is 
critical for v-Jun- (and c-Jun-) dependent transformation of avian cells. 
Mutational analysis supports the proposal that auto-repression is 
necessary but not sufficient for CEF transformation. Overexpression of a 
bzip mutant of c-Jun, lacking the amino terminal transactivation domain, 
has been reported to dissociate c-Jun down-regulation from cellular 
transformation (Castellazzi et al, 91). This has led to the proposal that 
Jun-induced cellular transformation is an active rather than a passive 
process, dependent on the complete replacement of endogenous AP-1 
DNA binding activity with transcriptionally active v-Jun-containing
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complexes. c-Jun-dependent transformation of avian cells presumably 
occurs by the same mechanism but through a qualitatively and 
quantitatively different pattern of gene expression.
CHAPTER V - RESULTS (2).
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CHAPTER V. - RESULTS 
FUNCTIONAL ANALYSIS OF THE c-JUN PROMOTER
V.A. c-JUN AUTO-REPRESSION
V.A.1. TRANSCRIPTIONAL AUTO-REPRESSION
Since overexpression of c-Jun or v-Jun induces a profound down- 
regulation of endogenous c-Jun protein expression (Figure 3.13), it was of 
interest to determine at what level repression had occured. To this end 
RNase protection analysis was performed on mRNA samples extracted 
from normal and ASV17-transformed CEFs, using an antisense RNA 
probe designed to distinguish between c-jun- and v-jun-specific transcripts 
(Figure 5.1).
As shown in Figure 5.1, the levels of c-jun mRNA were dramatically 
reduced in ASV17-transformed CEFs. Repression was not absolute as 
low, but detectable, levels of c-jun-specific transcripts were maintained in 
exponential, serum deprived and serum stimulated cultures, v-jun mRNA, 
in contrast, was expressed from the retroviral enhancer at constitutively 
high levels. The quantitation of c-jun mRNA was considered accurate as 
the input probe was in excess during the hybridization (lane 1).
From these results it was clear that the reduction in c-Jun protein in 
ASV17-transformed cells was due to the down-regulation of endogenous c- 
jun mRNA through transcriptional and/or post-transcriptional regulatory 
mechanisms
FIGURE 5.1
RNase Protection anaysis of total mRNA samples prepared from normal 
and ASV17 transformed CEFs. The cells were in growth phase (E), serum 
deprived (0) or serum-stimulated (15', 45'). 20ug of RNA was hybridized to 
10® cpm labelled antisense riboprobe. The riboprobe was prepared from 
Nco1 linearized pSPT19/JF4 (Dr E.J. Black - Figure 2.1) and included 
partial c-jun coding sequences and the 3' untranslated region (hatched 
box) which is specific to c-jun mRNA. The 925bp full length riboprobe is 
indicated by a broken arrowhead in the left hand lane. The band 
corresponds to a 0.01 x dilution of the riboprobe concentration included in 
the hybridzation. 850bp c-jun-specific transcripts are denoted by a light 
arrowhead and 560bp v-jun-specific transcripts by a bold arrowhead. The 
right hand lane illustrates a positive control of normal CEFs serum- 
stimulated for 2hrs in the presence of 0.1 mM Emetine.
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To determine whether the down-regulation of c-jun mRNA was due to 
reduced transcription of c-jun, the rate of c-jun transcription was measured 
in normal and ASV17-transformed cells by the Run-Off transcription assay. 
Nascent c-jun transcripts were detected by hybridization to a plasmid 
encoding c-jun 3' untranslated sequences (c-Jun(1)). Additional jun- 
containing plasmids were included in the assay which were anticipated to 
hybridize to both c-jun- and v-yun-specific transcripts. c-Jun(5) and v-Jun 
encode the full length c-jun and v-jun coding sequences respectively. A c- 
fos-specific plasmid was also included in the analysis to determine whether 
v-Jun-mediated transformation perturbed the expression of a major c-Jun 
dimerization partner. Positive and negative controls were provided by 
chicken GAPDH and pSPT19 sequences respectively. Details of each 
plasmid are outlined in Figure 5.3.
As shown in Figure 5.2, the rate of c-jun transcription was reduced in 
ASV17-transformed cells, indicating that v-Jun-dependent repression of c- 
Jun expression was, at least partially, directed at the level of transcription. 
Residual c-jun transcription, however, was detected in ASV17- 
transformed CEFs, which correlated with the low levels of c-jun mRNA 
detected in ASV17-transformed cells by RNase Protection analysis (Figure 
5.1). Since c-Jun protein was undetectable under these conditions (Figure 
3.5), this suggests that either the residual c-jun mRNA is not efficiently 
translated, or that alternative mechanisms operate to reduce the steady 
state level of c-Jun protein in addition to transcriptional repression.
FIGURE 5.2
Nuclear Run Off analysis of normal and ASV17 transformed CEF nuclei, 
prepared from cells in exponential growth. Approximately 3.2 x10^ cpm of 
TCA precipitable radioactivity was included in each hybridization. Plasmid 
DNAs were alkali denatured and immobilized onto a nitrocellulose filter 
using a Bio-Slot Microfiltration apparatus. 5ug of plasmid DNA was 
immobilized per slot and the filters fixed under vacuum at 80°C for 2hrs. 
Hybridization proceeded for 72hrs in a final volume of 1.8ml. The filters 
were wahed under high stringency and exposed overnight at -70°C.
Details of each plasmid included in the hybridization are outlined in figure 
5.3. c-Jun(1) represents the c-jun specific plasmid. The arrowhead 
indicates the v-Jun dependent repression of c-jun transcription in ASV17 
transformed CEFs.
CEF ASV17/CEF
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pSPT19
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FIGURE 5.3
VECTOR 
- pSPT19
The pSPT19 plasmid contains diametrically opposed SP6 and T7 transcription 
promoter sequences, separated by the multiple cloning site of PUC19. DNA 
fragments cloned into pSPT19 can be transcribed, with high efficiency, from the 
sense or the antisense strand, by SP6 and T7 RNA polymerases.
INSERTS
- pSPT19 ckGAPDH
1260bp amplified sequence of the avian GAPDH gene (Dugaiczyk 83), cloned 
into pSPT19, in the sense orientation, at the EcoRI restriction endonuclease 
site.
- pSPT19 c-Fos
Approximately 1300bp cDNA of avian c-fos cloned into pSPT19 at the EcoRI 
restriction endonuclease site. The orientation and sequence of pSPT19 c-Fos 
have not been determined.
- pSPT19 v-Jun
Approximately 1000bp BamH1 /EcoRI restriction fragment spanning the entire v- 
Jun coding sequence. The 1000bp fragment was subcloned into pSPT19 in the 
antisense orientation between the Bgl11 and EcoRI restriction sites.
- pSPT19 cJun(5)
1500bp Hindlll/Bgl11 restriction fragment, spanning the c-jun coding region and 
adjacent 3' and 5' untranslated sequences. The fragment was obtained from 
avian genomic c-jun (pSPT19-c-jun Clone A) and subcloned into pSPT19  
between the Hindlll and Bgl11 cloning sites.
-pSPT19cJun(1)
500 - 600bp amplified sequence spanning the c-jun specific untranslated region 
from a cloned c-jun cDNA, pSPT19/JF11 (Dr E.J. Black). The amplified 
fragment was generated using an EcoRI tagged 5' primer and an SP6 specific 3' 
antisense primer, and subcloned into pSPT19 at the EcoRI cloning site.
Sequences corresponding to the approximate sizes of c-jun (green) and v-jun 
(blue) mRNAs are illustrated, to identify regions of homology with the Jun 
specific plasmid DNAs.
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V.B. CHARACTERIZATION OF THE AVIAN c-JUN GENE 
PROMOTER
V.B.1. ISOLATION AND SEQUENCE ANALYSIS OF A GENOMIC 
AVIAN c-JUN CLONE
To investigate the mechanism of c-jun transcriptional auto-repression, it 
was necessary to clone the genomic gene and adjacent promoter 
sequences, c-jun had previously been reported to reside on a 5kb Hindlll 
restriction endonuclease fragment in genomic DNA derived from primary 
CEFs (Dr D.A.F. Gillespie; personal commun.). Using this information, 
genomic DNA was digested with Hindlll and size fractionated by sucrose 
gradient centrifugation. An enriched pool of approximately 5kb Hindlll 
fragments was purified and inserted into bacteriophage X1174 at the 
Hindlll cloning site, and screened with a labelled v-Jun coding sequence, 
derived from pSPT19-v-Jun (Figure 5.3). Positive phage clones were 
purified by secondary screening and the inserts subcloned into pSPT19 at 
the Hindlll site. Individual clones were orientated using a panel of different 
restriction endonucleases as described in Figure 5.4.
The primary sequence of this genomic c-jun clone, including the coding 
region and adjacent 5' untranslated promoter regions, was obtained and is 
presented in Figure 5.5A. This sequence differs from an independently 
derived c-jun sequence (Nishimura et al, 88) at several positions. Within 
the coding region, these mutations introduce five amino acid substitutions 
but have no effect on the final length or reading frame of the encoded 
protein. These alterations include: an alanine to proline substitution in the 
c-jun-specific 6 domain; a triplet amino acid substitution in the previously 
identified E regulatory region (Baichwal et al, 92); and a further glycine to
FIGURE 5.4
Restriction endonuclease map of the avian c-jun gene cloned into pSPT19 
at the Hindlll restriction site (pSPT19-c-jun/Clone A). Avian c-jun 
sequences are denoted in black; and pSPT19 sequences and polylinker 
restriction sites in green.
Panel A.
pSPT19-c-jun/Clone A undigested (1), or digested with Sacl(3). Lane 2 
illustrates a Sacl digestion of avian c-jun subcloned into pSPT19 in the 
antisense orientation. The 400bp Sacl fragment is denoted by a solid 
arrowhead. Bacteriophage X (Hindlll digested) and bacteriophage § 
X1174 (Haelll digested) marker tracks are illustrated in the left and right 
hand lanes respectively.
Panel B.
pSPT19 / Clone A digested with EcoRI (1), Ncol (2), Ncol & EcoRI (3), 
Accl (4), Accl & EcoRI (5), Xbal (6) and Xbal & EcoRI (7). The internal 
1000bp Ncol fragment is denoted by a light arrowhead; and the internal 
400bp Xbal fragment by a bold arrowhead. A bacteriophage X (Hindlll 
digested) marker track is illustrated in the left hand lane.
Panel C.
pSPT 19 / Clone A undigested (1), and digested with Hindlll (3) or EcoRI & 
Bgl11 (5). Even numbered lanes denote the parallel digestions of avian c- 
jun subcloned into pSPT19 in the antisense orientation. The 5kb Hindlll 
avian c-jun cloning fragment is denoted by a bold arrowhead; and the 
1.5kb EcoR1/Bgl11 fragment by a light arrowhead. A bacteriophage X 
(Hindlll digested) marker track is illustrated in the right hand lane.
The sizes of the restriction fragments are estimations approximated from 
the bacteriophage X and <|)X174 marker tracks. The restriction enzymes 
are denoted by their first letters, except for EcoRI which is denoted by an 
R.
A.
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B.
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FIGURE 5.5A
Primary sequence of avian c-jun obtained from genomic clone 
pSPT19/Clone A. The top panel contains partial 5' flanking sequences, 
including the downstream c-jun TRE-like site and adjacent RSRE (boxed in 
black and red respectively). Sequence variations from an independently 
derived c-jun sequence (Nishimura etal, 88) are underlined in red.
The c-jun coding sequence is illustrated in the lower panel. The initiation 
and termination codons are boxed in green. Sequence variations from the 
published sequence are underlined in red. The corresponding amino acid 
alterations are depicted by numbered blue codons and are presented in 
full in Figure 5.5B.
-202
ctaggggcgg ggtggccatg gcgaccggct gctatgcacc gggccgggcc
agcggccgct cccccgggag aggcggcggt acgaatgggg agcccgcggg
gltgacatcajt gdsctatttt tagcfcggctc ccggtacgct gataagtgaa
gggctgcacg ccgcgagcgg gctcagagcg cggggcgggc gggcggcagt
gggctctgtt ctatgagtgc aaacJatabaa cctactttct acgaggatgc
cctgaacgcc agcttcgcgc cgccggagag cggcggctat ggatataata
acgccaaggt gctgaagcag agcatgacgc tgaacctgtc cgacccggcc
agcagcctga agccgcacct gaggaacaag aacgccgaca
L U
tcctcacctc
ccccgacgtg gggctgctga agctggcctc cccggagctg gaacggctca
tcatccagtc cagcaacggg ttaatcacca ccacgccgac cccgacgcag
ttcctctgcc ccaagaacgt taccgacgag caagaggggt tcgccgacat
ggtcgtgaga gcgctggcgg aactgcacaa ccagaacacg
L2JIU
ctgcccagcg
L U
tcacctcagc cgcacaacct gttagcggcg gcatggcacc tgtgtcctcc
atggccggcg gcggcagctt caacacgagt ttgcacagcg agcccccggt
gtatgccaat ctcagcaact tcaaccccaa cgcgctcaac tccgcaccca
actacaacgc caacgcgatg ggctacgcgc cgcagcatca cataaacccc
cagatgcccg
lZ j
tgcagcatcc caggcttcag gctctgaaag aagagcctca
gactgtacct gaaatgccgg gggaaacccc tcccctgtcc cctattgaca
tggagtcgca ggagagaatc aaagccgaga gaaaacgcat gagaaacaga
attgcggcgt ccaaatgccg gaaaaggaag ttggaaagga ttgccaggtt
ggaagaaaaa gtgaaaactt tgaaagccca gaactcagag ctggcatcca
cggccaacat gctcagagaa caggttgcac agcttaagca gaaggtcatg
aaccatgtca acagcgggtg ccagctaatg ctaacacaac agttgcaaac
gtttjtgajaga gacggactta aataggaact gtgatgttgt ggtataacca
aac +1292
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alanine substitution in a downstream region not associated with any 
previously recognized c-Jun functional domains. A comparison of the 
amino acid sequence of this avian c-jun clone with other animal species 
revealed that four out of the five amino acid alterations were not conserved 
(Figure 5.5B). This was surprizing as identical sequence alterations were 
also found in two independent c-jun cDNAs sequenced by Dr E.J. Black 
(Dr E.J. Black; personal commun.).
Sequence alterations found in the 5' untranslated region included three 
insertions, each duplicating the previous base pair; one deletion, and five 
G - C transversions. The changes do not affect the sequence of the 
conserved downstream junTRE-like site and adjacent junRSRE (Figure 
5.5A - top panel).
V.B.2. DNase I HYPERSENSITIVE SITE ANALYSIS OF THE c-iun 
PROMOTER
As an initial step towards identifying potential regulatory sites within the c- 
jun gene, genomic DNA was prepared from CEF nuclei which had been 
digested with increasing concentrations of DNase I. Avian c-jun resides on 
a 5kb Hindlll fragment and a 20kb EcoRI fragment (Dr D.A.F. Gillespie; 
personal commun.). To locate the position of potential DNase I 
hypersensitivity sites within these fragments, equal quantities of DNase I 
treated genomic DNA were digested with Hindlll or EcoRI and resolved on 
1 % agarose gels for southern blotting analysis. The presence and location 
of DNase I hypersensitivity sites were mapped using c-jun-spec\f\c probes, 
derived from the 5' and the 3' region of the avian c-jun genomic clone 
(Figure 5.7B). As shown in Figure 5.6, increasing concentrations of 
DNase I did not reveal any hypersensitivity sites in Hindlll digested
FIGURE 5.5B
A comparison of the amino acid sequence of pSPT19 c-jun/Clone A (ckjun) 
with the published sequences of avian, human, and murine c-Jun. The 
blue box represents a discrepancy between the sequence of c-jun-Clone A 
and the c-Jun sequence established by Nishimura et al. Proline is present 
at this position in all other known species of c-Jun. The red boxes 
represent other sequence discrepancies in c-jun/Clone A that introduce 
alterations into the amino acid sequence of avian c-Jun. The sequence 
discrepancies were confirmed independently through sequencing of c-jun 
cDNAs by Dr E.J. Black.
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HUMAN A N MLREQVAQ LKQKVMNHVN SGCQLMLTQQ LQTF
Cons A N MLREQVAQ LKQKVMNHVN SGCQLMLTQQ LQTF
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FIGURE 5.6
DNase I Hypersite analysis of partial DNase I digested genomic DNA 
prepared from primary CEFs in exponential growth. The DNA was 
digested with Hindlll (panels A & B) or EcoRI (panel C), and resolved on a 
1% agarose gel. The Southern Blots were hybridized with labelled DNA 
probes obtained from avian c-jun Clone A (Figure 5.7B). Southern Blot A 
was hybridized with a 1.5kb Hindlll/Bgl11 probe; Blot B with a 1.9kb Nsi1 
probe and Blot C with a 3.5kb Hindlll/Bgl11 probe. The 5kb Hindlll and 
the 20kb EcoRI c-jun containing fragments are illustrated by labelled 
arrowheads. Bacteriophage X (Hindlll digested) marker tracks correspond 
to the left hand lanes of each blot. Hypersites 1 & 2 (HS-1, HS-2) are 
labelled on Southern Blot C.
A. DNase 1 (mg/ml)
0 10 35 45 55 60 65
6.6kb
4.5kb
c-jun (5kb)
B. DNase 1 (mg/ml)
0 10 35 45 55 60 65 70
6.6kb
4.5kb
c^un (5kb)
C . DNase 1 (mg/ml)
0 10 45 55 60 70
20kb
9.6kb
6.6kb
^  c-jun (20kb)
  HS-2 (8.6KB)
< -----------  HS-1 (6.3KB)
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genomic DNA. The gradual disappearance of the 5kb Hindi 11 fragment 
indicated that successful digestion had occured, but that no specific sites 
within the DNA were preferentially digested under these conditions. A 
different pattern was observed for the 20kb EcoRI fragment. EcoRI 
digested DNA exhibited two DNase I hypersensitivity sites, positioned 
approximately 6.4kb and 8.6kb from an adjacent EcoRI site. The 
appearance of the bands was transient which suggests that both 
fragments presented highly accessible target sequences for further DNase 
I digestion.
The precise location of each DNase I hypersensitivity site relative to avian 
c-jun was determined by orientating c-jun within the 20kb EcoRI restriction 
fragment. To this end genomic DNA was digested with the same panel of 
restriction enzymes previously used to map the position and orientation of 
c-jun within the 5kb Hindlll cloning fragment (Figure 5.4). Each restriction 
enzyme was combined with EcoRI or Hindlll to locate the internal 
restriction sites relative to an undefined and a defined flanking site. The 
position of avian c-jun relative to the EcoRI sites was defined when the 
spacing between two internal restriction sites was maintained with either 
flanking enzyme. As shown in Figure 5.4 and 5.7A, a spacing of 
approximately 1.2kb was maintained between the internal Bgl11 and Sacl 
sites. The relative position of avian c-jun and the two independent DNase I 
hypersensitivity sites was subsequently obtained, and is presented in 
Figure 5.7B.
As shown in Figure 5.7B, DNase I hypersensitivity sites 1 and 2 were both 
located to the 5' side of the c-jun coding region. The close proximity of 
DNase I hypersensitivity site 1 to the 5' Hindlll restriction endonuclease 
cloning site positioned it within a well defined regulatory region of the c-jun 
promoter (Figure 5.8A), and may provide an explanation for its apparent 
absence in Hindlll digested genomic DNA (Figure 5.6). The position of
FIGURE 5.7A
Southern blot analysis of double Restriction Enzyme digests of avian 
genomic DNA. 10ug of DNA was digested with EcoRI in combination with 
a panel of restriction enzymes, previously used to map the Hindlll 
fragment containing avian c-jun (Figure 5.4). The Southern Blot was 
hybridized with a random primed oligolabelled DNA probe corresponding 
to the 3.5kb Hindlll/Bgl11 fragment of avian c-jun Clone A (Figure 5.7B). 
Bacteriophage X (Hindlll digested) markers are illustrated in the left hand 
lane.
FIGURE 5.7B
The orientation and position of the c-jun coding region with respect to the 
EcoRI and Hindlll flanking restriction sites. Sequences to the 3' side of the 
5' Hindi 11 site are drawn to scale. The positions of the proposed DNase I 
Hypersites are denoted by HS-1 and HS-2. The DNA probes used in the 
hypersite analysis are represented by broken double arrowheads and 
drawn to scale.
A. EcoRI +
6.6kB
4.5kB
<4 6.1kb
<  5.0kB
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5 ’ ----------- ►  3 '
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DNase I hypersensitivity site 2 was less informative as it was located within 
a region of uncharacterized DNA at least 2.4kb upstream of the c-jun 
transcription start site.
V.C. c-jun PROMOTER SITE OCCUPANCY IN c-JUN- 
EXPRESSING (NORMAL) AND c-JUN-LACKING (ASV17- 
TRANSFORMED) CEFS
V.C.1. In Vitro DNA binding Analysis
Sequencing and mapping analyses identified the position of avian c-jun 
gene within the 5kb Hindlll cloning fragment. As shown in Figure 5.4, the 
5' Hindlll site was located approximately 200bp upstream of the start site 
of transcription. The intervening sequence represents a region of the c-jun 
promoter that contains several highly conserved, potential regulatory sites 
(Figure 5.8A). Their likely importance was underlined by the presence of a 
DNase I hypersensitivity site within close proximity of the 5' Hindlll cloning 
site (HS-1; Figure 5.7B).
To investigate the level of c-jun promoter site occupancy in c-jun- 
expressing (normal) cells, a panel of oligonucleotide probes 
corresponding to the conserved regions of the c-jun promoter were 
synthesized and incubated in a series of in vitro DNA binding reactions 
with normal CEF extracts. The pattern of binding was compared to the 
pattern obtained with ASV17-transformed CEF extracts to establish 
whether there were any changes in DNA binding activity which correlated 
with auto-repression.
FIGURE 5.8A
Sequence comparison of the published c-jun promoter sequences from 
avian, rodent and human DNA. The bottom line of each panel illustrates 
the regions of complete homology between the different species. The 
downstream TRE-like site and adjacent RSRE are boxed in blue and green 
respectively. The extended L oligonucleotide is denoted by a black 
arrowhead; the TRE containing M oligonucleotide by a blue arrowhead; 
and the RSRE containing R olignucleotide by a green arrowhead. 
Oligonucleotide probes corresponding to additional regions of homology in 
the cloned c-jun promoter sequences are boxed in black and labelled on
the figure.
con-1 Consensus 1
con-2 Consensus 2 - NF-jun site (Brach et al, 92)
Sp-1 Sp-1 site - Sp-1 site (Angel et al, 88)
TATA TATA-like - TATA-like (Angel et al, 88)
INR INR-like - Initiator-like site (Seto et al, 91)
The avian promoter sequences subcloned for DNase I footprinting analysis 
are contained within the two bold red arrowheads. The 5' arrowhead 
corresponds to the extreme 5' Hindlll cloning site of pSPT19/Clone A 
(Figure 5.4). The sequence was amplified from avian c-jun Clone A, 
tagged with 5' Hindlll and 3' Xbal restriction sites, and subcloned into 
pSPT19 at the Hindlll and Xbal cloning sites, in the antisense orientation 
(pSPT19/cJ-fp).
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The sequence of each oligonucleotide probe is presented in Figure 5.8A. 
Sequences were selected on the basis of their overall degree of homology 
to other animal species. Some, like the junTRE and junRSRE, represent 
previously recognized regulatory sites; whereas others, such as the 
CCAAT box and the Sp-1 element remain largely uncharacterized. Figure 
5.8B is typical of the binding pattern obtained for several of these 
oligonucleotides which were consistently recognized by specific binding 
complexes in normal, c-yt/n-expressing CEF extracts. Similar complexes 
were also detected in v-Myc-transformed and ASV17- transformed CEF 
extracts, indicating that gross changes in c-jun promoter occupancy at 
these sites were unlikely to be responsible for auto-repression.
Two exceptions to this overall pattern of binding were provided by the 
junTRE and adjacent junRSRE regulatory elements. Qualitative and 
quantitative differences in junTRE and junRSRE binding activities were 
observed between normal and ASV17-transformed CEF extracts that were 
specific to ASV17-transformed CEFs and correlated with auto-repression 
(Figure 5.9 & 5.10).
- iunTRE Binding Activity
A single junTRE binding complex was detected in normal CEF extracts, 
that was replaced by a weaker doublet in their ASV17-transformed 
counterparts (Figure 5.9A). The doublet was not observed in an equivalent 
extract prepared from v-Src transformed CEFs (CK29). The specificity of 
each binding activity was confirmed by competition analysis using 
unlabelled junTRE as a specific cold competitor (+ lanes). The qualitative 
and quantitative changes in junTRE binding activity detected in ASV17- 
transformed CEFs were also observed by DNase I footprinting analysis 
(Figure 5.9b). Footprinting was performed over a region of the c-jun
FIGURE 5.8B
Electrophoretic Mobility Shift analysis to compare the jun/CAAT and whole 
cell extracts. 10ug of extract was incubated in the presence(+) or absence 
(-) of a 100 fold excess of specific cold competitor, for 30min at 4°C. 2ul 
(~2 x105 cpm) of 5' end labelled, double stranded olignucleotide probe 
was added, and the contents incubated for a further 30min at 4°C. The 
binding reactions were resolved on a 4% non-denaturing polyacrylamide 
gel at 4°C. An additional transformed CEF extract (MC29) derived from v- 
Myc) infected CEFs was included to control for v-Jun specific and 
transformation specific effects. The MC29 binding patterns are illustrated 
in the right hand lanes of both gels.
CAAT BOX SP-1
CEF ASV17 MC29
+  -  +  -  +
CEF ASV17 MC29
+ + +
FIGURE 5.8B
FIGURE 5.9A
Electrophoretic Mobility Shift analysis to compare the junTRE binding 
activity in normal and ASV17 transformed whole cell extracts. 10ug of 
extract was incubated in the presence (+) or absence (-) of a 100 fold 
excess of specific cold competitor, for 30min at 4°C. 2ul (-2  x10^ cpm) 
of, 5' end labelled, double stranded olignucleotide M (junTRE) was 
added, and the contents incubated for a further 30min at 4°C. The 
binding reactions were resolved on a 4% non-denaturing polyacrylamide 
gel at 4°C. An additional transformed CEF extract (CK29), derived from 
v-Src infected CEFs, was included to control for v-Jun specific, and 
transformation specific effects. The CK29 TRE binding pattern is 
illustrated in the right hand lanes.
FIGURE 5.9B
DNase I footprinting analysis over the 171 bp c-jun promoter fragment 
depicted in figure 5.8. The fragment was 5' end labelled on the sense 
strand and incubated for 60-90min on ice, in the absence (-) or presence 
of approximately 30ug of nuclear protein extract, prepared from normal 
and ASV17 transformed CEFs. The binding reactions were partially 
digested with DNase I, over a range of concentrations, and resolved on a 
6% denaturing polyacrylamide gel. A double stranded sequencing 
reaction of the same strand was included to locate the positions of 
potential DNasel footprints. The junTRE and adjacent RSRE are 
illustrated on the sequencing reaction. The dideoxy Thymidine base 
analogue included in the sequencing reaction is denoted by a "T". The 
junTRE, DNasel protected footprint is indicated by a bracket on the right 
hand side of the autoradiograph.
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promoter identified in Figure 5.8A, which extends for 174bp downstream 
of the 5' Hindlll cloning site and spans the jun TRE and adjacent junRSRE. 
As shown in Figure 5.9b, the intensity of the DNase I protected footprint 
over the junTRE correlated with the relative intensities of the retarded 
protein:DNA complexes found in normal and ASV17-transformed CEF 
extracts (compare Figure 5.9A & 5.9B). The protected sequence was 
conserved between normal and ASV17-transformed extracts, suggesting 
that each protein complex recognized the same junTRE binding motif in 
vitro.
- iunRSRE Binding Activity
A junRSRE-specific binding complex was detected in normal CEF extracts 
that was absent in equivalent ASV17-transformed cultures (Figure 5.10A). 
The pattern of binding was specific to ASV17-transformed CEFs and not 
observed in a parallel c-Myc transformed extract.
DNase I footprinting analysis over the antisense strand of the c-jun 
promoter supported the in vitro DNA binding analysis. A DNase I protected 
footprint was detected using extracts prepared from normal CEFS, that 
encompassed the junRSRE and half of the adjacent junTRE. An 
equivalent pattern of protection was observed using ASV17-transformed 
CEF extracts. The similarity is presumed to result from an additional 
junRSRE-specific binding activity that was detected in both normal and 
ASV17-transformed CEFs (Figure 5.10A). Parallel digestions over the 
sense strand of the c-jun promoter were uninformative, as the junRSRE is 
refractory to DNase I digestion on this strand (Figure 5.9B; Flemington et 
a/,90; Rozek et al, 93; Herr et al, 94).
FIGURE 5.1 OA
Electrophoretic Mobility Shift analysis to compare the binding pattern of 
normal and ASV17 transformed cell extracts to the RSRE binding site in 
the c-jun promoter. 10ug of whole cell extract was incubated in the 
presence(+) or absence (-) of a 100 fold excess of specific cold competitor, 
for 30min at 4°C. 2ul (~2 x 105 cpm) of 5' end labelled double stranded 
oligonucleotide R was added, and the contents incubated for a further 
30min at 4°C. The binding reactions were resolved on a 4% non­
denaturing polyacrylamide gel at 4°C. c-Myc (wt Myc) and v-Myc (MC29) 
transformed CEF extracts were included in the binding reactions to control 
for v-Jun-specific and transformation-specific effects. A junRSRE binding 
complex specific to normal CEF extracts is indicated by a bold arrowhead. 
An additional junRSRE-specific complex detected in both cell types is 
indicated by a broken arrowhead
Figure 5.1 OB
DNase I footprinting analysis over the antisense strand of the 171 bp c-jun 
promoter fragment illustrated in figure 5.8. The antisense strand was 5' 
end labelled and incubated in the absence (-) or presence (+) of 
approximately 30ug of nuclear protein extract, prepared from normal and 
ASV17 transformed CEFs. The binding reactions were partially digested 
with DNase I over a range of concentrations, and resolved on a 6% 
denaturing polyacrylamide gel. A double stranded sequencing reaction of 
the same strand was included as before (Figure 5.9B). The dideoxy base 
analogues included in each reaction are denoted by their first letters: 
Adenine, Cytosine, Guanine, Thymidine. The junTRE and RSRE binding 
sites are marked on the sequencing reaction. The junRSRE DNase I 
protected footprint is indicated by a bracket on the right hand side of the 
autoradiograph.
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IV.C.2. ANALYSIS OF THE RELATIONSHIP BETWEEN iunTRE AND 
junRSRE BINDING ACTIVITIES IN NORMAL CEF EXTRACTS
The close proximity (Figure 5.8A) and overlapping DNase I protected 
footprints (Figure 5.9A & 5.1 OA) of the junTRE and junRSRE binding sites, 
prompted an investigation into whether both sites could be occupied 
simultaneously. To this end an extended oligonucleotide was synthesized 
that spanned both potential regulatory elements (Figure 5.8A). 
Oligonucleotide L was incubated in an in vitro DNA binding reaction with 
normal CEF extracts, and the pattern of binding compared to that obtained 
for the two individual sites. In support of previous analyses, the junTRE 
(M) and junRSRE (R) were recognized by specific DNA binding complexes 
in normal CEF extracts (Figure 5.11 A). The junTRE was bound more 
avidly than the junRSRE, but both complexes were competed equally by 
their respective unlabelled oligonucleotides. The extended L 
oligonucleotide was recognized by two independent binding complexes 
which exhibited virtually equivalent mobilities in non-denaturing acrylamide 
gels as the individual junTRE- and junRSRE-specific binding activities. 
Since cooperative binding between adjacently bound factors would appear 
as a single retarded complex of an altered mobility, this pattern suggests 
that the junTRE and junRSRE operate as mutually exclusive binding sites 
when the L-oligonucleotide is in probe excess. The relative intensities of 
the junTRE and junRSRE binding complexes did not completely support 
this hypothesis. As shown in Figure 5.11 A, the affinity of the junRSRE 
binding complex was increased relative to the junTRE binding complex, in 
the context of the L oligonucleotide, suggesting that an element of 
cooperativity may exist between the junTRE and junRSRE binding sites in 
vivo.
FIGURE 5.11 A
Electrophoretic Mobility Shift Analysis to compare the binding pattern of 
normal CEF extracts to the junTRE (M), junRSRE (R), and junTRE & 
junRSRE (L) containing double stranded oligonucleotides (Figure 5.8). 
10ug of whole cell extract was incubated in the presence (+) or absence (-) 
of a 100 fold excess of specific cold competitor for 30min at 4°C. 2ul (~2 x 
105 cpm) of 5' end labelled oligonucleotide probe was added to the 
reaction and the contents incubated for a further 30min at 4°C. The 
binding reactions were resolved on a 4% non denaturing polyacrylamide 
gel at 4°C. The junRSRE binding complex is denoted by a bold 
arrowhead; and the junTRE binding complex by a light arrowhead.
FIGURE 5.11B
DNasel footprinting analysis over the sense strand of the 171 bp c-jun 
promoter fragment described in figure 5.8. 30ug of CEF nuclear protein 
extract was incubated with 1 ug of a specific cold competitor 
oligonucleotide for 30min at 4°C. 1 ul of 5' end labelled footprinting probe 
was added to the reaction and the contents incubated for a further 60min 
at 4°C. The binding reactions were partially digested with a range of 
DNasel concentrations, and resolved on a 6% denaturing polyacrylamide 
gel. The junTRE and RSRE binding sites are indicated on the sequencing 
reaction at the left hand side of the autoradiograph and the junTRE 
DNasel protected footprint by a bracket on the right hand side of the 
autoradiograph.
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A pattern of competitive binding to the junTRE and junRSRE regulatory 
elements was supported by DNase I footprinting analysis using extracts 
prepared from normal CEFs (Figure 5.11B). The DNase I protected 
footprint corresponding to the junTRE binding site was competed by cold 
oligonucleotides spanning the junTRE (M) or the junTRE and adjacent 
junRSRE (L), but was virtually unaffected by equivalent concentrations of 
oligonucleotides containing the junRSRE (R), or an unrelated, c-Myc 
binding "E" Box sequence. As shown in lane 3, the junTRE binding 
complex was weakly competed by the junRSRE-containing oligonucleotide. 
The level of competition was reduced relative to the junTRE-containing 
oligonucleotide but did support the proposal that an element of 
cooperativity may exist between the two sites.
Mutually exclusive binding of the junTRE- and junRSRE-specific binding 
activities was further supported by gel retardation and cross-competition 
analysis. Cold oligonucleotides representing the junTRE (M), the 
junRSRE (R) and the combined sites (L), were used as competitors in 
binding reactions between labelled "M", "R" or "L" oligonucleotides and 
normal CEF extracts. As shown in Figure 5.12, the junTRE and junRSRE 
binding complexes were specifically competed by their respective cold 
oligonucleotide probes, and by the extended "L" oligonucleotide spanning 
both sites. An identical pattern of competition was also observed on the 
extended "L" oligonucleotide thereby confirming the identity of the junTRE- 
and junRSRE-specific protein complexes and their pattern of mutually 
exclusive binding.
FIGURE 5.12
Cross-competition analysis to investigate the binding specificity of junTRE 
and junRSRE binding activities in normal CEF
extracts. 10ug of whole cell extract was incubated in the presence or 
absence (-) of a 100 fold excess of specific or non-specific cold competitor 
oligonucleotides for 30min at 4°C. 2ul (-2  x 105 cpm) of 5' end labelled, 
double stranded, oligonucleotide probe was added, and the contents 
incubated for a further 30min at 4°C. Panel A represents a binding 
reaction using olignucleotide M as probe (junTRE); panel B a binding 
reaction using oligonucleotide R as probe (junRSRE); and panel C, a 
binding reaction using the combined oligonucleotide L as probe 
(junTRE/RSRE). The nature of the cold competitors included in each 
binding reaction are indicated on the figure. Cold competitors, CM1 and 
SRE, were gifted by W. Clark and Dr. A. Lang, and correspond to the 
Myc "E" Box consensus sequence and the Serum Response Element 
respectively.
The binding reactions were resolved on a 4% non-denaturing poly­
acrylamide gel at 4°C. The junTRE specific binding complex is denoted by 
a bold arrowhead and the junRSRE specific binding complex by a light 
arrowhead.
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1V.C.3. CHARACTERIZATION OF THE iunTRE AND junRSRE BINDING 
COMPLEXES
- junTRE Binding Complexes
To investigate the nature of the junTRE binding complexes present in 
normal and ASV17-transformed CEF extracts, a panel of different 
polyclonal antisera was included in the in vitro DNA binding reactions. As 
shown in Figure 5.13, the junTRE binding complexes in ASV17- 
transformed cell extracts, appeared identical to complexes II and III 
formed using the collagenase TRE (compare Figure 3.16B with 5.13). 
Like colTRE complexes II and III, the junTRE binding complexes were 
completely disrupted by c-Jun-specific antisera, partially disrupted by a 
Fos/FRA-specific antiserum and the upper complex disrupted by a gag- 
specific antiserum. The comparable antibody reactivity and electrophoretic 
mobility of the junTRE- and colTRE-specific protein complexes present in 
ASV17-transformed extracts, suggested that both contained the same 
composition of binding proteins. A contrasting pattern was observed for 
the junTRE binding activity detected in normal CEF extracts. The 
appearance of the junTRE binding complex closely resembled that of the 
collagenase TRE binding complex 1 in terms of electrophoretic mobility, 
but the antibody reactivity profile was quite distinct. The junTRE binding 
complex was partially disrupted by the c-Jun-specific antisera and only 
very weakly disrupted by the Fos/FRAspecific antiserum (Figure 5.13). 
This indicated that non-c-Jun-containing complexes constituted at least 
part of the junTRE binding activity in normal CEF extracts. ColTRE 
complex I, in contrast, was shown to consist predominantly of c-Jun- 
containing complexes (Figure 3.16A & 3.16B). These observations 
suggest that normal, but not ASV17-transformed, CEFs express a variety
FIGURE 5.13
Electrophoretic Mobility Shift analysis to compare the composition of 
junTRE binding activities in normal and ASV17 transformed extracts. 10ug 
of whole cell extract was incubated in the presence of 2ul of rabbit 
polyclonal antisera for 30min at 4°C. 2ul (-2x10^ cpm) of 5' end labelled, 
double stranded oligonucleotide M (junTRE) was added and the contents 
incubated for a further 30min at 4°C. The binding reactions were resolved 
on a 4% non-denaturing polyacrylamide gel at 4°C.
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of different TRE binding proteins that preferentially combine to form 
complexes with alternative specificities for individual TRE binding sites.
- junRSRE Binding Complexes
To investigate the nature of the junRSRE binding complex in normal CEF 
extracts, an extended panel of different polyclonal antisera was included in 
the in vitro DNA binding reactions. The panel was also incubated in a 
parallel series of junTRE binding reactions as it included antisera not 
previously tested. As shown in Figure 5.14A, the junRSRE binding 
complex was completely disrupted by an antiserum raised against the 
human Related Serum Response Factor C4 (RSRF-C4). This showed that 
the junRSRE binding activity in normal CEFs was predominantly comprised 
of RSRF-related protein complexes. A weaker disruption of the junRSRE 
binding complex was observed with the Fos/FRA-specific antibody (lane 
6). This was unexpected as the Fos and FRA proteins are not recognized 
dimerization partners of the RSRF transcription factor family and have not 
been reported to bind to the junRSRE in vitro. The remaining antisera, 
including a FRA2-specific antibody, had no effect on the junRSRE binding 
activity.
Parallel binding reactions using the junTRE, confirmed previous analyses 
(Figure 5.13), and demonstrated that non-c-Jun-containing complexes 
predominate in the normal junTRE binding activity (Figure 5.14B). Two 
additional antisera, anti FRA2 and anti RSRF, had no effect, indicating 
that neither protein contributed to the junTRE binding activity present in 
normal CEF extracts.
FIGURE 5.14A
Electrophoretic Mobility Shift analysis to investigate the composition of 
junRSRE binding activities in normal CEF extracts. 10ug of whole cell 
extract was incubated in the presence of 2ul of rabbit polyclonal antisera 
for 30min at 4°C. 2ul (-2x105 cpm) of 5' end labelled, double stranded 
oligonucleotide R (junRSRE) was added and the contents incubated for a 
further 30min at 4°C. The binding reactions were resolved on a 4% non­
denaturing polyacrylamide gel at 4°C.
FIGURE 5.14B
Electrophoretic Mobility Shift analysis to investigate the composition of 
junTRE binding activities in normal CEF extracts. 10ug of whole cell 
extract was incubated in the presence of 2ul of rabbit polyclonal antisera 
for 30min at 4°C. 2ul ( -2 x 1 0 )5  cpm) of 5' end labelled, double stranded 
oligonucleotide M (junTRE) was added, and the contents incubated for a 
further 30min at 4°C. The binding reactions were resolved on a 4% non­
denaturing polyacrylamide gel at 4°C.
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1V.C.4. MECHANISM OF v-JUN SPECIFIC REPRESSION OF junRSRE 
BINDING ACTIVITY
- RSRF Expression in Primary CEFs
To determine whether the absence of detectable junRSRE binding activity 
in ASV17-transformed CEFs was caused by a v-Jun-specific down- 
regulation of RSRF protein expression, western blot analysis was 
performed on normal and ASV17-transformed cell extracts. A HeLa cell 
extract was included in the analysis as a positive control as these cells 
have been reported to express high levels of RSRF-C4 (Dr. R. Treisman; 
personal commun.). RSRF protein expression was detected using a 
polyclonal RSRF-specific antiserum kindly provided by Dr R. Treisman. 
Anti RSRF-C4 was raised against the carboxy-terminal domain of human 
RSRF-C4. The peptide sequence is shared by an alternatively spliced 
varient of RSRF-C4: RSRF-C9, but not by an another member of the 
RSRF gene family, RSRF-C2, which is transcribed from an independent 
gene (Pollock et al, 91; Yu et al, 92). As shown in Figure 5.15, RSRF 
protein was detected in normal and ASV17-transformed extracts, and in a 
parallel culture of c-Myc transformed CEFs. The migration of the avian 
RSRF protein was distinct from the protein detected in HeLa cells, and did 
not conform exactly to the predicted molecular weight of RSRF-C4. RSRF- 
C4 has a calculated molecular mass of 52kD but undergoes extensive 
post-translational modification in vivo that alter the mobility of the protein in 
SDS/acrylamide gels (Dr. R. Treisman; personal commun.). Consequently 
it is not possible to determine whether the RSRF expressed in avian cells 
represents RSRF-C4 or an alternatively spliced varient such as RSRF-C9 
(Pollock et al, 91; Yu et al, 92). It was clear, however, that the level of 
RSRF expression did not vary between normal and ASV17-transformed
FIGURE 5.15
Western Blot Analysis of denatured whole cell protein extracts. The left 
hand lanes (x3) represent denatured extracts prepared directly from a 
lysed T25 tissue culture flask (section II.D.Ic). Approximately equal 
concentrations of each extract were loaded per lane. Protein 
concentrations were estimated from a Coomassie Blue stained protein gel. 
The right hand lanes (x5) represent whole cell protein extracts prepared for 
electrophoretic mobility shift analysis and subsequently denatured in SDS 
sample buffer. 20ug of non denatured extract was diluted in a final volume 
of 50ul of 1x SDS sample buffer, and sonnicated as described in section 
II.D.Ic. The extract was cleared in a bench top microfuge and the 
contents loaded into a single gel lane. The HeLa cell extract was kindly 
provided by T Jamison and the c-Myc infected CEF extract from Dr D. 
Crouch. PC1 and PV2 represent extracts prepared from first round soft 
agar clones derived from PC/SFCV and PV/SCFV transfected CEFs 
(Figure 3.13A).
The samples were resolved on a 9% acrylamide gel and transferred to 
ECL nylon membrane using a CAM LAB Semi-Dry Blotter. The proteins 
were visualized by ECL detection with a 1:2000 dilution of anti-RSRF. The 
presumed human RSRFC4 is denoted by a bold arrowhead and the 
putative avian RSRF by a light arrowhead.
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cell extracts (compare lanes 1 & 2 and lanes 5 & 6), indicating that 
repression of RSRF protein expression was unlikely to be responsible for 
the absence of junRSRE binding activity in ASV17-transformed CEFS.
- iunRSRF Inhibitory Factor(s)
To investigate whether a repressor of RSRF binding activity was present in 
ASV17-transformed CEFs, normal extracts were mixed with transformed 
cell extracts and incubated in a standard binding reaction with labelled 
junRSRE-containing oligonucleotide (R). Parallel binding reactions were 
assembled in the presence or absence of binding buffer and incubated at 
30°C for 15min prior to the addition of labelled probe. These conditions 
mimic those of an in vitro dimerization reaction (sectionll.D.4a), and were 
included to ensure the detection of potential inhibitory factors that might 
otherwise have been masked by standard gel mobility shift assay 
conditions (section II.D.6b).
As shown in Figure 5.16, the junRSRE binding activity in normal CEF 
extracts was consistently unaffected by the presence of ASV17- 
transformed cell extract, even though the transformed cell extracts 
exhibited no junRSRE binding activity. These results demonstrated that 
the absence of junRSRE binding activity in transformed cell extracts was 
not due to the presence of an inhibitory factor which was active in vitro.
- iunRSRF Accessory Factors
Immunological analysis of the RSRE binding activity in normal CEF 
extracts suggested the presence of an RSRF-related transcription factor 
and a Fos/FRA related protein (Figure 5.14A). To investigate the function 
of the Fos/FRA component, bacterially expressed c-Jun and/or bzipFos,
FIGURE 5.16
Electrophoretic Mobility Shift analysis to investigate whether an inhibitor of 
junRSRE binding activity is present in ASV17 transformed CEF extracts. 
5ug of CEF extract (1), ASV17 transformed CEF extract (2), or both cell 
extracts (3) were incubated in the presence of 2ul (~2.0 x10^ cpm) 5' end 
labelled, double stranded oligonucleotide R (junRSRE). Three 
independent incubation protocols were performed to optimize the 
conditions of binding.
Left Hand Lanes (x3)- Incubate extracts for 30min at 4°C 
Middle Lanes (x3)- Incubate extracts for 15min at 30°C; add
binding reagents and probe, and incubate for a 
further 30min at 4°C.
Right Hand Lanes (x3) - Incubate binding reagents and extract for 15min
at 30°C; add probe and incubate for a further 
30min at 4°C.
The binding reactions were resolved on a 4% non-denaturing 
polyacrylamide gel at 4°C. The RSRE specific binding activity is denoted 
by a solid arrowhead.
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containing the basic region and adjacent leucine zipper, were included in 
the binding reactions to determine whether occupancy of the adjacent 
junTRE or titration of the Fos/FRA-related protein would effect the integrity 
of the junRSRE-bound protein complex.
As shown in Figure 5-17A, junRSRE binding activity in normal and ASV17- 
transformed cell extracts, was unaffected by the addition of exogenous c- 
Jun or bzipFos in the context of the minimal junRSRE-containing 
oligonucleitide (R). This was not a consequence of inefficient exogenous 
protein dimerization as c-Jun alone, or in combination with bzipFos, 
bound strongly to the collagenase TRE (lanes 11-13). The TRE binding 
activity of bzipFos was undetectable in the absence of full length c-Jun, 
consistent with the inability of c-Fos to homodimerize in vitro (Reviewed in 
Curran, 91).
Exogenous c-Jun and bzipFos had a contrasting effect in the context of the 
extended oligonucleotide, L (Figure5-17B). Using this oligonucleotide, the 
junRSRE binding complex in normal CEFs was completely disrupted by the 
addition of c-Jun (compare lanes 3 & 7) or the co-addition of c-Jun and 
bzipFos (compare lanes 3 & 9). bzipFos alone had no effect on the 
integrity of the junRSRE-specific complex (compare lanes 3 & 5) but did 
markedly disrupt the junTRE binding activity in ASV17-transformed CEF 
extracts, presumably due to the formation of v-Jun/bzipFos heterodimers 
(compare lanes 4 & 6). Perhaps significantly, bzipFos did not disrupt the 
junTRE binding activity in normal CEFs (compare lanes 3 & 5), thereby 
supporting the proposal that normal and ASV17-transformed CEFs 
express distinct junTRE binding activities in vitro (section IV.C.3). The 
junTRE binding activities detected in normal and ASV17-transformed CEFs 
were similarly distinguished by the addition of exogenous c-Jun. Full 
length c-Jun had virtually no effect on the junTRE binding activity in 
ASV17-transformed CEFs, suggesting that c-Jun homodimers or c-Jun/v-
FIGURE 5.17A
Electrophoretic Mobility Shift analysis to investigate the effects of exogenous Jun and Fos 
proteins on the junRSRE binding activity in normal (odd numbers) and ASV17 transformed 
(even numbers) CEF extracts. 10ug of extract was incubated with approximately 2.5ug 
bacterially expressed protein for 15min at 30°C. 2ul ('2.0 x10^ cpm) 5' end labelled, 
double stranded oligonucleotide R (junRSRE) was added and the binding reaction 
incubated for a further 30min at 4°C. Lanes 11-13 were included as a positive control to 
monitor the intrinsic DNA binding activities of bacterially expressed Jun and bzip-c-Fos to 
an end labelled collagenase TRE probe.
The binding reactions were resolved on a 4% non-denaturing polyacrylamide gel at 4°C. 
The RSRE specific binding activity is denoted by a red arrowhead; the bzipFos/c-Jun 
colTRE binding activity by a green arrowhead; and the c-Jun colTRE binding activity by a 
black arrowhead.
A table identifying the exogenous proteins added per lane is located at the end of Figure 
Legend 5.17B
Electrophoretic Mobility Shift analysis to investigate the effects of exogenous Jun and Fos 
proteins on the junTRE and junRSRE binding activities in normal (odd numbers) and 
ASV17 transformed (even numbers) CEF extracts. 10ug of extract was incubated with 
approximately 2.5ug bacterially expressed protein for 15min at 30°C. 2ul (-2.0 x105 
cpm) of 5' end labelled, double stranded oligonucleotide L (junTRE + junRSRE) was 
added and the binding reaction incubated for a further 30min at 4°C. Lanes 11-13 were 
included as a positive control to confirm the DNA binding activities of bacterially expressed 
c-Jun and bzipFos on the collagenase TRE. The binding reactions were resolved on a 4% 
non-denaturing polyacrylamide gel at 4°C. The junTRE specific binding activity is denoted 
by a blue arrowhead; the RSRE specific binding activity by a red arrowhead; the c- 
Jun/bzipFos binding activity by a green arrowhead; the c-Jun binding activity by a black 
arrowhead; and the putative bzip c-Fos/v-Jun binding activity by a brown arrowhead.
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Jun heterodimers have little or no affinity for the junTRE binding site in vitro 
(compare lanes 4 & 8). The corresponding activity in normal CEFs was 
enhanced in the presence of exogenous c-Jun protein, at the expense of 
the junRSRE binding complex (compare lanes 3 & 7). This, together with 
the differential affinities of Jun homodimers and Jun/Fos heterodimers for 
the junTRE, supported the hypothesis that titration of a Fos/FRA- 
accessory protein was both disrupting the integrity of the junRSRE protein 
complex and inducing a concomitant increase in junTRE binding activity 
through the formation of c-Jun/Fos-FRA heterodimers.
Co-additions of c-Jun and bzipFos confirmed these observations. The 
exogenous proteins induced a disruption of junTRE binding activity in 
normal and ASV17-transformed extracts, and the appearance of junTRE- 
bound c-Jun/bzipFos heterodimers (compare lanes 9 & 10 with lane 11). 
The normal junTRE binding activity was less affected by the exogenous c- 
Jun and bzipFos proteins, presumably due to the presence of non-c-Jun- 
containing complexes with a strong affinity for the junTRE binding site 
(Figure 5.14B). The appearance of the c-Jun/bzipFos heterodimer also 
induced a concomitant displacement of the junRSRE binding complex in 
normal CEFs. The displacement could be the consequence of mutually 
exclusive binding on the combined junTRE/junRSRE-containing 
oligonucleotide and/or the titration of a Fos/FRA junRSRF accessory 
protein by excess full length c-Jun. The absence of c-Jun/Fos-FRA 
heterodimers at the junTRE (compare lanes 7 & 9) presumably indicates 
their lower affinity for the junTRE relative to c-Jun/bzipFos heterodimers, 
but does not distinguish between the displacement and titration 
hypotheses.
These results demonstrated the dual effects of exogenous c-Jun and 
bzipFos on the adjacent junTRE and junRSRE binding activities in normal 
CEFs. The relative contribution made by the displacement of junTRE-
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bound endogenous factors and the Jun-mediated titration of Fos/FRA 
junRSRF accessory factors to the integrity of the junRSRE protein complex 
was not addressed. The enhanced junTRE binding activity in the presence 
of full length c-Jun strongly supported the formation of c-Jun/Fos-FRA 
heterodimers through Jun-mediated titration of junRSRF accessory 
proteins. However, the negative results obtained using a minimal 
junRSRE-containing oligonucleotide did not favour this interpretation, and 
suggested that Jun-mediated titration was ineffective in the absence of 
mutually exclusive binding.
V.D. FUNCTIONAL ANALYSIS OF THE c-jun PROMOTER
To further investigate the role of the c-jun promoter in the down-regulation 
of c-jun expression, c-jun promoter sequences were linked to the 
chloramphenicol acetyl transferase (CAT) gene and analysed for functional 
activity using a transient CAT expression assay (Figure 5.18B).
V.D.1. VARIABILITY IN TRANSIENT CAT EXPRESSION ASSAYS
The variability of results obtained in transient CAT expression assays is 
mainly due to the efficiency with which plasmid DNA is introduced into the 
cell. To minimize the internal variation of transient transfection assays and 
to maximize the transfection efficiency, various approaches were taken.
FIGURE 5.18A
Western Blot analysis of c-Jun and v-Jun expressing cells to establish the 
status of exogenous and endogenous Jun expression. PC-1 and PV-2 
were derived from first round soft agar colonies of PC/SFCV and PV/SFCV 
transfected CEFs (Figure 3.13A). Virus particles were collected from PC 
and PV single cell colonies and used to re-infect primary CEFs. The cells 
were expanded and selected in G418 over five successive passages. 
CEFs and ASV17 transformed CEFs were harvested at an equivalent 
passage for the analysis. Remaining cells were frozen in separate vials at 
-70°C for use in subsequent CAT transfections (Figure 5.19 & 5.20). 
Approximately equal concentrations of whole cell protein extract were 
resolved on a 9% acrylamide gel and transferred to ECL nylon membrane 
using a CAM LAB Semi-Dry Blotter. The proteins were visualized by ECL 
detection with a 1:4000 dilution of 730/5. The relative positions of 
exogenous and endogenous Jun proteins are illustrated on the figure.
FIGURE 5.18B
A plasmid map to illustrate the derivation of pCATb - cJ400 which was 
used in all subsequent functional analyses of the c-jun promoter (Figures 
5.19 - 5.21). An approximately 400bp Hindlll/Sstl (Sac1) c-jun promoter 
fragment was excised from pSPT19 / Clone A (Figure 5.4), and subcloned 
into the pUCBM21 shuttle vector at the Hindlll and Sacl restriction sites in 
the poly linker (Boehringer Mannheim). The c-jun promoter fragment was 
re-excised as an ~400bp Hindlll/Xbal fragment, and inserted into pCAT - 
Basic at the Hindlll and Xbal poly linker restriction sites, in the sense 
orientation.
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42kD
^ p 6 8  gag c-Jun 
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- Cell Culture and Transfection Conditions
Experience has shown that cell culture and transfection conditions are 
major contributers to variability in transient expression experiments. To 
reduce the former source of variability between independent transfections, 
primary CEFs were plated at low density on 60mm dishes to ensure 
healthy growth and optimum expression of introduced plasmid sequences. 
Normal cells were derived from a single pooled batch of chicken embryos. 
c-Jun- and v-Jun-transformed cultures were derived from primary CEFs 
infected with virus particles harvested from expanded PC/SFCV or 
PV/SFCV soft agar colonies (section II.A.3b). Virus spread was monitored 
by western blot analysis and G418 selection. Each culture was expanded 
through the same number of passages, and frozen down in multiple 
aliquots for subsequent transfection. These cell cultures were plated out at 
the same density as normal CEFs and transfected under identical culture 
conditions (section II.D5a).
To maximize transfection efficiency, DOTAP, a commercial transfection 
reagent was used which delivers DNA into the cell by liposome-mediated 
fusion. DOTAP forms cationic liposomes in aqueous solution that interact 
spontaneously with DNA and fuse with the cell membrane. This method of 
DNA transfer is very gentle. It avoids cytotoxic effects and enables cells to 
be transfected with high efficiency. Variability between different
DNA/DOTAP preparations was reduced by performing each transfection in 
triplicate and repeating each set of transfections on three separate 
occasions. Triplicates were transfected with DNA/DOTAP solutions, made 
up using the same reagents but mixed separately. Each dish was treated 
as an independent experimental observation. To compare the expression 
of a reporter plasmid in different cell backgrounds, DNA/DOTAP 
preparations were expanded appropriately and divided equally between
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cultures of different cell types. Each preparation was assumed to 
represent, as far as possible, an identical transfection carried out on non­
identical cell types.
Different plasmid DNA preparations were obtained by alkali lysis and 
caesium gradient centrifugation (section II.B.6). The DNA was dialysed 
and the concentration checked by OD2 6 O anc* 0^280 measurements. A 
constant total amount of DNA (Table 5.A) was added to a fixed number of 
plated cells in each transfection. The c-jun promoter-CAT construct 
represented 3ug of the final concentration of DNA. When required, the 
amount of DNA per transfection was equilibrated to 6ug (or 7ug) per 200ul 
using PAT plasmid DNA, as PAT vector sequences are contained within 
the c-jun promoter-CAT reporter construct (Figure 5.18B). The quantities 
of plasmid DNAs in micrograms added per transfection are outlined in 
Table 5.A
- Hirts Supernatants
Hirts supernatants provide a simple assay to quantify the uptake of plasmid 
DNA in different cell types. Chromosomal and plasmid DNA is extracted 
from nuclear cell pellets and digested with an appropriate restriction 
enzyme for Southern Blotting analysis. The blots are probed for the 
presence of plasmid sequences and autoradiographs quantified by 
densitometric scanning. Hirts supernatants were used to control for DNA 
uptake in a series of transient transfection assays designed to compare the 
activity of a single reporter plasmid in different cell backgrounds (section 
V.D.2a). Each supernatant represented the contents of a single 60mm 
dish. To compare the transfection efficiency between different cell types, 
it was necessary to assume the same number of cells in each dish. This 
was not achievable as each cell type exhibited an independent growth rate,
TABLE 5.A
Details of each transient transfection assay are outlined in tables 1 and 2. 
Single transfections (Table 1) were performed in different c-Jun and v-Jun 
expressing cell backgrounds (Figure 5.18 & 5.19). Assay 1 represents the 
test tranfection; assay 2, the negative control; and assay 3, the positive 
control.
Double transfections (Table 2) were performed in normal CEFs. The test 
reporter (pCATb-cJ-400) or the negative control (pCAT-Basic) were 
transfected in the absence (assays 1 & 4) or presence of the B-gal control 
reporter, pHSV-B-gal, (assays 2 & 5) and one of a panel of c-Jun or v-Jun 
expressor plasmids, pRc/RSV VJ-0/ VJ-1/ CJ-3 (assay 3 & 6). The B- 
galactosidase activity was unaffected by the presence of the pCAT-Basic 
plasmid sequences (data not shown). Consequently, the results outlined 
in Figure 5.21 and Table 5.C represent double transfections corresponding 
to assay types 4, 5 & 6.
All transfections were performed as described in section II.D.5.
TABLE 5.B
Results of the statistical "t test". Test results were expressed as a 
proportion of the control (CEF) mean for each assay. Single transient 
transfection assays were performed in different cell backgrounds to 
compare the functional activity of a c-jun promoter fragment (pCATb-cJ- 
400) in normal CEFs and in CEFs expressing high levels of c-Jun (PC-1) 
or v-Jun (PV-2 & ASV17). proteins. The assays were repeated three times 
in exponential (Table 1) and serum stimulated (Table 2) cells. Each 
transfection was performed in triplicate. Results from triplicate assays 
were pooled for each cell background and the 95% Confidence Intervals 
calculated.
TABLE 5.C
Mean (p) and Standard Deviations (a) for CAT (Bold Figures) and B- 
galactosidase (Light Figures) activities in CEFs co-transfected with 
pCATb-cJ400 and pHSV-B-gal, and a panel of c-Jun and v-Jun 
expressing plasmids (Table 5.A). The values represent the mean and 
Standard Deviation of three dishes within the same experiment. The 
experiment was repeated three times with different concentrations of c-Jun 
and v-Jun expressing plasmids. The results in Table 5.C are illustrated in 
Figure 5.21. Figures 5.21 A and 5.21 B illustrate the mean enzyme activites 
displayed in tables 1 and 2 respectively. The numbers on the bar charts 
correspond to the dish numbers shown in each table.
TABLE 5.A
(1)
-------------------------------------------------  SINGLE
TRANSFECTIONS
1 2
DNA (ug)
pCATb-cJ-400 3.0
pCAT Basic 3.0
PAT (carrier) 3.0 3.0
GAL4 CAT 
GAL4VP16
(2)
DOUBLE TRANSFECTIONS
DNA (ug)
pCATb- 3.0 3.0
cJ-400
pCAT 3.0 3.0 3.0
Basic
PAT 4.0 2.0 4.0 2.0
(carrier)
pHSV - 2.0 2.0 2.0
pgal
pRc/RSV 2.0
plasmids
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but the transient nature of the assay, together with the inefficiency of DNA 
uptake, made large fluctuations in cell numbers unlikely and small 
fluctuations relatively insignificant.
Internal Standard?
CAT expression assays enable the activity of any given promoter to be 
quantified under different conditions. To investigate whether fluctuations in 
CAT activity are a direct consequence of a specific gene promoter or due 
to a more general effect, an unrelated promoter is commonly included in 
the transient expression assay as an internal standard. pHSV-Bgal was 
chosen as the internal standard for the transient expression assays 
described in section V.D.2b. pHSV-Bgal expresses the lacZ gene, 
encoding B-galactosidase, from the HSV-2 IE-5 gene promoter (Figure 
2.2) and was kindly provided by J. O'Prey.
V.D.2. EXPERIMENTAL PROCEDURE
Two alternative approaches to the CAT expression assay were used to 
determine whether overexpression of c-Jun of v-Jun would perurb the 
function of the c-jun promoter.
V.D.2a Transfection into Different Cell Backgrounds
In the first approach a c-jun promoter-CAT construct (pCATb-cJ-400) was 
transfected into different c-Jun- and v-Jun-overexpressing cells, to 
examine their effects on the functional activity of a c-jun promoter 
fragment. The reporter plasmid was constructed from the avian genomic
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c-jun clone and included those sequences approximately 400bp 
downstream of the 5' Hindlll cloning site. The fragment was subcloned 
into the commercially available pCAT-Basic plasmid as described in Figure 
5.18B. The c-Jun- and v-Jun-overexpressing cells were derived from 
ASV17-transformed CEFs, or from PC/SFCV and PV/SFCV virally- 
infected CEFs. Viral infections were monitored by G418 selection, and the 
levels of exogenous and endogenous Jun protein expression quantified by 
western blot analysis. In accordance with previous results, c-Jun- and v- 
Jun-overexpressing CEFs expressed undetectable levels of endogenous 
p39 c-Jun (Figure 5.18A).
Jun-overexpressing and normal CEFs were transfected with pCATb-cJ- 
400, and grown under normal growth conditions for 48hrs as described in 
section II.D.5a. A parallel series of dishes was serum deprived and then 
serum stimulated for 30mins to investigate the effect of high c-Jun and v- 
Jun expression on a serum-induced c-jun promoter fragment. Negative 
and positive controls were provided by an empty pCAT-Basic vector and a 
co-transfection with Gal4/CAT and Gal4A/P16, respectively. Gal4/VP16 
encodes a strong transactivator domain that activates CAT expression 
through the Gal4 DNA binding site (Cousens et al, 89; Lillie et al, 89; 
Sadowski et al, 89). Details of each transfection are presented in Table 
5A.
Hirts supernatants were performed on the pCATb-cJ-400 transfections to 
control for DNA uptake. The CAT activities were adjusted accordingly, 
and expressed as a proportion of the mean of the normal CEF activity in 
each transfection. Expressing the results in this way enabled the level of 
CAT activity in c-Jun- and v-Jun-overexpressing CEFs and normal CEFs to 
be compared directly over three independent transient expression assays. 
Nine observations were obtained for each cell background as each 
transfection was performed in triplicate. The observations were analysed
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by a statisitical "t-test" to determine their significance in relation to the 
normal mean.
V.D.2b Co-Transfections into Primary CEFs
As an alternative approach to investigating the effects of c-Jun and v-Jun 
on the functional activity of the c-jun promoter, primary CEFs were co­
transfected with equal molar ratios of pCATb-cJ-400 and c-Jun- or v-Jun- 
overexpressing plasmids. The expression plasmids were kindly provided 
by Dr I. Morgan and are described in detail in Figure 5.20 The advantage 
of this system is that it provides a direct correlation between c-Jun and v- 
Jun overexpression and the activity of the c-jun promoter, in the absence 
of any contributing cell-type-specific factors. Its main disadvantage is an 
inability to curb exogenous protein expression to within physiological 
levels. Consequently, transient expression results can be distorted by 
non-specific effects such as squelching.
Co-transfections were performed with pHSV-Bgal as an internal 
comparison for c-jun promoter activity. The assay for B-galactosidase 
activity relies on the enzymatic cleavage of o-nitrophenyl-B- 
galactopyranoside to o-nitrophenol which is yellow in colour and can be 
quantified spectrophotometrically at 420nm. Interpretation of these results 
assumes that the molar ratio of lac Z and pCATb-cJ-400 available for 
expression is the same in parallel transfections of normal CEFs. On the 
basis of this assumption, trends in CAT and B-galactosidase activity were 
compared in each transfection and used to determine the specificity of the 
c-Jun- and v-Jun-dependent effects on the functional activity of the c-jun 
promoter.
FIGURE 5.20
A plasmid map to illustrate the structure of the pRc/RSV - c-Jun and v-Jun 
expressing plasmids (Dr I.M. Morgan). pRc/RSV CJ-3 was obtained by 
cloning the Xba1 insert of RCAS-CJ-3 (Bos 90) into pRc/RSV at the Xbal 
cloning site; pRc/RSV VJ-0 by cloning the Hindlll/Xbal insert of RCAS-VJ- 
0 (Bos et al, 90) into pRc/RSV at the Hindlll and Xbal sites; and pRc/RSV 
CJ-1 by excising the Clal insert of RCAS-VJ-1 (Bos et al, 90), converting 
the Clal sites to Xbal sites and cloning the Xbal fragment into pRc/RSV at 
the Xbal cloning site. Details of the RCAS adaptor plasmid are outlined 
according to Bos et al.
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V.D.3. RESULTS
V.D.3a Transfections into Different Cell Backgrounds
As shown in Figure 5.19, the CAT activity of pCATb-cJ-400 was severely 
depressed in c-Jun- and v-Jun-overexpressing CEFs. The individual bars 
represent the mean value for three independent observations, corrected 
for plasmid DNA uptake from Hirts supernatants. The repression was 
specifically directed at the c-jun promoter sequences as transfections with 
the pCAT-Basic plasmid alone produced low background levels of CAT 
activity throughout. This contrasted with the consistently high levels of 
CAT activity exhibited by co-transfections of Gal4/VP16 and Gal4/CAT, 
and indicated that gene repression was not a general feature of c-Jun- and 
v-Jun-overexpressing cells.
To determine the significance of c-Jun- and v-Jun-dependent repression of 
the c-jun promoter, CAT activities were grouped according to cell type, 
and expressed as a proportion of the mean activity found in normal CEFs 
(Table 5.B). The true mean value was calculated within 95% confidence 
intervals for each group of nine observations using a statisitical "t-test". 
True means of greater than 1.0 indicate a significant elevation in CAT 
activity relative to normal cells, whereas true mean values of less than 1.0 
indicate the reverse. As shown in Table 5.B, values of less than 1.0 were 
calculated for each cell type under both growth conditions analysed. From 
this it was concluded that the observed repression of the c-jun promoter, 
in the presence of high levels of c-Jun or v-Jun protein, was statistically 
significant within a 95% confidence interval.
FIGURE 5.19
Panels A. B & C:
Autoradiographs of typical TLC plates used for measuring CAT activity of 
pCATb - cJ400 (panel A), pCAT - Basic (negative control; panel C), and 
Gal4/CAT + Gal4A/P16 (positive control; panel B), in independent cell 
backgrounds (Figure 5.18A).
A "Hirts" analysis of genomic DNA, isolated from pCATb-cJ400 
transfected cells, is illustrated directly below panel A. Each lane 
represents the contents of a single 60mm tissue culture dish. The DNA 
was extracted and digested in the presence of Hindlll and Xbal to release 
~ 4360bp pCAT - Basic plasmid vector sequences (denoted by a blue 
arrowhead). The samples were resolved on a 1% agarose gel with 
Bacteriophage X (Hindlll digested) markers (left hand lane). The Southern 
Blot was probed against a random primed oligolabelled pCAT - Basic 
probe linearized with Xbal. Lanes 1-12 on the Southern Blot correspond to 
Lanes 1 -12 on the pCATb - cJ400 TLC plate.
Panel D:
Expression of pCATb-cJ400 in separate c-Jun and v-Jun expressing cell 
backgrounds. Each value represents a mean of three dishes within the 
same experiment. The experiment was performed three times with similar 
results. The CAT activity is expressed relative to a negative control 
representing parallel transient transfections in the presence of the 
promoterless pCAT - Basic vector sequences. The mean values were 
derived from the experiment described above in panels A and B.
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TABLE 5.B
(1)
-  Test Activity as a Proportion of the Control (CEF) Mean -
Single Transfections: ASV17 PC-1 PV-2
Assay
1 0.051 0.018 0.009
0.018 0.056 0.04
0.05 0.02 0.032
2 0.037 0.023 0.043
0.036 0.047 0.029
0.028 0.127
3 0.336 0.041 0.085
0.058 0.052 0.108
0.076 0.031 0.119
95% Confidence •0.004 • 0.1695 0.02413 - 0.04610 0.0318 - 0.0998
Interval
(2)
-- Test Activity as a Proportion of the Control (CEF)
Mean -
Single Transfections: ASV17 PC-1 PV-2
Assay
1 0.093 0.8 0.211
0.121 0.051 0.110
0.89 0.174 0.047
2 0.017 0.076 0.115
0.090 0.050 0.132
0.024 0.056 0.078
3 0.024 0.042 0.069
0.069 0.033 0.052
0.044 0.070
95% Confidence -0.0620 - 0.3669 -0.0591 - 0.3796 0.0495 - 0.1047
Interval
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V.D.3b Co-Transfecions
Co-transfections of pCATb-cJ-400 and pCAT-Basic with c-Jun and v-Jun 
expression plasmids also led to a c-Jun- and v-Jun-dependent repression 
of CAT activity, although in this case parallel transfections using pHSV-B 
gal revealed a similar trend in the levels of B-galactosidase activity (Figure 
5.21; Table 5.C). The expression of B-galactosidase is driven by the 
HSV-2 IE-5 gene promoter in the pHSV-Bgal reporter plasmid. The HSV-2 
IE-5 gene promoter contains no recognizable AP-1 DNA binding sites, 
suggesting that c-Jun- and v-Jun-associated repression of B-galactosidase 
activity, was mediated through an indirect effect (Gaffney et al, 85). 
Indirect repression is dependent on high levels of protein expression 
(section I.B.6b). To investigate whether the Jun associated repression of 
the HSV-2 IE-5 gene promoter was a titratable activity, and distinct from 
that mediating the repression of the c-jun promoter, co-tranfections were 
repeated with 0.1 x and 0.05x dilutions of the c-Jun and v-Jun expression 
plasmids. As shown in Figure 5.21, the titration failed to completely 
abolish the repression of either enzyme activity. Under these conditions, 
the trends in CAT and B-galactosidase activity were virtually identical, 
indicating that Jun-mediated repression of the c-jun and the HSV-2 IE-5 
gene promoters was not represented by two seperable activities at these 
c-Jun and v-Jun concentrations.
FIGURE 5.21
Transcriptional repression of c-jun (pCATb-cJ400) and HSV-IE5 (pHSV-B 
gal) promoters in the presence of high levels of exogenous c-Jun and v- 
Jun proteins. Parallel trends in activity were observed in the presence of 
2ug (panel A: lanes 3-6), 0.2ug (panel B: lanes 3-6) and 0.1 ug (panel B: 
lanes 7-10) of pRc/RSV c-Jun and v-Jun expressing plasmids (Figure 
5.20). The values represent a mean of three independent dishes within 
the same experiment. The experiment was performed three times using 
different concentrations of pRc/RSV plasmids.
Panel A:
Lane Reporter Plasmid c-Jun I v-Jun
pCATb-cJ400 pHSV-Bgal Expressing Plasmid
1 +
2 + +
3 + + pRc/RSV
4 + + pRc/RSV VJ-0
5 + + pRc/RSV VJ-1
6 + + pRc/RSV CJ-3
Panel B: Transient transfections were carried out as above using 0.2ug 
(lanes 3-6) or 0.1 ug (lanes 7-10) of pRc/RSV expression plasmids. 
Otherwise lanes 3-6 in panel A correspond to lanes 3-6 and lanes 7-10 of 
panel B.
% 
C
A
T 
C
o
n
v
e
rs
io
n
 
% 
C
A
T 
C
o
n
v
e
rs
io
n
A
C A T  A C T IV IT Y
1 2 3 4 5 6
C A T  A C T IV IT Y
1 2 3 4 5 6 7 8 9  10
B -g a l  A C T IV IT Y
E
c
o
CM
0)
o
ccc-Q
o
C /5
n
<
1 2 3 4 5 6
£c
o
CM
Q)
o
cre
o
(/)-Q
<
1 2 3 4 5 6 7 8 9  10
B -g a l  A C T IV IT Y
FIGURE 5.21
TABLE 5.C
(I)
>ISH REPORTER PLASMID EXPRESSION p Enzyme Activity Z Enzyme Activity
pCATb-cJ400 pHSV-(3gal PLASMID CAT (3-gal CAT |3-gal
(% conv) (A420nm) (%conv) (A420nm)
1 + . 38.50 2.30 3.81 0.040
2 + + - 27.40 1.36 1.68 0.063
3 + + pRc/RSV (xl) 25.30 0.87 3.32 0.064
4 + + VJ-0 (xl) 8.89 0.47 0.78 0.019
5 + + VJ-1 (xl) 5.29 0.19 0.78 0.003
6 + + CJ-3 (xl) 5.09 0.24 0.12 0.032
(2)
)ISH REPORTER PLASMID EXPRESSION p Enzyme Activity a Enzyme Activity
pCATb-cJ400 pHSV-(3gal PLASMID CAT (3-gal CAT (3-gal
(% conv) (A420nm) (%conv) (A420nm)
1 + 24.20 1.76 1.51 0.136
2 + + - 7.71 0.38 0.10 0.048
3 + + pRc/RSV (x 0.1) 9.29 0.47 0.78 0.065
4 + + VJ-0 (x 0.1) 5.33 0.24 0.17 0.009
5 + + VJ-1 (x 0.1) 2.37 0.10 0.32 0.008
6 + + CJ-3 (x 0.1) 3.50 0.14 0.90 0.023
7 + + pRc/RSV (x 0.05) 5.65 0.43 0.14 0.032
8 + + VJ-0 (x 0.05) 12.00 0.54 0.082 0.061
9 + + VJ-1 (x 0.05) 5.09 0.30 1.00 0.024
10 + + CJ-3 (x 0.05) 8.48 0.51 1.24 0.041
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CHAPTER VI - DISCUSSION 
FUNCTIONAL ANALYSIS OF THE c-JUN PROMOTER
VI.A. c-JUN AUTO-REPRESSION IS MEDIATED PRIMARILY 
AT THE LEVEL OF TRANSCRIPTION
The auto-repressing properties of c-Jun and v-Jun were initially inferred 
from the dramatic down-regulation of endogenous c-Jun protein in c-Jun- 
and v-Jun-overexpressing CEFs (Figure 3.13A). RNase protection 
analysis demonstrated that v-Jun auto-repression was primarily directed at 
the level of transcription (Figure 5.1). c-jun mRNA levels are controlled by 
both transcriptional and post-transcriptional regulatory mechanisms 
(section IV.A.1). The precise contribution made by post-transcriptional 
regulation was not investigated, but run-off analysis was performed to 
examine the effect of v-Jun on the rate of endogenous c-jun expression. 
The sensitivity of the run-off assay was hampered by weak hybridization, 
due to the short length of the c-jun-specific probe (c-jun(1)), but clearly 
showed that a significant proportion of v-Jun-dependent auto-repression 
was mediated through a down-regulation of endogenous c-jun transcription 
(Figure 5.2).
Transcriptional auto-repression has been observed for other members of 
the immediate early gene family, including c-myc and c-fos (Grignani et al, 
90; Rivera et al, 90). An additional effect of v-Jun was its concomitant 
repression of endogenous c-fos expression (Figure 5.2). The functional 
significance of this was not investigated, but it is intruiging that c-Fos is a 
major dimerization partner of c-Jun, and that both proteins have been
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implicated in the regulation of each others expression (Herr et al, 94, 
Konig etal, 89; Rivera etal, 90; section VI.E.).
VLB. REGULATORY ELEMENTS IN THE c-JUN PROMOTER
Sequence and restriction endonuclease mapping analysis identified the 
proximal promoter sequences contained within the genomic avian c-jun 
clone (Figure 5.4 & 5.5A). The region included approximately 200bp 
upstream of a putative transcriptional start site identified in an 
independently derived avian c-jun sequence (Nishimura et al, 88). A 
comparison of c-jun promoter sequences from different animal species 
revealed a remarkable degree of conservation over the proximal promoter 
region (Figure 5.8A). The homology included recognized c-jun regulatory 
elements such as the proximal junTRE and adjacent junRSRE, and 
extended over a number of previously uncharacterized sites such as the 
putative initator sequence and TATA-like box. The significance of the 
conserved sequences in the vicinity of the proximal promoter was 
supported by DNase I hypersensitive site analysis, which was performed 
as an initial step towards identifying potential regulatory sites in the c-jun 
promoter. Two sites of DNase I hypersensitivity were identified in 
chromatin prepared from c-jun-expressing, exponential CEFs (Figure 
5.7B). HS-2 was located upstream of the 5' Hindlll cloning site and may 
represent an unrelated regulatory element or a long range enhancer 
sequence. The close proximity of HS-1 to the 5' Hindlll cloning site was 
more informative and suggested that sequences in the vicinity of the 
proximal promoter may be involved in regulating c-jun transcription in 
these cells.
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VI.C. DIFFERENCES IN c-JUN PROMOTER SITE 
OCCUPANCY IN NORMAL AND ASV17-TRANSFORMED 
CEFs
Since the c-jun proximal promoter sequences exhibited a high degree of 
homology with other species, it was of interest to determine whether any 
specific changes in promoter site occupancy correlated with auto­
repression. An in vitro DNA binding analysis of independent conserved 
sequences in the c-jun promoter demonstrated that the majority were 
occupied under c-yu/7-expressing (normal CEFs) and c-yun-repressing 
(ASV17-transformed CEFs) conditions (Figure 5.8A & 5.8B). The high 
level of occupancy suggested that multiple sequence specific binding sites 
contribute to the regulation of c-jun expression and that gross changes in 
c-jun promoter site occupancy are not associated with auto-repression in 
vivo. Two exceptions to the overall pattern of binding were provided by the 
previously characterized proximal junTRE and junRSRE regulatory 
elements, which were differentially occupied depending on the 
transcriptional status of the c-jun gene.
- iunTRE Binding Activity
The junTRE binding activity in normal CEFs was represented by an 
apparently homogenous retarded band but contained only a proportion of 
c-Jun-reactive protein complexes (Figure 5.14B). This, together with the 
low proportion of Fos/FRA-containing complexes, suggested that distinct 
subsets of TRE-binding proteins recognize the junTRE and colTRE in
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normal CEFs (compare Figure 5.14B & 3.16B). Differences between 
junTRE and colTRE binding activites in vivo have been described in 
several independent reports (Herr et al, 94; Muegge et al, 93; van Dam et 
al, 93). In particular, c-Jun/ATF-2 (or ATF-2-related) heterodimers have 
been isolated from HeLa and NIH3T3 cells by their specificity for the 
proximal and distal junTRE binding sites in vitro (Herr et al, 94; van Dam 
et al, 93). c-Jun/c-Fos heterodimers express a high affinity for the colTRE 
but, in contrast to ATF-containing heterodimers, have been isolated as 
low affinity proximal junTRE binding complexes in vitro (Herr et al, 94). 
The precise composition of junTRE binding activity in normal CEFs was 
not examined but the predominant or exclusive expression of c-Jun in 
primary CEFs (Figure 3.16A), together with the ability of c-Jun to 
heterodimerize with ATF-2 and recognize CRE and CRE-related elements 
such as the junTRE (Chatton et al, 94; Hai et al, 91), strongly supports a 
contribution by ATF-2 or ATF-2-related heterodimers.
The junTRE binding activity in ASV17-transformed CEF extracts was 
quantitatively and qualitatively distinct from that of normal cells (Figure 
5.9A). Two junTRE-specific binding complexes were identified that 
resembled colTRE complexes II and III in terms of their electrophoretic 
mobility in non-denaturing acrylamide gels (compare Figure 3.15 & 5.9A). 
The electrophoretic resemblance was confirmed by antibody analysis 
which demonstrated an identical pattern of reactivity at the junTRE and 
colTRE using ASV17-transformed CEF extracts (compare Figure 3.16A & 
5.13). This observation led to the proposal that v-Jun directs the down- 
regulation or inactivation of multiple junTRE-specific proteins, and thereby 
facilitates an exclusive occupancy of junTRE binding sites with v-Jun- 
containing complexes.
The junTRE-specific binding patterns of normal and ASV17-transformed 
CEFs were confirmed by DNase I footprinting analysis of the c-jun
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promoter. The junTRE was protected from DNase I digestion using 
extracts derived from either normal or ASV17-transformed CEFs, but the 
protected sequence was more clearly defined when c-jun promoter 
fragments were incubated in the presence of normal CEF extracts (Figure 
5.9B). A relatively weak pattern of protection was observed using an 
equivalent concentration of ASV17-transformed CEF extract. The pattern 
of binding correlated with that detected by EMSA analysis, and did not 
reflect the high levels of p65 gag-v-Jun expression detected in ASV17- 
transformed CEFs (Figure 3.5). Overexpression of the v-Jun oncoprotein, 
together with the apparently exclusive presence of v-Jun-containing 
complexes at the junTRE, supports the hypothesis that v-Jun-dependent 
repression of c-jun is mediated, at least in part, by an exclusive 
replacement of endogenous junTRE binding complexes with low affinity v- 
Jun-containing alternatives.
- iunRSRE Binding Activity
A single junRSRE binding activity in normal CEFs was absent in ASV17- 
transformed cell extracts (Figure 5.1 OA). DNase I footprinting analysis with 
normal CEF extracts revealed an extended region of protection centred 
over the junRSRE and half of the adjacent junTRE binding site. A 
comparable pattern of protection was observed using ASV17-transformed 
CEF extracts (Figure 5.1 OB). This was attributed to an additional junRSRE 
binding complex detected in both cell types (Figure 5.1 OA).
The junRSRE binding activity in normal CEFs was completely disrupted by 
an antiserum raised against an RSRF family protein, RSRF-C4 (Figure 
5.14A). The RSRF transcription factors were isolated by their sequence 
homology to the SRF over the DNA binding domain, and specifically 
recognize RSRE regulatory elements in vitro and in vivo (Pollock etal, 91).
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Homology between the RSRFs and the SRF extends over a 56aa region 
described as the MADS BOX (Pollock et al 91). The MADS BOX 
characterizes all SRF and SRF-related proteins and is essential for high 
affinity DNA binding and the recruitment of accessory proteins that 
maximize the transcriptional response (Hill et al, 93; Treisman et al, 92; 
Wynne et al, 92). The recruitment domain is located at the carboxyl- 
terminus of the MADS BOX and is poorly conserved between the SRF- 
related proteins. This has led to the hypothesis that specific accessory 
factors interact with different SRF-related proteins in vivo. In support of 
this proposal the mammalian transcription factor SRF and the yeast 
regulatory protein MCM1 interact with distinct accessory factors in vivo but 
contain DNA binding domains that are 70% identical. The SRF- and 
MCM1-specific accessory factors have been proposed to influence the 
choice of binding site and thereby contribute to the related but distinct 
binding affinities of both proteins (Dalton et al, 93; Marais et al, 93; 
Pollock et al, 91; Wynne et al, 92).
Accessory protein interactions are less well defined for the RSRF 
transcription factor family. Like the SRE, the RSREs are commonly 
associated with non-related sequence-specific binding sites that contribute 
to RSRF-dependent transactivation (Flemington et al, 90; Zhu et al, 93). 
This, in addition to reports of cooperative interactions between the RSRFs 
and helix-loop-helix proteins during muscle-specific gene expression (Yu et 
al, 92; Zhu etal, 93), suggests that accessory protein interactions may be 
important regulators of RSRF function in vivo. In support of this proposal, 
characterization of the junRSRE binding activity in normal CEFs identified 
the presence of a Fos/FRA-related protein in the RSRF-containing protein 
complex (Figure 5.14A). A relationship between Fos/FRA and the RSRFs 
has not been previously reported, but interactions between monomeric 
Fos proteins and unrelated transcription factors are well documented in the
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literature (Masuda et al, 93; Stein et al, 93(i); Stein et al, 93(ii)). The 
precise nature of the putative Fos/FRA-related component was not 
investigated in this analysis. FRA2 has been identified as the most 
abundant Fos family TRE binding protein in primary CEFs (Suzuki et al, 
94), but transcriptional expression of c-fos was detected in exponential 
CEF cultures that were equivalent to those used to prepare non-denatured 
whole cell extracts for EMSA analysis (Figure 5.2). The nature of the 
Fos/FRA-related component may be important for the temporal regulation 
of jun-RSRF activity in vivo, and for the interaction between the RSRF 
protein complex and the junRSRE. c-Fos for example is rapidly and 
transiently induced in reponse to cell stimulation, whereas FRA2 exhibits 
slower and more prolonged kinetics of expression (Kovary et al, 91; 
Kovary et al, 92). Both transcription factors bind consensus TRE half sites 
in vitro, as heterodimers with the Jun proteins (Suzuki et al, 91), but their 
affinity for TRE-like varient sequences has not been determined.
VI.D. c-JUN AUTO-REPRESSION CAN BE REPRODUCED IN 
FUNCTIONAL ASSAYS
Transient CAT-expression assays confirmed the auto-repressing 
properties of c-Jun and v-Jun. A proximal c-jun promoter fragment was 
dramatically and significantly down-regulated in c-Jun- and v-Jun- 
overexpressing CEFs. The repression was specific to the proximal c-jun 
promoter sequences and a direct consequence of c-Jun and v-Jun 
overexpression (Figure 5.19, Table 5.B). An equivalent response was 
obtained using c-Jun and v-Jun expression plasmids and the c-jun 
promoter-CAT construct to co-transfect normal CEF cultures (Figure 5.20
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& 5.21). However, under these conditions an unrelated promoter-CAT 
construct lacking detectable TRE binding sites was also down-regulated, 
suggesting that the repression represented a squelching artefact of non- 
physiological levels of c-Jun and v-Jun expression.
VI.E. POSSIBLE MECHANISMS OF JUN-MEDIATED AUTO­
REPRESSION
The results presented in section V.C. describe changes in occupancy at 
the junTRE and adjacent junRSRE that correlate with transcriptional 
repression of the c-jun gene. The differences in promoter site occupancy 
were observed in extracts prepared from ASV17-transformed CEFs which 
express virtually undetectable levels of endogenous c-Jun protein (Figure 
3.5). An apparently equivalent down-regulation of endogenous c-Jun was 
demonstrated in parallel cultures of high c-Jun-expressing CEFs (Figure 
3.13A), suggesting that auto-repression is a consequence of high Jun 
expression and not dependent on additional qualitative mutations in the v- 
Jun oncoprotein. The levels of p39 c-Jun detected in normal CEFs are 
consistently lower than those of exogenous p65 gag-v-Jun in ASV17- 
transformed cells (Figure 3.3A). This, together with a mechanism of 
quantitative auto-repression, may provide an explanation for the relatively 
slow decline in c-jun mRNA following serum stimulation and the 
persistence of c-jun mRNA in serum deprived CEFs compared to their v- 
Jun-transformed counterparts (Figure 5.1).
Two mechanisms are described below that could account for concentration 
dependent auto-repression of the c-jun gene.
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- Mutually Exclusive Binding to Adjacent Regulatory Elements
In vitro DNA binding and cross-competition analysis suggested that the 
junTRE and junRSRE regulatory elements in the c-jun promoter were not 
simultaneously occupied in normal CEFs (Figure 5.11 & 5.12). A pattern of 
mutually exclusive binding was supported by the converse effects of 
exogenous c-Jun and bzipFos on junTRE and junRSRE binding in vitro. 
The junRSRE binding activity was completely disrupted in the presence of 
c-Jun and bzipFos whereas the binding activity to the junTRE was 
markedly enhanced (Figure 5.17B). A parallel effect was not observed 
using a minimal junRSRE-containing oligonucleotide, suggesting that the 
junTRE binding site is required for the displacement but not the binding of 
the junRSRE-specific protein complex (Figure 5.17A).
Mutually exclusive patterns of DNA binding are commonly associated with 
gene regulation in vivo. They function as a concentration-dependent 
switch between transcriptional induction and repression and often control 
opposing physiological mechanisms such as differentiation and 
proliferation. Expression of the osteocalcin gene, for example, triggers 
the onset of osteoblast differentiation, and is regulated by the mutually 
exclusive binding of Vitamin D3 and Jun/AP-1. A hormone reponse 
element within the osteocalcin gene promoter presents overlapping binding 
sites for Vitamin D3 and Jun/AP-1, which independently activate and 
repress osteocalcin gene expression respectively, depending on the 
relative concentrations of each within differentiating and proliferating cells 
(Owen etal, 90; Schule etal, 90(i».
The pattern of binding at the junTRE and junRSRE was unlike that of the 
osteocalcin gene promoter in that both complexes were present, and 
capable of binding to the c-jun promoter, in normal, exponentially growing 
CEFs (Figure 5.11 A), c-jun mRNA was detected under these conditions of
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growth (Figure 5.1), suggesting that a dual pattern occupancy, at the 
junTRE and junRSRE binding sites, is compatible with c-jun expression in 
vivo. A single pattern of occupancy was observed in ASV17-transformed 
CEFs (Figure 5.12). The absence of junRSRE binding, correlated with a 
dramatic down-regulation of c-jun mRNA (Figure 5.1). These observations 
have led to the proposal that c-jun expression is regulated by the balance 
of occupancy at the junTRE and junRSRE binding sites, with the absolute 
levels of c-jun expression reflecting the amount of junRSRE binding activity 
present within the cell. If only one site can be occupied at any one time 
then it must be presumed that different cells within a culture are either 
occupied at the junTRE or at the junRSRE. This, together with the 
asynchronous growth of exponential cultures suggests that there may be 
heterogeneity of occupancy at the junTRE and junRSRE that is possibly 
regulated during the cell cycle.
Exclusive occupancy of the junTRE was characteristic of ASV17- 
transformed CEFs. The pattern correlated with repression of endogenous 
c-jun and may represent an extreme consequence of mutually exclusive 
binding not observed in normal asynchronous cultures. Expression of an 
RSRF-related protein was unaffected in ASV17-transformed CEFs (Figure 
5.15). The same antiserum recognized the junRSRE binding complex in 
normal CEFs (Figure 5.14A), suggesting that v-Jun down-regulates c-jun 
expression through a physical inhibition of the junRSRF DNA binding 
activity.
Competitive binding at the junTRE and junRSRE regulatory elements 
would support this hypothesis. The competitive model proposes that high 
levels of the v-Jun oncoprotein facilitate exclusive junTRE occupancy in 
ASV17-transformed CEFs, that physically inhibits binding to the adjacent 
junRSRE and thereby down-regulates c-jun expression. The model is 
complicated by the composition of junTRE binding complexes in normal
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and ASV17-transformed cells. Only a proportion of the junTRE binding 
activity in normal cells was recognized by c-Jun-specific antisera (Figure 
5.14B). The junTRE binding activity in ASV17-transtormed CEF extracts, 
in contrast, was virtually entirely composed of v-Jun-containing complexes 
(Figure 5.13). These observations have led to the proposal that one 
consequence of v-Jun overexpression is the replacement of endogenous 
junTRE binding complexes with v-Jun-containing alternatives. Qualitative 
differences in junTRE binding activity may simply facilitate mutually 
exclusive binding in vivo. Alternatively they may express more active 
functions that contribute to the autoregulatory properties of the v-Jun 
oncoprotein.
- Sequestration
An alternative model for Jun-mediated auto-repression favours a Jun- 
specific disruption of junRSRE binding activity in vivo. The model 
proposes that high levels of v-Jun (or c-Jun) sequester a factor required for 
the formation of the junRSRE binding complex. Jun-specific sequestration 
would provide an explanation for the dramatic down-regulation of 
endogenous c-Jun protein in c-Jun- and v-Jun-expressing cells (Figure 
3.13A) in spite of the high and equivalent levels of RSRF protein detected 
in both cell types (Figure 5.15), and the qualitatively distinct junTRE 
binding activities exhibited by normal (c-Jun-expressing) and ASV17- 
transformed (v-Jun-expressing) CEFs (Figure 5.9A).
Previous reports have identified the importance of a functional leucine 
zipper domain for c-Jun-dependent auto-repression in vivo (Castellazzi et 
al, 91). A leucine zipper-dependent interaction has not been reported 
between c-Jun and the RSRF proteins, but is widely recognized to 
mediate heterodimerization between the Jun and Fos transcription factor
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families (Ransome etal, 89). A Fos/FRA-related component was identified 
within the junRSRE-specific RSRF complex in normal CEFs (Figure 
5.13A). If this component was essential for optimal DNA binding activity of 
the RSRF proteins on the junRSRE, its sequestration through specific 
dimerization with excess v-Jun (or c-Jun) could effectively weaken the 
affinity of the junRSRE/RSRF interaction and thereby displace the RSRF- 
containing protein complex.
Addition of exogenous c-Jun to the in vitro DNA binding reactions 
effectively supported this hypothesis. The addition induced a displacement 
of junRSRE binding activity that was accompanied by a concomitant 
enhancement in junTRE binding. The elevated junTRE binding activity was 
attributed to the appearance of a novel Jun-Fos/FRA heterodimer due to a 
Jun-dependent sequestration of RSRF-specific Fos/FRA-related accessory 
factors. A contribution from exogenous c-Jun homodimers was excluded 
as a parallel effect at the junTRE was not observed using ASV17- 
transformed CEF extracts (Figure 5.17B). Addition of exogenous bzipFos 
failed to disrupt the integrity of the junRSRE binding activity in vitro. This 
was presumably due to the inability of Fos transcription factors to 
homodimerize and was used as further evidence to support the existence 
of a Fos/FRA-related RSRF-accessory factor. Exogenous v-Jun was not 
included in the analysis but was predicted to induce an equivalent 
disruption of junRSRE binding as v-Jun contains an identical leucine zipper 
domain to the c-Jun protein (Maki etal, 87; Nishimura etal, 88).
A role for Fos/FRA proteins in the formation of the junRSRE binding 
complex suggests a novel interactions between the Fos and RSRF protein 
families. The Fos proteins have been identified in multiple cases of 
transcriptional cross talk but are commonly associated with an additional 
Jun component in vivo. Jun proteins have been reported to directly 
displace Fos in interactions mediated through the Fos leucine zipper
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domain (Stein et al, 93(ii)), or to physically participate in the multiprotein 
complex as an AP-1 heterodimer (Boise et al, 93; Jain et al, 92; Konig et 
al, 89; Masuda et al, 93; Wang et al, 94). The proposed interaction 
between the junRSRF and a Fos/FRA-related protein did not involve an 
additional Jun component (Figure 5.14A). Consequently, a Fos-specific 
functional domain is presumed to direct a productive interaction in vivo. 
The contribution made by Fos/FRA DNA binding to the overall integrity of 
the junRSRE binding complex was not investigated, but the highly 
conserved spacing of junTRE and junRSRE regulatory elements in c-jun 
promoter sequences of different species suggests that additional contacts 
between Fos/FRA-related proteins and the DNA may be significant (Figure 
5.8A). The junRSRE binding activity was detected using a minimal 
junRSRE-containing oligonucleotide, spanning the entire junRSRE and 
half of the adjacent junTRE. TRE binding sites represent palindromic 
sequences of two overlapping half sites that are independently recognized 
by Jun and Fos proteins in the AP-1 heterodimer (Abate et al, 90(i); Risse 
et al, 89). Consequently, the Fos/FRA - RSRF interaction could be 
strengthened by additional contacts between the Fos/FRA-related proteins 
and the adjacent TRE half site. The displacement of junRSRE binding 
complexes by full length c-Jun protein together with the ability of c-Jun to 
contact specific bases within TRE half sites suggests that the DNA may 
provide a secondary anchoring function rather than the primary stimulus 
for the RSRF:Fos/FRA interaction. The assymetrical nature of palindromic 
TRE sequences presumably optimizes the affinity of Fos/FRA:DNA 
interactions in the presence of the complete element, and may provide an 
explanation for the low level of cooperativity between junTRE and 
junRSRE binding sites in vitro (Figure 5.11A & 5.11B).
These observations have led to the proposal that the Fos/FRA-related 
protein may be required for the formation of the junRSRE binding complex
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and that the primary interaction is strengthened by additional contacts with 
adjacent DNA sequences. A titratable Fos/FRA-related accessory factor 
would provide a Jun-sensitive switch for the regulation of c-jun expression 
and possibly contribute additional transactivation activity to the RSRF- 
related proteins, analagous to the function of Elk-1 within the SRF ternary 
complex (Hill etal, 93; Marais etal, 93).
The models outlined above provide alternative, but not necessarily 
mutually exclusive, mechanisms for the correlation between c-jun 
expression and occupancy of the junRSRE binding site that is observed in 
the absence of detectable changes in RSRF protein expression. The 
Competitive Binding Model proposes that junTRE and junRSRE binding 
factors compete for overlapping regulatory elements within the c-jun 
promoter thereby mediating a concentration-dependent switch in gene 
expression. High levels of Jun protein, for example, would direct an 
increase in junTRE binding activity and a concomitant passive 
displacement of junRSRE binding factors on the c-jun promoter (Figure 
5.22A). In the Sequestration Model for auto-repression high levels of c- 
Jun or v-Jun are proposed to actively displace junRSRE binding 
complexes through a Jun-mediated sequestration of a Fos/FRA-related 
junRSRF-accessory factor. A sequestration mechanism would be 
sensitive to the absolute levels of Jun expression and indirectly facilitate an 
exclusive pattern of occupancy at the junTRE (Figure 5.22B).
Observations such as the element of cooperativity between the junTRE 
and the junRSRE and the qualitative differences in junTRE occupancy in 
ASV17-transformed CEFs, support a mechanism of Jun-mediated auto­
repression that includes both Jun-dependent sequestration and mutually 
exclusive binding. Consequently, an alternative model has been proposed 
to account for the cumulative results presented in this report. In the
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Combined Model for auto-repression, a primary consequence of high c- 
Jun or v-Jun expression is the Jun-dependent sequestration of junRSRF- 
specific accessory factors. The concomitant displacement of junRSRE 
binding complexes from the c-jun promoter is then proposed to release the 
junTRE binding site and promote a corresponding increase in junTRE 
occupancy by cell-type-specific factors that may be significant for 
subsequent transrepression and the physical exclusion of further junRSRE 
binding activity (Figure 5.22C).
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c-jun mRNA was induced with rapid and transient kinetics in response to 
serum stimulation. The pattern of expression was characteristic of other 
immediate early genes and dependent on transcriptional and post- 
transcriptional levels of regulation. Additional translational and post- 
translational regulatory mechanisms were proposed to contribute to the 
distinct kinetics of c-Jun protein expression under these conditions. 
Expression of endogenous p39 c-Jun was dramatically and specifically 
extinguished in the presence of the v-Jun oncoprotein, irrespective of the 
growth status of the cells. Overexpression of exogenous c-Jun induced an 
equivalent response indicating that auto-repression was mediated through 
high levels of c-Jun or v-Jun expression and not dependent on additional 
qualitative mutations in the v-Jun oncoprotein. The consequences of Jun- 
mediated auto-repression for endogenous AP-1 DNA binding activity were 
directly related to the apparently exclusive expression of c-Jun in normal 
CEF cultures. The down-regulation of endogenous c-Jun in ASV17- 
transformed cells was associated with a replacement of c-Jun-containing 
AP-1 DNA binding complexes with v-Jun-containing alternatives. The 
absence of auxiliary Jun family proteins may facilitate the displacement 
and thereby contribute to the unique transforming activity of v-Jun in avian 
cells.
v-Jun-mediated auto-repression was primarily directed at the level of 
transcription. The response was reproduced by transient CAT expression 
assays which confirmed the importance of high c-Jun and v-Jun 
expression and proximal c-jun promoter sequences for functional down- 
regulation in vivo. To identify potential regulatory elements in the proximal 
c-jun promoter, specific sequences were selected on the basis of
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homology between different animal species and examined for changes in 
DNA binding activity that correlated with the down-regulation of 
endogenous c-Jun expression. A high level of promoter site occupancy 
was observed in normal c-yu/7-expressing CEFs. The overall pattern was 
unchanged in ASV17-transformed CEFs with the exception of the adjacent 
junTRE and junRSRE regulatory elements which were differentially 
occupied depending on the transcriptional status of the c-jun gene. The 
junTRE was exclusively occupied by v-Jun-containing complexes in 
ASV17-transformed CEFs. A junRSRE-binding complex was consistently 
absent in spite of high and equivalent levels of RSRF protein expression in 
normal and v-Jun transformed cells. The identification of an RSRF-related 
protein binding to the junRSRE in normal CEFs suggested that the 
exclusive pattern of occupancy in ASV17-transformed CEFs was mediated 
through a physical inhibition or disruption of junRSRE binding activity. 
Mutually exclusive binding or a Jun-mediated sequestration of RSRF- 
specific accessory factors were proposed as possible explanations for the 
absence of junRSRE binding activity in ASV17-transformed cells. The 
identification of a Fos/FRA-related protein in the RSRF-related protein 
complex supported the requirement for accessory factor interactions that 
could be disrupted by high levels of c-Jun or v-Jun. The competitive 
pattern of binding at the junTRE and junRSRE together with the qualitative 
differences in junTRE binding complexes in ASV17-transformed cells, 
suggested that both mechanisms may be important for the physical 
disruption of junRSRE binding activity in vivo and the concomitant 
transrepression of the c-jun gene.
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Amendment To Chapter VI
During the oral examination of this thesis some discrepancies were raised 
between the in vivo footprinting data and the in vitro gel shift analysis that will 
be addressed in more detail here.
In particular, a junRSRE-specific complex was identified by gel retard 
analysis that was common to both normal and ASV17-transformed CEF 
extracts (Figure 5.10). DNase 1 footprinting analysis over the junRSRE 
regulatory element corroborated the in vitro data and indicated that the 
junRSRE was occupied under both c-jun expressing (normal) and c-jun 
repressing (ASV17-transformed) conditions. In addition, it was suggested 
that the upper junRSRE-specific protein complex actually represented a 
doublet that was both Fos- (upper band) and FRA2- (lower band) reactive 
(Figure 5.14). Neither complex was considered completely absent from 
extracts prepared from ASV17-transformed CEFs (Figure 5.10).
In the light of these observations the models proposed in the final chapter of 
this thesis cannot be considered, and indeed were never intended, as 
absolute explanations of the data. They do not account for the presence of a 
junRSRE-specific complex under c-jun repressing conditions, or the 
quantitative differences in junTRE binding activity between normal and 
ASV17-transformed CEF extracts (Figure 5.9). In addition, the sequestration 
model for Jun-mediated auto-repression was primarily based on experiments 
using high concentrations of bacterially expressed, and therefore unmodified, 
c-Jun to disrupt junRSRE-specific binding complexes in vitro (Figure 5.17). 
Consequently, the models can only be considered as hypothetical proposals 
that may account for some, but not all, of the in vitro observations. Their 
relevance in vivo remains to be addressed through functional assays such as 
the CAT expression assays described in chapter V.D.
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